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i 
Abstract 
Herpesviruses are ubiquitous and are found worldwide, most 
animal species can be infected with multiple herpesviruses. 
Some cause clinical disease and others remain symptomatic 
throughout life. Herpesviruses are found in both captive and 
wild animals including Asian elephants (Elephas maximus).  
 
Elephant Endothelioltropic Herpesvirus (EEHV) has been 
reported in both captive and wild Asian elephants, with a 
number of cases being reported in North America, Europe and 
Asia. It has been suggested that EEHV is associated with 
haemorrhagic disease, which has been attributed to a number 
of Asian elephant deaths, affecting mostly juveniles and 
calves. Clinical signs can vary from weight loss, lethargy, 
depression, cyanosis of the tongue and sudden death. 
Molecular testing using qPCR has enabled the detection of 
individual variants of EEHV, this thesis investigates the EEHV1 
variant. EEHV1 has been highlighted as the variant that is 
more frequently associated with deaths. 
 
This thesis includes five studies investigating different aspects 
of EEHV. Including, the relationship between pregnancy and 
EEHV viral shedding, the use of an amended human protocol 
for culturing endothelial cells, EEHV tissue tropism, a potential 
genetic or familial link between EEHV associated deaths and 
the detection of potential co-pathogens. 
 
The main findings from this thesis include: 1) the use of a 
longitudinal study investigating a potential link between the 
physiological stress of pregnancy and EEHV viral shedding. 
    Abstract
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This study suggested there was no link between pregnancy 
and EEHV viral shedding however other stressors may be 
involved. 2) Using an amended human umbilical vein 
endothelial cell protocol, the culture of Asian elephant 
endothelial cells was successful. The cells from this study may 
be used in subsequent drug testing and vaccine development. 
3) Quantitative PCR was used to determine EEHV1 tropism in 
tissues from two deaths associated with the virus. Tropism 
appeared to be for the heart and liver. 4) This thesis provides 
results from a preliminary study into a potential link between 
EEHV associated deaths. The data from an Asian elephant 
genogram shows there is the possibility of a genetic or familial 
link, which requires further investigation. 5) A number of 
tissues from deaths associated with EEHV and or death from 
other causes were investigated for the presence of potential 
co-pathogens, including the presence of encephalomyocarditis 
virus (EMCV), using microarray technology. The results 
indicated there were no co-pathogens present in the tissues. 
 
This thesis adds to the current published data, and includes 
the first known preliminary study investigating a potential 
genetic link between elephant deaths due to EEHV. 
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Introduction 
Elephant Endotheliotropic Herpesvirus (EEHV) is a host specific 
herpesvirus of both African and Asian elephants. It is thought 
that there are 7 variants of EEHV (EEHV 1-7); EEHV-2 and 6 
found in African elephants and 1, 3, 4, 5 and 7 in Asian 
elephants (Latimer et al., 2011). Clinical disease varies 
between African and Asian elephants; in African elephants 
clinical disease is rarely reported. In Asian elephants by 
contrast, EEHV is the suspected agent of haemorrhagic fever 
syndrome.  The progression of disease in this syndrome can 
be rapid and result in death within 1-5 days (Richman et al., 
2000a). EEHV is present asymptomatically in most captive 
Asian elephants, and most animals go through periods of viral 
shedding without clinical disease. When clinical disease or 
death occurs, it is usually in juveniles aged between 1 and 5 
years old. EEHV is not only present in captive populations, but 
also occurs in wild Asian elephants, deaths have been reported 
in India, Cambodia and Thailand, it has also been reported in 
wild elephants who can carry EEHV asymptomatically (Reid et 
al., 2006, Zachariah et al., 2013, Stanton et al., 2014). 
In 2011 it was reported that there had been over 60 cases in 
the USA and 33 in Europe, with a fatality rate of 85% (Latimer 
et al., 2011), this has significant consequences for the 
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successful management of elephant populations in captivity. 
Asian elephants are currently listed as endangered on the 
International Union for Conservation of Nature (IUCN) red list, 
and are listed under the Convention on International Trade in 
Endangered Species (CITES) appendix II, in which 
international trading is regulated by the use of import and 
export permits (Choudhury et al., 2008). 
 
EEHV can be studied in captive elephants to understand more 
about the virus, what if any impact this would have on wild 
populations is currently unknown. A greater understanding of 
how the virus is transmitted is needed, it is also unclear why 
some elephants can maintain a lifelong asymptomatic EEHV 
infection, whereas others develop clinical disease, and 
whether the genetics of the individual play a role in this. When 
clinical disease does occur, veterinarians usually treat the 
animal with anti-herpetic drugs such as famciclovir, however, 
it is unknown if other pathogens are also present with EEHV, 
and what effect this has on clinical disease. 
 
Studying EEHV and understanding more about the virus and 
clinical disease could allow the development of new strategies 
to reduce the number of deaths in both captive and wild 
populations.
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1        Literature review 
1.1      Taxonomy and distribution 
The order Proboscidea contains the families Moeritherium and 
Deinotheriidae and sub order Elephantiformes, which contains 
elephants and their extinct relatives. Extinct Elephantiformes 
include Mammutidae (mastodons), Gomphotheriidae 
(Gomphotheres), and Stegodontidae (Stegodontids). The 
family Elephantidae includes the African elephant (Loxodonta 
africana), Asian elephant (Elephas maximus) and Mammoths 
(Figure 1). It has also been suggested that Elephantidae 
should be classified into two groups, Elephatini and 
Loxodontini. Elephantini would include the Asian elephant, 
mammoths and fossil relatives, and the second group 
Loxodontini would include African savannah and forest 
elephants and extinct relatives (Rohland et al., 2010). 
 
The position of the Mammoths and their relation to African and 
Asian elephants has been the subject of much debate, with 
some studies suggesting mammoths are more closely related 
to African elephants and others suggesting Asian elephants. 
Using ancient mammoth mitochondrial DNA to investigate the 
evolution of Elephantidae, Krause et al. (2005) reported that 
the African elephant diverged from the mammoth first, and 
the Asian elephant diverged 440,000 years later, suggesting 
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that the mammoth is more closely related to the Asian 
elephant.  
 
 
Figure 41: Cladogram showing the evolutionary position of the Asian 
elephant (Musgrove and Stockdale, 2011). The order Proboscidea contains the 
families Moeritherium and Deinotheriidae and sub order Elephantiformes containing 
elephants and their extinct relatives. Extinct Elephantiformes include Mammutidae, 
Gomphotheriidae and Stegodontidae. The family Elephantidae includes Loxodonta 
(African elephant), Elephas (Asian elephant) and Mammoths. Image reproduced 
with permission. 
 
African elephants are found in 37 countries throughout Central 
and Southern Africa. They have become extinct in 3 countries, 
The Gambia (1913), Burundi (1970’s) and Mauritania 
(1980’s); they also became extinct in Swaziland in the 1920’s 
but have since been reintroduced in the 1980’s and 1990’s 
(Blanc, 2008). It was reported in 2014 that African elephants 
had become extinct in Senegal, Somalia and Sudan (Larson, 
2014, Al Jazeera News, 2014) (Figure 2).  
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There is much debate surrounding how many species of 
African elephant exist; currently the African species include 
the African bush elephant Loxodonta africana and the African 
forest elephant L.africana cyclotis. The forest elephant is found 
in forest environments; they are smaller in stature and 
possess straighter tusks in comparison to the bush elephant 
(Blanc, 2007).  
 
 
Figure 42: Range of the African elephant according to the IUCN red list. 
The current geographic distribution of the African elephant can be seen in yellow 
outlined in orange (International Union for Conservation of Nature, 2008). Image 
reproduced with permission. 
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1.1.1      Conservation concerns 
African elephants (Loxodonta africana and Loxodonta cylotis 
combined) are currently listed as vulnerable according to the 
IUCN; between 1996 and 2004 they were listed as 
endangered, and since 2004 they have been listed as 
vulnerable. For a species to be classified as endangered it is 
classed as not critically endangered, but at a very high risk of 
extinction in the near future. Whereas for a species to be 
classed as vulnerable the species is facing a high risk of 
extinction but in the medium term future (Altshuler, 2006). 
 
The most important reason for the decline of the African 
elephant is habitat loss; however, there are also other factors 
such as poaching and human elephant conflict. Illegal 
poaching has increased the value of ivory, male African 
elephants are targeted especially those with the largest tusks. 
This may have led to a shift in sex ratio with a reduction in the 
number of breeding males (Sukumar, 2006). Ivory poaching 
was a significant problem in the 1970’s and 1980’s; during 
this period around 100,000 elephants were killed each year. 
This led to a trade ban by CITES in 1989 (World Wildlife Fund, 
Unknown). The trade in ivory was restricted and generally 
pieces that can be dated to pre 1989 can be sold. In certain 
countries governments have implemented stricter rules, for 
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example, in Denmark, only ivory pre-dating 1947 only can be 
sold. If you inherit or own ivory you must be able to prove its 
age (Kennedy, 2011). Despite this ban, ivory poaching has 
still continued, with unregulated markets in 10 out of 37 
African elephant range countries (Lemieux and Clarke, 2009). 
The success of the ivory ban has been under much debate as 
there have been variable results regionally. There were 65,000 
elephants in Kenya in 1979, 19,000 in 1989 and 31,363 in 
2007, which is an increase of 12,636 animals after the ban. By 
contrast, in 1979 there were 377,700 elephants in DRC, 
85,000 in 1989 and 23,714 in 2007, this is a loss of 61,286 
after the ban (Van Aarde and Jackson, 2006, Blanc, 2007). 
 
1.1.2      Asian elephant 
The Asian elephant (Elephas maximus) includes a number of 
subspecies: the Indian elephant (Elephas maximus indicus), 
the Sri Lankan elephant (Elephas maximus maximus), the 
Sumatran elephant (Elephas maximus sumatranus) and the 
pygmy elephant (Elephas maximus borneenisis) (Sukumar, 
2006).  
 
The range of the Asian elephant covers 13 countries in Asia 
(Figure 3). There are several dense populations located in 
Southern and North East India, as well as populations in 
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Myanmar (Burma), Malaysia, Sri Lanka, Nepal, Indonesia and 
Thailand (Sukumar, 2006) (Figure 3). Recent research using 
mtDNA and microsatellites supports the hypothesis that 
pygmy elephants located in Borneo are not from later 
importations, but are actually native to Borneo and have 
undergone an independent evolution from animals originally 
located there (Fernando et al., 2003). 
 
A large number of Asian elephants are kept captive in range 
countries in a non-zoo environment. The use of elephants in 
agriculture and logging has been beneficial, due to their ability 
to move heavy loads (de Silva, 2013). Elephants can be of 
great economic value as there is a growing interest in 
ecotourism and tourist activities, such as elephant rides, 
trekking and elephant painting. Animals are housed in 
elephant camps along with their mahouts, who ride and take 
care of them. Asian elephants are also used for religious and 
cultural activities, especially in temple processions (Food and 
Agriculture Organization of the United Nations, 2002). 
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Figure 43: Range of the Asian elephant according to the IUCN red list. The 
location of Asian elephant populations are indicated by yellow areas (McCue et al., 
2012).  Image reproduced with permission. 
1.1.2.1 Conservation concerns 
According to the IUCN Asian elephants have been listed as 
‘endangered’ since 1986, prior to that date, they were classed 
as very rare but thought to be stable or increasing. They have 
been listed under CITES Appendix I since 1975 (Delecluse and 
Hammerschmidt, 1993). 
 
Currently the population is thought to be decreasing; a survey 
from 2006 estimated that there are between 38,500-52,500 
elephants in Asia. The highest population density occurs in 
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India, home to 60% of wild Asian elephants (Sukumar, 2006). 
A number of Asian elephants are also kept in captivity 
worldwide, with 64 zoos in Europe and 36 zoos in the USA 
holding Asian elephants; this is 44% and 25% of the total 
number of zoos worldwide holding all elephants respectively 
(International Species Information System (ISIS), 2013).  
 
There are a number of reasons for the decline of the Asian 
elephant including warfare, habitat loss, human elephant 
conflict and animals being taken from the wild to supply 
captive populations in zoos and circuses. Warfare has affected 
Asian elephants as there are a large number of unexploded 
landmines in countries such as Sri Lanka and Cambodia 
(Harris, 2000, Fernando et al., 2011). In Sri Lanka, 
approximately 3% of Asian elephant deaths occur from 
stepping on landmines each year; crippling injuries can also 
occur, including limb and trunk loss (Haturusinghe and 
Weerakoon, 2012).  
 
Human elephant conflict (HEC) has also resulted in the loss of 
Asian elephants; this is mostly due to crop raiding, where the 
loss of elephants is the result of retaliation from farmers such 
as shooting, poisoning or electrocution. It has been estimated 
that over 200 elephants each year are killed in Sri Lanka due 
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to HEC (Fernando et al., 2011). Methods used by farmers to 
keep elephants away from their crops can be harmful to the 
elephants.  This includes the use of ‘Hakkapatas’’, small land 
mines which the farmer covers in fruit or vegetables; when 
the elephant attempts to eat the food, the mine explodes, and 
may cause substantial damage to the head (Fernando et al., 
2011).   
 
In captivity Asian elephant populations are currently 
unsustainable, with more elephants dying than are being born. 
This may be due to high calf mortality and a large number of 
juveniles dying before they are old enough to have 
reproduced. Without the development of successful breeding 
programmes or the introduction of wild caught animals into 
captive groups, populations of captive elephants will continue 
to decline (Sukumar 1992). A study in 1998 concluded there 
are more stillbirths, and juvenile deaths in captivity, than 
occur in elephants in facilities located in range countries. The 
study included elephants in 25 European Endangered Species 
Programme (EEP) and Survival Species Plan (SSP) zoos 
located in Europe and North America, the Pinnawela elephant 
orphanage in Sri Lanka, and elephants at the Tamilnadu forest 
department in India.  The results suggested that in zoos, 25% 
of elephant calves were still born, compared to zero at 
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Pinnawela and 3% in the Tamilnadu forest department. 
Twenty-three percent of elephants in zoos died between the 
ages of 0 and 5; this was compared to Pinnawela (9%) and 
The Tamilnadu forest department (7%) (Taylor and Poole, 
1998). However, a more recent study suggests higher calf 
mortality in wild populations.  In a study of young semi wild 
captive Asian elephants aged between zero and five years, it 
was reported that 26.3% of juveniles died before the age of 
one year, with the most common causes of death being 
general weakness/mother agalactica (50%) and accidents 
(37.5%). Whereas in those aged one to four years, the main 
cause of death was accidents (54.1%), and 34% of those aged 
between four and five died due to disease. The main cause of 
death overall was accidents in both females (43.3%) and 
males (41.7%) (Mar et al., 2012). 
 
1.2      Genetics 
1.2.1      Current knowledge 
Studying the genetics of both humans and animals can 
provide valuable information on disease, populations and 
parentage. The use of genetic screening in humans can 
provide valuable information on the susceptibility to certain 
diseases. Screening has been developed for a number of 
diseases including the Leucine-Rich Repeat Kinase 2 (LRRK2) 
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gene mutation which is linked to familial Parkinson’s disease 
(Nichols et al., 2005), and the BRCA1 and 2 genes linked to 
breast cancer (Ford et al., 1998, Recchia et al., 1999). 
However, there are many ethical arguments against 
genetically predicting the susceptibility to disease, especially 
diseases for which no treatment is available. Being made 
aware of disease susceptibility may cause psychological harm 
(Huang et al., 2002a).  It also raises a number of questions 
such as can genetic information be kept confidential, and do 
family members have rights or access to the information 
(Lapham et al., 1996). Genetics can also be used to gather 
information on populations; such as the determination of 
genetic bottlenecks and their use in detecting recent 
population declines (Beckmann and Soller, 1986) and 
measuring genetic differentiation between populations (Tanzi 
et al., 1983, Williams et al., 1990). 
 
Another use of genetics is parentage genetic testing which is a 
useful tool especially in the animal breeding industry; 
thoroughbred parentage testing has been used in the horse 
breeding industry to ensure animals are pure bred (Tozaki et 
al., 2001, Lee and Cho, 2006, Choi et al., 2012). Parentage 
testing has also been conducted on numerous other species 
including Atlantic salmon (Salmo salar) and North American 
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Bison (Bison bison) (Schnabel et al., 2000, Rengmark et al., 
2006). 
 
There are a number of methods and techniques that can be 
used to determine parentage, including microsatellites. 
Microsatellites are sections of DNA where a sequence is 
repeated, it may be a repeat of two different base pairs (di), 
three base pairs (tri) or four base pairs (tetra) (Turnpenny 
and Ellard, 2011). They are used as genetic markers as they 
are highly polymorphic, have a high mutation rate and they 
can occur at numerous locations throughout the genome 
(Crooijmans et al., 1993, Schlötterer et al., 1998). 
 
Microsatellites are useful in determining parentage and genetic 
diversity of elephant populations. A number of microsatellites 
have been identified in African elephants, including 
dinucleotide (Nyakaana and Arctander, 1998, Comstock et al., 
2000, Kongrit et al., 2008) trinucleotide (Fernando et al., 
2001), and tetranucleotide repeats (Fernando et al., 2001, 
Archie et al., 2003). However, a smaller number have been 
identified for use in studying Asian elephant genetics (Eggert 
et al., 2000, Fernando et al., 2001). 
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Analysis of microsatellite markers and mitochondrial genes 
have been used to determine genetic differences in both 
African and Asian elephants. A study by Fernando et al. 
(2000) presented the genetic differences between 118 Asian 
elephants and four captive African elephants. The Asian 
elephants were located in mainland Asia (North India, Bhutan, 
Vietnam and Laos) and Sri Lanka, whereas the African 
elephants were located in zoos in the USA. PCR was used to 
amplify 630 nucleotides of mitochondrial DNA, which includes 
part of the control region. The results showed a distinct 
genetic variation between African and Asian elephants, with 54 
polymorphic sites, whereas within Asian elephant populations 
a total of 27 polymorphic sites were found. Two distinct 
haplotype assemblages were found in the populations, 
assemblage α consisting of 7 haplotypes (A-G) and 
assemblage β consisting of 10 haplotypes (H-Q). The highest 
nucleotide diversity was observed in Bhutan, the highest 
haplotype diversity was in Vietnam, and the genetic diversity 
was lowest in India. Haplotype E was the most frequent, as it 
was observed in Bhutan, India, Laos, Vietnam, and Sri Lanka; 
by contrast, haplotypes A and Q were observed less 
frequently, with both of these haplotypes observed in Vietnam 
and Laos. Two haplotypes (E and L) were observed in Sri 
Lanka and the mainland (North India, Bhutan, Vietnam and 
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Laos). A further study by Vidya et al. (2004) looked at  
mitochondrial DNA (mtDNA) and microsatellites of 224 free 
ranging Asian elephants located in India, 5 haplotypes were 
reported. This study found 5 haplotypes and all samples from 
Southern India fell into clade β as described by  
Fernando et al. (2000).   
 
Both microsatellites and mtDNA have been used to determine 
genetic diversity in captive populations. In a study of both 
captive and wild born Asian elephants located in North 
America, 20 microsatellite loci were recorded for 201 
elephants. Of these, 164 were wild born, and 74 of them had 
a confirmed country of origin; 37 were captive born.  
Seventeen of the 20 microsatellites used were derived from 
those used in African elephants (Lei et al., 2012). Two mtDNA 
lineages were observed; these were clades α and β, as 
described previously by Fernando et al. (2000). Haplotypes of 
both α and β clades were present in wild born animals from 
Thailand, Myanmar and India, whereas only β clade 
haplotypes were found in individuals from Malaysia and Sri 
Lanka. Both wild born and captive Asian elephants showed 
similar genetic diversity (Lei et al., 2012) (Table 1). 
 
                                                                   Literature review 
 
18 
     
Table 1: Mitochondrial DNA (mtDNA) clades present in elephant 
populations in Asia.  
Location mtDNA Clades present Reference 
Thailand α and β (Lei et al., 2012) 
Myanmar α and β (Lei et al., 2012) 
India α and β (Lei et al., 2012) 
Malaysia Β (Lei et al., 2012) 
Sri Lanka Β (Lei et al., 2012) 
Southern India Β (Vidya et al. (2004) 
 
1.3      General biology 
1.3.1      Behaviour and biology 
Elephants are mega herbivores and consume large amounts of 
low nutritional value vegetation and plant material. They are 
mixed feeders, engaging in both grazing and browsing, and 
feed for between 12 and 15 hours per day; although they may 
feed for longer. Therefore, they have large ranges similar to 
other mega herbivores; it has been estimated that range sizes 
of Asian elephants are between 34-320km2 per individual. This 
figure is a conservative estimate, and the size of feeding 
ranges may be determined by a number of factors (Sukumar, 
2006). In comparison the estimates of ranges for African 
elephants vary considerably within the literature Owen-Smith 
(1988) reported ranges of cow herds between 240km-1800km 
in the Kruger National Park and Tsavo East National Park 
respectively. Bull herds in the Pongola Nation Park ranged 
between 40-61km and cow herds were between 17 and 36km, 
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this is considerably small than those reported by Owen-Smith 
(1988), the results of the study may not accurately reflect the 
actual size of the African elephant range as the national park 
area was small at 103km2. 
 
There are numerous difficulties and limitations in studies 
looking at elephant ranges, distribution and factors affecting 
distribution. There are a limited number of studies within the 
literature that discuss these aspects of Asian elephant 
behaviour, these studies use methods such as direct 
observations, dung appearance rates, comparing statistics and 
correlations. Whilst this may be useful it is important to 
consider the methodological limitations such as the possibility 
of variable detectability, selection bias and limited spatial 
scales (which lead to range size underestimation) (Varma, 
2008, Kumar et al., 2010, Rood et al., 2010, Gaucherel et al., 
2010, Jathanna et al., 2015, Koirala et al., 2016). 
1.3.2      Social behaviour 
Social structure has been better studied in African elephants 
than in Asian elephants. African elephant society begins with a 
primary unit of a mother, and her offspring. The joint family 
unit or ‘kin group’ consists of a number of related cows (adult 
females), sisters, mothers, daughters and young males (de 
Silva, 2013). Group sizes depend on a variety of factors; a 
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larger group provides the benefits of close social contact and 
protection from predation.  However, with a large number of 
animals, foraging becomes less efficient, with food then 
becoming a limiting resource, especially during the dry 
season. African elephant family groupings usually consist of 5- 
10 individuals, with Asian elephants forming smaller groupings 
of 5 individuals (Sukumar, 2003). 
 
Male Asian elephants remain with their mother in the family 
unit until puberty. At around 6 years of age, they start 
spending time away from social groups, and by the age of 9, 
they spend most of their time alone or in small infrequent 
bachelor herds (de Silva, 2013). In another study, bulls 
associated with family units for around 23% of their time, 
especially when a female was in oestrus (Sukumar, 1992). 
 
Herd structure and socialisation differs between Asian and 
African elephants, Asian elephants have looser social bonds 
with other individuals. Asian elephants in the Uda Walawe 
National Park (in Sri Lanka) tend to spend more time with 
certain individuals than with others; this may be due to family 
bonds, food locations or other preferences. As the individuals 
within a herd change on a regular basis, it is not clear if there 
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is a matriarch within Asian elephant society (de Silva et al., 
2011, de Silva, 2013). 
 
1.3.3      Reproduction 
The gestation period of an Asian elephant is approximately 22 
months. Young are reared by their mother and other cows 
within the herd, and there is a distinct absence of paternal 
care (Sukumar, 2003). When an African adult female elephant 
gives birth, it is a community event, with other adult females 
tending to the mother attentively; as elephants are 
allomothers, other females in the group take part in infant 
care (Lyons, 2015). In African elephants during the first few 
years of life a calf is frequently guided and touched by other 
members of the herd to provide reassurance (Moss, 1975). 
 
The duration of the receptive phase of oestrus in Asian 
elephants varies from between 2 to 8 days and there are no 
obvious changes in behaviour in the females. The length of the 
oestrus cycle is on average 16 weeks long; the luteal phase 
lasts around 10 weeks and the follicular phase lasts around 6 
weeks. The follicular (non-luteal) phase marks the point of 
ovulation and male interest increases at this point (Hess et al., 
1983). The elephant has two surges of luteinizing hormone 
(LH) during the follicular phase. The first surge is named 
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anovulatory LH, which occurs 2 weeks after progesterone 
concentration drops. As ovulation is not induced at this point, 
the second surge occurs between 19-22 days after the first 
surge, and is named ovulatory LH as after this surge ovulation 
occurs. A double surge in LH has been confirmed in both 
African and Asian elephants. (Kapustin et al., 1996, Brown et 
al., 1999).  
1.3.3.1 Captive breeding 
Asian elephant populations in captivity are not sustainable, 
with higher death rates than birth rates due to low fertility 
rates and high calf mortality. To determine this, Wiese (2000) 
analysed data from 698 Asian elephants from the North 
American Asian Elephant Studbook using population 
management software. To predict population growth, age 
specific mortality and fecundity were calculated and to ensure 
a best case scenario, “optimistic” values were used. Ages were 
estimated for those that were wild caught, however, it was 
determined that these estimations would not have altered the 
predications. 
The number of captive elephant calves dying in Europe during 
their first year of life is between 2.3 and 3.4 times greater 
when compared to working elephants in Burma (Taylor and 
Poole, 1998). To determine Taylor and Poole (1998) circulated 
a questionnaire to 14 EEP zoos, 178 SSP members, 16 Indian 
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zoos, and 23 other establishments with captive elephants such 
as logging camps. The questionnaire asked questions 
regarding Asian elephant demography, herd details, 
husbandry, management routines, breeding records, enclosure 
size, diet, and training. Of the 46 western establishments 22% 
responded; data was not given for the number of Asian 
establishments that responded. However, the results from this 
study are limited as the data was gathered in 1996, therefore 
it may be useful to repeat this study to understand the current 
situation, as significant changes may have been made in the 
intervening period.  
 
It has been suggested that there are three factors for Asian 
elephant mortality in zoos: 1) being transferred to a new zoo 
has been noted to decrease survival, 2) origin; elephants in 
zoos that were wild born showed better survival compared to 
captive born, and 3) how recent the animal entered the 
population (Taylor and Poole, 1998). In a study of Asian 
elephant reproduction, it was reported that reproductive rates 
were lower in Asian elephants in European zoos compared to 
their range country counterparts (Taylor and Poole, 1998). 
Reproductive success was limited in European zoos, with 50% 
(10/20) reporting 1 live young per mature female every 6-7 
years, whereas the Pinnawela elephant orphanage reported 1 
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live young per mature female every 5 years (Taylor and Poole, 
1998). There are a number of problems which may increase 
failure to conceive in captivity. Problems include limited 
opportunities for males to mate in captivity due to restricted 
access to females, this is also observed in range country 
captive Asian elephants (Taylor and Poole, 1998). Females in 
captivity are not able to choose their mating partner; this is 
not helped by a lack of males in captivity. There are difficulties 
in keeping male Asian elephants in captivity due to musth, 
where bulls may pose a danger to other elephants and 
keeping staff, during this time the male may be tethered or 
confined (Taylor and Poole, 1998). Due to the above reasons 
natural reproduction in captivity is difficult; successful artificial 
insemination may increase the chances of captive populations 
becoming more stable  (Brown et al., 2004).  
 
Zoo populations have previously been sustained by the import 
of wild animals, and in the past 40 years, growth in the 
captive population is due to importations. This study is limited 
as data was collected in 1999, however, a repeat of this study 
would give more up to date population predictions (Wiese, 
2000). Increasing the success of breeding in captivity is 
considered important to sustain captive populations; because 
there are a limited number of successfully breeding males and 
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females in captivity, this will eventually lead to a reduction in 
the genetic pool (International Species Information System 
(ISIS), 2013). The population in North America is currently 
aging; this suggests that the number of fertile females will 
decrease further in this group; it is likely to be the same in 
Europe.  
 
It may be possible that in the future, management changes 
may lead to increased fertility rates or a reduction in infant 
mortality rates. 
 
1.3.4      Elephant immune system 
The immune system protects the body from foreign bodies 
and microbes such as bacteria, parasites and viruses. There 
are two main types of immunity: acquired and innate. 
Acquired immunity is only present in vertebrates and is 
characterised by memory and specificity, there are two main 
types of cells which carry out the acquired immune response 
and “remember” the pathogen, B cells and T cells. (Akira et 
al., 2001, Alberts et al., 2002). B cells carry out an antibody 
response (humoral response), activated and antibodies are 
secreted. The antibodies then bind to the foreign antigen 
which then causes inactivation. The result of this is that the 
foreign antigen is not able to bind to the host (Alberts et al 
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2002). T cells are involved in a cellular response (cell 
mediated response), where T cells react to the presence of 
foreign antigens present on the cell surfaces of the host, the T 
cell is therefore able to “kill” a virus infected cell before it is 
able to replicate (Alberts et al 2002). 
As B cells, T cells and NK cells are able to  create 
immunological memory it leads to an enhanced immune 
response when exposed to a pathogen previously encountered 
(Orme, 1988, Kurtz and Franz, 2003). However, the acquired 
immune system may recognise harmless molecules as being 
harmful, this can result in conditions such as asthma or 
allergies (Hammad and Lambrecht, 2008, Holgate, 2012). 
Innate immunity is evolutionarily older and found in many 
diverse organisms. It is characterised by the capability to 
distinguish between self and foreign “material” and the 
response is not specific to individual pathogens, however, 
unlike acquired immunity it is not able to provide long lasting 
immunity (Akira et al., 2001, Alberts et al., 2002). Acquired 
immunity is known to develop slowly, especially during initial 
exposure, during this time the body is protected from infection 
by the innate immune system (Alberts et al., 2002). There are 
a number of cells that function within the innate immune 
systems such as NK cells, macrophages and neutrophils. In 
the innate immune response NK cells are not directly involved 
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in destroying or attacking foreign microbes, but are able to 
destroy compromised host cells such as virus infected cells. 
Recent evidence suggests they are part of both the acquired 
immune system and the innate immune system, they have the 
ability to “remember” pathogens like B cells and T cells. NK 
cells share similarities with T cells, such as the ability to 
conduct perforin or granzyme mediated killing (DiSanto et al., 
1995, Paust et al., 2010). Macrophages are able to bind 
bacteria molecules on their surface, the macrophage is then 
triggered and the bacteria is engulfed and destroyed through a 
process called respiratory burst (Janeway et al., 2005). 
Another cell that is able to destroy foreign microbes using 
respiratory burst is neutrophils, which are the most common 
type of phagocyte (Stvrtinova et al., 1995). Neutrophils have 
granules within their cytoplasm which are able to kill or inhibit 
growth of foreign microbes such as bacteria or fungi 
(Brinkmann et al., 2004). 
 
There is limited information about the elephant immune 
system and this appears to be a gap in the literature. The 
morphology and function of the elephant immune system is 
thought to be the same as that in other mammals, with bone 
marrow being the main site for the maturation of B 
lymphocytes and the thymus for the maturation of T 
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lymphocytes (Lowenstine, 2006). Anatomically, the immune 
system of the elephant is also made up of lymph nodes 
(associated with lymphatics), hemal nodes (associated with 
the vascular system), tonsils, spleen, bone marrow and 
mucosal associated lymphoid tissue (in the form of palatine 
tonsils) (Lowenstine, 2006). 
 
Studying the immune system of the Asian elephant may 
provide more information on the effectiveness of the immune 
response, disease susceptibility and general immune function.  
To investigate the immune system many studies in other 
species have looked at the expression of cytokines, which are 
produced by cells such as T lymphocytes, B lymphocytes, 
endothelial cells, macrophages and mast cells. The expression 
of cytokines has been studied due to their involvement in the 
hosts’ immune response, sepsis, inflammation and as a 
marker of disease severity (Oberholzer et al., 2000, Bozza et 
al., 2007, Goldberg, 2009). There is limited information on 
cytokine expression in the Asian elephant. Landolfi et al. 
(2009) developed and validated a series of cytokine RT-PCR 
assays to characterise immune responses in Asian elephants.  
Cytokines investigated included TNF alpha (cell signalling 
protein), TGF beta (multifunctional), interferon gamma 
(induces an array of immune responses), interleukin 2 
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(regulates homeostasis and immune activation particularly of 
T cells), interleukin 4 (induces differentiation of helper T cells 
into TH2 cells), interleukin 10 (inhibits macrophage functions), 
and interleukin 12 (activates immune responses and may play 
a role in haematopoiesis), and could be detected in the 
peripheral whole blood obtained from Asian elephants, 
(Hennessey et al., 1993, Wolf et al., 1994, Rincón et al., 
1997, Thompson et al., 1998, Aggarwal, 2003, Gaffen and Liu, 
2004, Gattoni et al., 2006). 
 
 Landolfi et al. (2009) has contributed a number of cytokine 
gene sequences for future study. It may also serve as the 
foundation for a number of future studies including comparing 
the immune responses of both healthy and diseased 
individuals, this may allow for a greater understanding of 
disease susceptibility. However, the functional significance of 
these key cytokines in Asian elephants must be inferred from 
other species, as there is no direct evidence confirming their 
function in the Asian elephant. 
 
RT-PCR studies of cytokine gene expression require only the 
gene sequence for the gene of interest and as such are 
relatively easily transferred to exotic species. In contrast, the 
use of functional assays (for example ELISPOT assays to 
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measure T cell activity) require reagents that are more 
difficult to generate, for example, specific antibodies and may 
require extensive optimisation of culture systems to study 
elephant immune cells in vitro. It is also difficult to perform 
experimental studies in live animals and there are a number of 
ethical concerns especially when working with endangered 
species. 
1.3.4.1 Immunomodulation and stress 
Immunomodulation is the normal processes by which the 
immune system regulates itself. Regulatory T cells are a type 
of T cell that are modulate and supress the immune response 
and so maintaining homeostasis. It has been shown that 
regulatory T cells are able to inhibit both cytokine function and 
T cell proliferation and downregulation, it is also though that 
they may play a role in preventing autoimmunity (O'garra and 
Vieira, 2004, Kondelkova et al., 2010). There are a number of 
proposed suppression mechanisms used by regulatory T cells, 
such as the prevention of co-stimulation, the production of 
inhibitory cytokines such as interleukin 35 and 10 and the 
production of Granzyme B which is able to induce effector cell 
apoptosis (Read et al., 2000, Gondek et al., 2005, Collison et 
al., 2007, Walker and Sansom, 2011). If dysregulation of 
regulatory T cells occurs it may lead to the development of 
certain autoimmune diseases (Kondelkova et al., 2010). 
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Certain medications (immunomodulators) can be used to 
normalise or regulate the immune system which are used in 
the management of certain disease such as Crohn’s disease 
and inflammatory bowel disease (Punati et al., 2008, Sokol et 
al., 2010). There are other types of immunomodulators such 
as female sex hormones which alter the sensitivity of the 
immune system (Wira et al., 2015).  
Psychological stressors can have multiple effects on the 
immune system, impairing its ability to fight off infection and 
alter normal immune response, such as the disruption of 
certain networks of communication for instance signals linking 
the endocrine system, the nervous system and the immune 
system and the inhibition of antibody production (Rabin, 
1999). The sympathetic nervous system can be continuously 
activated under chronic stress, when the parasympathetic 
nervous system does not counteract, this the immune system 
can be activated, this is achieved through an increase in 
proinflammatory cytokines, having been observed in patients 
with depression (Won and Kim, 2016). 
1.4      Diseases of elephants 
1.4.1      Non-infectious diseases 
There are a number of non-infectious diseases and conditions 
affecting elephants. This review will focus on several important 
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non-infectious conditions of captive elephants including: 
obesity, foot problems and degenerative joint disease. 
However, the list is not exhaustive.  
1.4.1.1 Obesity 
It has been suggested that obesity is a problem in both 
captive Asian and African elephants; this is the presence of 
excessive amounts of body fat. One study suggested that 
captive Asian elephants were 21% heavier than their wild 
counterparts, and African elephants were 27% heavier 
(Palanivelrajan et al., 2015). There are a number of suggested 
reasons as to why obesity is occurring including: 1) hay 
quality, this is a staple part of the captive elephant diet, but it 
may not provide the correct proteins, minerals and vitamins in 
comparison to a wild elephant diet, 2) overfeeding, 3) low 
fibre diet and 4) insufficient exercise/activity (Hatt and Clauss, 
2006, Association of Zoos and Aquariums, 2011a). Captive 
elephant diets differ to their wild counterparts as they are fed 
pellets, which provide vitamins and minerals not found in hay. 
They are also fed a number of supplements including biotin, 
vitamin E, Zinc, bran, oats and produce (Bowling et al., 1997). 
Produce includes fruits and vegetables such as apple, carrots 
and bananas, as they are considered to be high in sugar this 
may be a contributing factor in obesity (Coote and Bruford, 
1996). A number of publications have suggested that a lack of 
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exercise may lead to increased health problems in captive 
elephants, such as pododermatitis, degenerative bone disease 
and obesity (Mikota et al., 1994, Roocroft and Oosterhuis, 
2001, Gaskin et al., 1980). Obesity can also lead to other 
conditions such as foot lesions and joint problems (Csuti et al., 
2001). It is thought obesity in captive elephants may be 
contributing to their low reproductive success. As obesity may 
also be linked to the presence of benign uterine tumours 
(leiomyomas) leading to infertility, as is thought to be the 
case in humans (Hildebrandt and Göritz, 1995, Montali et al., 
1997, Sato et al., 1998).   
 
In the USA AZA provides zoos with recommendations for 
exercise programmes to try and increase the amount of 
activity captive elephants undertake (Association of Zoos and 
Aquariums, 2011a). Wild elephants are known to undertake 
large amounts of walking each day; Leggett (2010) found that 
wild African elephants travelled between 0.38-0.63km/hr, 
captive African elephants have been found to travel around 
0.4km/hr which is towards the lower end of that travelled by 
their wild counterparts (Leighty et al., 2009, Rothwell et al., 
2011). However, these studies only included a small number 
of elephants, the size of the enclosure may influence the 
ability or desire to exercise.  It is also important to consider 
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exercise is not only about the distance walked, but also other 
activities engaged in during that time, such as varied terrain, 
pulling or pushing trees which would involve muscular effort. 
More research is needed to better understand activity and 
space used by captive elephants. 
1.4.1.2 Foot problems 
Foot problems are commonly seen in elephants, 50% of which 
will be affected by a foot problem at least once in their lifetime 
(Csuti et al., 2001). With captive elephants, enclosure design 
is important and has an impact on foot heath; it is essential to 
provide the correct floor substrate and drainage in both 
elephant barns and outdoor areas. In outdoor areas, 
limestone, granite or clay soil should not be provided as it 
may become lodged into crevices on the soles of the feet. Foot 
health can be improved by providing an enclosure that is 
similar to their natural habitat including natural substrates and 
suitable vegetation (Buckley, 2008). There are a large number 
of non-infectious and infectious conditions that can affect 
elephant feet. Non-infectious conditions include foreign bodies, 
irritation and abrasions. Infectious diseases include foot and 
mouth disease, which can lead to lameness due to swollen 
skin around the toenails; elephant pox which can lead to the 
feet becoming infected and toenails can detach from the foot; 
and pododermatitis which may appear as a localised abscess 
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or infection around the nails, this may be due to moisture and 
the lack of routine foot care (Murray, 2006). Foot problems 
and injuries especially lacerations and foreign bodies also 
occur in wild populations and are thought to be common 
(Csuti et al., 2001). 
1.4.1.3 Degenerative joint disease (DJD) 
DJD is a common problem in captive Asian and Africa 
elephants and is associated with lameness. There is no single 
cause for DJD and other joint problems such as arthritis, but 
contributing factors may include: using a hard concrete 
substrate, inadequate exercise, obesity and wet conditions 
(Fowler and Mikota, 2006). The chaining of elephants may 
also contribute to the development of DJD, as they maybe 
chained for long periods and their movement is limited. 
Elephants that resist chaining or pulling on the chain may 
cause more joint damage (Firyal and Naureen, 2007). It is 
also thought that DJD may develop from the acquisition of 
infectious agents such as Mycoplasma. A previous study 
looking for arthritogenic agents in two groups of captive 
elephants (62 Asian elephants and 5 African) found 28/35 
genital tracts were colonized by one or more Mycoplasma spp. 
Both rheumatic disorders and lameness were found in some 
animals, and were found to be correlated with Mycoplasma 
antibody titres (Clark et al., 1980). 
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The most important clinical sign is lameness. However, the 
presence of lameness occurs after structural changes have 
occurred to the joint. Cartilage damage within the joint leads 
to proteoglycans being released into the synovial fluid. The 
result of this is an inflammatory reaction leading to 
inflammation of the synovial membrane (synovitis). Further 
inflammation of the joint is then caused by a destructive 
release of enzymes mediated by prostaglandins and 
interleukins (Fowler and Mikota, 2006). As the disease 
progresses fibrosis of soft tissue and inflammation can cause a 
decrease in movement, and advanced DJD can lead to bone 
pain (Fowler and Mikota, 2006). 
 
A diagnosis can be made with the use of radiography. Most 
captive elephants are trained to lift their feet for inspection, 
this enables radiography without the use of a chemical 
restraint (Hittmair and Vielgrader, 2000). Radiography can 
show characteristic changes associated with DJD such as 
sclerosis and decreased joint space (Fowler and Mikota, 2006). 
 
Treatment of DJD can include changes in husbandry and a 
variety of different treatments including nonsteroidal anti-
inflammatories (NSAIDS). NSAIDS are used as they interrupt 
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prostaglandin synthesis, however overuse may also supress 
proteoglycan synthesis, proteoglycans are an important 
constituent of cartilage (Fowler and Mikota, 2006). Successful 
treatment can include glucocorticoids, antibiotics and hot/cold 
compresses (Palanivelrajan et al., 2015). A number of 
enrichment opportunities available to captive elephants may 
help to maintain joint health. These include substrates that 
allow for digging and swimming, which relieves joints as it 
provides a non-weight bearing exercise. However, exercise 
should not begin until inflammation has been reduced (Fowler 
and Mikota, 2006). 
 
1.4.2      Infectious diseases 
1.4.2.1 Mycobacterium spp 
Mycobacterium is a genus of Actinobacteria, this genus 
includes many species found in the environment, and it also 
contains pathogens known to cause diseases in both humans 
and animals such as Mycobacterium tuberculosis and 
Mycobacterium leprae. This review concentrates on pathogens 
of this genus known to cause the disease tuberculosis. 
 
Mycobacterium tuberculosis is an obligate bacterial pathogen, 
and is one of the causative agents of tuberculosis (TB). It can 
be difficult to identify the bacteria using gram staining as 
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there is a waxy coat on the cell surface making it impervious 
to the staining technique, this means it can appear as both 
gram negative and gram positive in clinical tests (Fu and Fu-
Liu, 2002).  
 
TB was described in elephants by ancient people more than 
2000 years ago (Iyer, 1937).  Two circus elephants died of the 
disease in 1996 (Mikota et al., 2001). Symptoms of TB in 
elephants include weight loss, weakness and coughing, 
although it can go undetected in elephants for many years and 
may not be noticed until post mortem examination.  
 
A number of tests have been used to diagnose the disease in 
elephants including the intradermal tuberculin test, enzyme 
linked immunosorbent assay (ELISA) and  acid-fast  smears 
(The United States Animal Health Association Elephant 
tuberculosis subcommittee, 2012). The Tuberculin skin test 
called the Mantoux skin test is used to diagnose the disease in 
humans, this involves injecting a standard dose of tuberculin 
intradermally, if a person has been exposed, an immune 
response occurs and the reaction is read by measuring the 
size of the papule. Elephants can also be diagnosed using a 
skin test, although tests may be altered depending on the 
species being tested; different tuberculin extracts may be 
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used, standard tests in the UK for cattle use a preparation of 
M.bovis AN5 (Mikota et al., 2001).  Intradermal tuberculin 
tests are also used to diagnose TB in other animals such as 
cattle.  One study of captive elephants in North America 
surveyed 539 elephants of which 18 tested positive (3.3%) 
using the intradermal tuberculin test (Mikota et al., 2000). A 
more recent study used The Elephant TB STAT-PAK rapid flow 
test which detects antibodies in sera specific to M. 
tuberculosis, and bacterial cultures from trunk washes. The 
small study of four elephants located in Thailand reported the 
presence of M. tuberculosis in the four animals tested. The 
study also concluded transmission of M. tuberculosis to the 
four elephants, was likely to have been contracted from 
humans (Angkawanish et al., 2010). 
 
The United States Animal Health Association has published 
guidelines on the testing and treatment for TB. The guidelines 
state that all captive elephants must be tested annually using 
the rapid flow Elephant TB STAT-PAK antibody assay, using a 
blood sample (Mikota et al., 2000, Mikota et al., 2001).  
 
There are three management options when TB occurs in 
elephants, these are; isolation, euthanasia and treatment. It is 
thought that the most effective therapy depends on rapid 
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diagnosis, and includes adequate plasma drug levels, 
adequate length of treatment and close monitoring of the 
elephant. It is suggested that antibiotics are administered 
orally but directly, as it is not recommended to put the drug 
over the feed which likely reduces the efficacy. Drugs used for 
initial treatment include; isoniazid, pyrazinamide, rifampicin, 
ethambutol and streptomycin. There is currently no published 
data indicating the cost of treating TB in elephants. 
 
Multi drug resistance, is thought to occur; typically resistance 
to isoniazid and rifampicin (Törün et al., 2005), if this occurs, 
it is recommend to use second line drugs. Second line drugs 
include aminoglycosides (amikacin and capreomycin), 
ethionamide, and quinolones (Jordheim et al., 2013).  
Although it can be difficult to detect TB in any species, early 
diagnosis and treatment are thought to be necessary. In 
humans there are several factors that influence the critical 
intervention point where treatment is initiated including: age, 
access to medical services, and the presence of co-infections 
(Tsara et al., 2009).  
 
As described above TB can be difficult to detect and also 
difficult to treat. Nepal has taken action to try and reduce the 
number of cases of TB in Asian elephants and is a high priority 
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issue for the Nepalese government, which began elephant TB 
surveillance in 2006, followed by the standardisation of TB 
treatment in 2008. The Nepalese government aimed to 
minimize the transmission of TB at the captive-wild interface 
with the introduction of the Nepal Elephant Tuberculosis 
Control and Management Action Plan. The aims of the plan 
included introducing a programme to diagnose and treat TB 
among both captive elephants and their mahouts, establish a 
monitoring system, develop and establish an education 
programme to teach elephant staff, tourists and local 
communities and to also include control initiatives for TB in 
humans and livestock including a collaborative One Health 
initiative. However, the plan does not detail how the success 
of the programme is going to be measured or how the data is 
going to be reported (Department of National Parks and 
Wildlife Conservation, 2011). There is no published data to 
show if this control and management action plan was 
successful. Assessing the success of the control measures 
requires further research, and if the measures were shown to 
be successful, they could be introduced into other range 
countries. 
1.4.2.2 Bacillus anthracis 
Bacillus anthracis, is a gram positive, rod shaped, endospore 
forming bacteria (Baillie and Read, 2001). It is the causative 
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agent of anthrax, is highly contagious and has been reported 
in almost all mammalian species. Anthrax can be cutaneous, 
where lesions appear on exposed skin, or pulmonary or 
gastrointestinal with clinical signs including anorexia and 
fever. Gastrointestinal anthrax can cause cyanosis, dyspnoea 
and sudden death.  A combination of anti-inflammatories, 
antibiotics and analgesics have been used successfully to treat 
animals (World Organisation for Animal Health et al., 2008). 
 
Elephants can become infected through eating contaminated 
vegetation and soil, and infection has been reported in both 
captive and wild populations of African and Asian elephants 
(Rao and Acharjyo, 2006). In 1927 an outbreak of anthrax 
among staff and elephants at a zoo in the UK was reported, 
the study does not indicate if the elephants were African or 
Asian. The outbreak resulted in the sudden deaths of two 
elephants (clinical signs were not reported). Blood smears 
were taken from the heart, liver, kidney, spleen and lungs, 
and tissues were also submitted for aerobic and anaerobic 
cultures. Large, square ended bacilli were visible in all smears. 
A second elephant died and was subjected to a post mortem 
examination, multiple smears also showed numerous bacilli. 
(Scott, 1927). A diagnosis of anthrax was made for both 
animals. The source of the infection remains unclear (Scott, 
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1927). A second outbreak of anthrax was reported at Chester 
Zoo, UK in 1964 this included African elephants (Jordan, 
1964). 
 
 A number of deaths have occurred in wild populations; clinical 
signs were not observed; however, post mortem examinations 
have been conducted on a number of animals. Examination of 
the carcass showed blood leaking from the eyes and trunk, 
post mortem examinations revealed absence of rigor mortis, 
dark tarry blood and uncoagulated blood (Priya et al., 2009, 
Yasothai and Shamsudeen, 2014). 
 
Priya et al. (2009) reported blood smears from trunk and 
ocular blood samples from a wild Asian elephant revealed a 
number of truncated-end rods typical of B. anthracis infection. 
Anthrax was confirmed using a mouse inoculation test (MIT), 
where infected tissue from the animal was inoculated into 
mice, which were then killed and examined for the presence of 
B. anthracis (Priya et al., 2009). 
 
Yasothai and Shamsudeen (2014) confirmed the presence of 
anthrax in an Asian elephant using blood smears. The smears 
displayed the characteristics of the McFadyean reaction, which 
is a staining reaction that displays a blue cell surrounded by a 
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pink capsule, characteristic of an anthrax bacilli infection 
(Yasothai 2013). Anthrax has also been discovered to be the 
cause of death retrospectively in a number of cases; a study 
in the Etosha National park, Namibia reported 10 Anthrax 
related deaths in wild African elephants between 1969 and 
1970 (Ebedes, 1976). 
1.4.2.3 Cowpox virus 
There are a number of zoonotic pox viruses including cowpox 
virus (CPXV) which is a member of the Orthopoxvirus genus 
within the Poxviridae family.  CPXV is thought to be the 
causative agent of the disease cowpox, similar to the highly 
contagious and now eradicated smallpox in humans. CPXV 
inspired the small pox vaccine developed by Edward Jenner. 
Human cases are rare, though a case in a laboratory worker 
has been reported. An ulcerated lesion appeared on the finger 
of the employee, other symptoms included chills, headaches 
and body aches. The employee had handled mice that were 
inoculated, the inoculant was discovered to have been 
contaminated with CPXV (Robert, 2012). 
 
CPXV is frequently transmitted by rodents, especially 
woodland rodents, such as the common rat (Rattus 
norvegicus); one report indicated that 20% of wood mice, 
20% of bank voles (Myodes glareolus) and 33% of field voles 
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(Microtus agrestis) had antibodies to cowpox virus (Crouch et 
al., 1995).  
 
CPXV has occasionally been transmitted to zoo animals; this 
includes captive Asian elephants (E. maximus), anteaters 
(Myrmecophaga tridactyla), and okapis (Okapia johnstoni). 
This also includes a number of felid species such as the lion 
(Panthera leo), puma (Puma concolor), jaguar (Panthera 
onca), and cheetah (Acinonyx jubatus). There have been 
reports of transmission from elephants to humans. Kurth et al. 
(2008) and Hemmer et al. (2010) described CPXV 
transmission from rats to Asian elephant and subsequent 
transmission from elephant to humans. CPXV is also thought 
to have been responsible for some stillbirths in Asian 
elephants. An active CPXV infection was detected in a stillbirth 
from a previously vaccinated dam. Signs of cowpox infection 
seen in the calf included papules over the skin, as well as 
lesions on the trunk and around the eyes (Wisser et al., 
2001). 
  
1.4.2.4 Leptospira spp 
Species of the Leptospira genus are spirochaete bacteria; the 
genus includes some pathogenic species including L. 
interrogans, the causative agent of Leptospirosis. 
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Leptospirosis is a common rodent borne zoonotic infection. In 
a study of wild brown rats (Rattus norvegicus) in the UK, 
using multiple testing methods including serological and non-
serological testing, 14% of rats were positive for Leptospira 
spp by at least one test (Webster et al., 1995). In contrast a 
more recent study of R. norvegicus in Denmark found a 
prevalence rate of between 48 and 89% in five different sewer 
locations (Krøjgaard et al., 2009). Leptospira spp are also 
found in livestock and domesticated animals. Most cases of 
leptospirosis in livestock are sub clinical, but where an acute 
infection is present reproductive loss may occur through: 
stillbirth, abortion, and infertility (Bolin and Alt, 1999). 
Infected bovine calves may show clinical signs such as 
jaundice, pulmonary congestion, fever, meningitis and death 
may also occur (Bolin and Alt, 1999). In cattle younger 
animals are more seriously affected in comparison to older 
animals (Bolin and Alt, 1999). Leptospirosis can be diagnosed 
using various methods including serological testing. Non-
serological testing methods such as PCR can also be used (Van 
Eys et al., 1989). A more recent study used nested PCR to 
confirm the presence of leptospires in the urine of cattle 
(Daibata et al., 1999). 
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Leptospirosis has been reported in captive Asian elephants; in 
a study of 42 captive Asian elephants in India, all were found 
to be positive for at least one Leptospira interrogans serovar 
(Vengadabady et al., 2009). By contrast, another study in 
India found a lower prevalence rate, 7/51 (13.7%) serum 
samples tested positive for the presence of L.interrogans 
serovar antibodies (Shivraj et al., 2009). Death due to 
Leptospira infection in Asian elephants has been reported, 
including the death of a 6 year old juvenile in India; nephritis 
and adrenal cortical infection were observed in this case 
(Fowler and Mikota, 2006). 
 
In elephants, clinical signs may include weight loss, anorexia, 
uveitis, jaundice, ventral oedema, genital and skin lesions. 
Treatment with tetracycline, doxycycline and enrofloxacin 
have been successful (Fowler and Mikota, 2006).  
1.4.2.5 Yersinia spp 
Yersinia is a genus of gram negative, rod shaped bacteria that 
is capable of both aerobic and anaerobic respiration. A number 
of pathogens within the Yersinia genus are pathogenic to both 
humans and animals, including Y. pestis, Y. 
pseudotuberculosis and Y. enterocolitica. Y. pestis known to 
cause plague, evolved from the relatively benign Y. 
pseudotuberculosis an estimated 1500-20,000 years ago 
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(Eisen and Gage, 2009).  Y. pestis is primarily flea borne and 
a large number of flea species are able to be infected (>80). 
Despite the diverse number of mammalian hosts, many 
mammals are not able to develop a high level infection 
required to infect feeding fleas (Eisen and Gage, 2009). Highly 
susceptible species include rodents. With a high abundance of 
rodents, there is often a rapid and sustained spread which can 
elevate both human and wildlife exposure (Eisen and Gage, 
2009).  In Europe a number of rodents are thought to be 
maintenance hosts, whereas in North America this includes 
black-tailed prairie dogs. A previous study investigated the 
prevalence of Y. pestis in the black-tailed prairie dog eco-
system using nested PCR (Hanson et al., 2007).  Hanson et al. 
(2007) found in 2003, 23% of burrows contained fleas positive 
for Y. pestis. A PCR test for the detection of Y. pestis was 
developed in 1994 (Norkina et al., 1994), more recently a 
real-time PCR has been developed to detect Y. pestis in the 
sputum of humans (Loïez et al., 2003). The development of 
antibiotics led to a drop in the number of plague cases; 
initially treatment was with sulfonamide and then 
streptomycin (Galimand et al., 2006). Currently streptomycin 
remains the antibiotic recommended for treatment, however, 
multidrug resistance has been reported (Galimand et al., 
1997, Galimand et al., 2006). 
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Exposure to Y. pestis has been reported in a wild African 
elephant, however, there have been no reports in Asian 
elephants.  A serological study in South Africa found 1/330 
(0.3%) of wild African elephants were seropositive (Gordon et 
al., 1979). Infection and clinical disease have not been 
described in elephants and little is known about the epizootic 
potential.  
1.4.2.6 Toxoplasma gondii 
Toxoplasma gondii is a ubiquitous obligate, intracellular 
parasite found in a large number of warm blooded mammals, 
and is the causative agent of Toxoplasmosis (Centers for 
Disease Control, 2015). T. gondii undergoes sexual 
reproduction within its definitive hosts, which are thought to 
be Felid species, including domestic cats (Webster, 2007).  
 
T. gondii infection has been reported in both wild and captive 
populations of elephants with no apparent clinical signs 
(Dangolla et al., 2006). A number of previous studies have 
investigated the prevalence of T. gondii in both captive and 
wild elephant populations. Using a modified agglutination test, 
Dangolla et al. (2006) found a serologic prevalence of (14/45) 
32% in captive Asian elephants located in Sri Lanka.  By 
contrast, a more recent study conducted in Thailand used a 
latex agglutination test to detect specific IgG antibodies, and 
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determined that antibodies were present in 33.04% of those 
studied (Wiengcharoen et al. (2012). The route of 
transmission to elephants and other herbivores is thought to 
be by ingesting oocysts shed by felids by faecal-oral 
transmission (Dubey, 2006), in contrast to the ingestion of 
infected meat associated with infection in carnivorous species 
(Dubey and Beattie, 1988). 
1.4.2.7 Encephalomyocarditis virus (EMCV) 
EMCV is a single stranded RNA virus with a worldwide 
distribution; it is a small non-enveloped Cardiovirus of the 
subfamily Picornaviridae (Grobler et al., 1995). It is thought to 
cause encephalitis, myocarditis, reproductive disorders and 
sudden death in pigs (Dea et al., 1991, Koenen et al., 1999).  
There are currently no drugs available for the treatment of 
EMCV, however, treatment with iodine-based disinfectants at 
60ᵒC for 30 minutes can inactivate the virus (Carocci and 
Bakkali-Kassimi, 2012). 
 
The route of transmission is thought to be either from eating 
infected rodents (in carnivorous species), or from food and 
water supplies contaminated with the faeces of infected 
rodents (Maclachlan and Dubovi, 2011). EMCV has been 
reported worldwide in a number of species, including in zoos 
located in Australia (ring tailed lemur (Lemur cata), squirrel 
                                                                   Literature review 
 
51 
     
monkey (Saimiri sciureus), mandrill (Mandrillis sphinx), 
chimpanzee (Pan troglodytes), pygmy hippopotamus 
(Choeropsis liberiensis), and goodfellow’s tree kangaroo 
(Dendrolagus goodfellowi)) and Italy (Black lemur (Eulemur 
macaco macaco), ring tailed lemur (Lemur cata), red ruffed 
lemur (Varecia variegata), white fronted lemurs (Eulemur 
albifrons), Barbary macaque (Macaca jacchus), common 
marmoset (Callithrix jacchus)) (Reddacliff et al., 1997, Canelli 
et al., 2010).  
 
EMCV has also been reported in wild African elephants in 
South Africa, and in pig herds in Belgium, Cyprus, Greece, UK, 
Austria, USA, Korea and Japan. 
A study of European (Italy, Greece, Belgium, Cyprus, France, 
Austria and UK) pigs using serologic detection, suggested 
prevalence rates in endemic areas (defined as an area where 
EMCV occurs regularly) of 8.2% to 66% and non-endemic 
areas of 0% to 5.4% (Maurice et al., 2005).  Serological 
prevalence rates in pigs have also been reported outside 
Europe including Korea (6.9-12.4%) and Japan (up to 56%) 
(Sato et al., 1998, Lyons, 2015). 
EMCV has been reported in both wild and captive populations 
of African and Asian elephants, and has resulted in death 
(Simpson et al., 1977, Gaskin et al., 1980, Grobler et al., 
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1995, Richman et al., 1999, Lamglait et al., 2015). A variety 
of tissues can test positive for EMCV using methods which 
detecting responses from the host’s immune system, and 
those directly detecting EMCV RNA.  Viral isolation has been 
successful from a number of tissues including heart, liver, 
kidney, spleen and pancreas in a range of primates and 
hoofed animals (Wells et al., 1989). Osorio et al. (1996) 
tested an EMCV vaccine in pigs, baboons and macaques; the 
vaccine was developed using a genetically modified 
mengovirus. In baboons, it may be necessary to give multiple 
vaccinations, depending on the size of the animal and the 
dosage administered. An alum adjuvant vaccine for use in pigs 
has also been developed, this vaccine uses an inorganic 
aluminium salt as the adjuvant; trials of the vaccine protected 
against EMCV challenge in pregnant sows. The number of 
abortions and stillborn animals was less in the vaccinated 
animals compared to controls (Jeoung et al., 2012). There 
have been a number of vaccine trials, but a vaccine for EMCV 
in pigs is not currently available for commercial use in the UK 
(National Office of Animal Health, Unknown) or in the USA 
(United Sates Department of Agriculture and Animal and Plant 
Health Inspection Service, 2013). An experimental oil-
adjuvant vaccine has also been trialled in a group of juvenile 
African elephants after it showed success in both mice and 
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pigs. The  juvenile elephants were vaccinated and 
subsequently exposed to EMCV; they showed high levels of 
antibody titres, and none showed any clinical signs of disease 
(Hunter et al., 1998).  
1.4.2.8 Elephant Endotheliotropic Herpesvirus 
(EEHV) 
EEHV is a double stranded DNA herpesvirus found in African 
and Asian elephants both in the wild and in captivity (Fickel et 
al., 2001, Reid et al., 2006). The first noted case of a herpes 
like virus of elephants was found in the lungs of wild African 
elephants in Southern Africa (McCully et al., 1971).  
 
In Asian elephants, EEHV is thought to be associated with 
haemorrhagic disease, and can result in sudden death. It is 
thought to be species specific; currently only elephants are 
thought to be affected this includes both African and Asian 
elephants. Clinical signs in Asian elephants include anorexia, 
lethargy, cyanosis of the tongue and sudden death (Ossent et 
al., 1990, Richman et al., 1999, Richman et al., 2000a, Ehlers 
et al., 2001, Garner et al., 2009, Sripiboon et al., 2013, Atkins 
et al., 2013).  
 
 In African elephants, clinical cases are rarely reported. The 
naming convention for the elephant-specific herpesvirus is 
                                                                   Literature review 
 
54 
     
currently under much debate; many publications refer to the 
virus as Elephant Endotheliotropic Herpesvirus (EEHV), 
whereas others refer to the virus as EIHV (Elephantid 
herpesvirus) (Ehlers et al., 2006). The current taxonomic 
naming convention mentioned in The International Code of 
Virus Classification and Nomenclature refers to the virus as 
Elephantid herpes virus; however, the accepted acronym is 
not mentioned (Törün et al., 2005). Throughout this study it 
will be referred to as EEHV. 
 
This virus will be discussed in greater detail in section 2.6.3. 
1.5      Herpesviruses 
1.5.1      Taxonomy 
Herpesviruses are large linear double stranded, enveloped 
viruses; they are members of the Herpesviridae family. There 
have been around 200 herpesviruses described, but the actual 
number in nature is likely to be higher as many may be 
currently undetected due their life cycle. They are found in a 
wide range of species, including humans. Most species are 
host to multiple herpesviruses (Pellett and Roizman, 2007).   
 
The Herpesvirales order contains three families.   
Alloherpesviridae, which contains herpesviruses known to 
infect fish and amphibians. 
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Herpesviridae, which contains three sub families 
(Alphaherpesvirinae, Betaherpesvirinae and 
Gammaherpesvirinae) of viruses known to infect mammals, 
reptiles and birds (Figure 4). There are 4 genera within each 
subfamily; Alphaherpesvirinae contains the following genera: 
Iitovirus, Mardivirus, Simplexvirus and Varicellovirus, 
Betaherpesvirinae: Cytomegalovirus, Muromegalovirus, 
Proboscivirus and Roseolovirus, and Gammaherpesvirinae, 
Lymphocryptovirus, Macavirus, Percavirus and Rhadinovirus 
(Figure 4). Malacoherpesviridae contains herpesviruses known 
to infect bivalves. There are also a number of unassigned 
herpesviruses that have not been assigned to a particular 
family (Davison 2009).  
 
For a virus to be included in the Herpesviridae family the 
primary criterion is virus morphology: it must have a spherical 
shape, and consist of four components which include the core, 
Figure 44: The order Herpesvirales including examples of viruses within 
each sub family. The above diagram is adapted from (Davison et al., 2009, 
Maclachlan and Dubovi, 2011) 
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the capsid, the envelope and the tegument. The core must 
contain a single copy of double-stranded, linear DNA which is 
packed into the capsid at a high density, and the capsid must 
also be icosahedral in shape (Mundy, 2014). Virus morphology 
is used to determine families, whereas serology (using 
neutralizing antibodies which are targeted against envelope 
glycoproteins) and genomics (to determine nucleic acid 
similarity) are used to determine how closely related the 
viruses are to one another (Mundy, 2014).  
 
Viruses in the Alphaherpesvirinae genus have a short 
replication cycle and have a wider host range than the Beta 
and Gammaherpesviruses  (Pellett and Roizman, 2007), 
Alphaherpesvirinae currently includes 36 species in 5 genera.  
 
All Betaherpesviruses are highly species-specific in their 
infectivity. They have a long slow replication cycle in 
comparison to Alphaherpesviruses, and remain cell associated 
(contained within cells) (Mocarski Jr et al., 2007). The latent 
stage of the Betaherpesvirinae subfamily occurs within 
leukocytes (Pellett and Roizman, 2007). Betaherpesviruses are 
found in a number of animals including humans, there are 
currently 15 herpesviruses assigned to 4 genera in this genus 
including EEHV1. 
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 Gammaherpesviruses have a narrow host range, and 
replication speed differs depending on the viral strain. Latency 
occurs within lymphocytes, and replication occurs within the 
epithelial cells of the host. Gammaherpesvirinae currently 
contains 29 species contained within 4 genera.  
 
A fourth sub-family Deltaherpesvirinae has recently been 
suggested. Proposed viruses to be included within this sub -
family are EEHV1A, EEHV1B and EEHV2, as it is thought that 
they evolved as a branch between Beta and 
Gammaherpesvirinae. EEHV is currently included in the 
Betaherpesvirinae sub-family along with a number of other 
betaherpesviruses of mammals. EEHV is included in the genus 
Proboscivirus, it is the only virus in this genus (Figure 5). 
 
 
Figure 45: Sub family Betaherpesvirinae showing the position of 
Elephantid herpesvirus 1 within the four genera. The herpesvirus found in 
elephants is highlighted in red. Adapted from (Davison et al., 2009) 
1.5.2      Structure 
Herpesviruses can range in size from 120-260nm (Pellett and 
Roizman, 2007). The virion has several components including 
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the core, the capsid, the tegument and the envelope (Figure 
6).  
 
 
Figure 46: Herpesvirus structure diagram showing major components. The 
complex structure of a herpesvirus includes a large number of glycoprotein spikes 
attached to the lipid envelope, an outer tegument located between the tegument 
and the lipid envelope, the tegumet located between the inner and outer tegument, 
an inner tegument located between the tegument and the capsid, an icosahedral 
capsid and a DNA core containing linear DNA. Diagram adapted from Amen 2011. 
 
The core consists of DNA wrapped around a torus,  a 
cylindrical structure, 70nm in external diameter and 50nm in 
height (Furlong et al., 1972). The viral capsid consists of 162 
capsomers (12 pentons and 150 hexons) and is icosahedral in 
shape; the role of the capsid is to encase and protect the DNA  
(Pellett and Roizman, 2007, Brown and Newcomb, 2011). The 
tegument is variable in size and shape and forms a layer 
around the capsid (Rixon, 1993). Mettenleiter et al. (2006) 
suggested that the tegument is split into two subcellular 
compartments, the inner and the outer tegument, with each 
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compartment containing a different array of proteins.  The 
lipid envelope encases the complete virion, comprising of host 
cell lipids with a number of glycoprotein spikes protruding 
from the envelope surface (up to 14nm in length). A well-
studied example, Human Herpes simplex virus, has three 
distinct types of spikes containing the glycoproteins: 
glycoprotein B (gB), glycoprotein C (gC) and glycoprotein D 
(gD). Their distribution across the envelope differs; gB spikes 
occur in clusters and are the most numerous, gC spikes occur 
randomly, and gD spikes appear to be irregularly distributed 
(Stannard et al., 1987). 
 
1.5.3      Genome organisation 
The core of a herpesvirus consists of viral DNA, which  is linear 
and double stranded; the size of the DNA varies between 120-
250 kilo-base pairs (kbp), depending on the species of virus 
(Pellett and Roizman, 2007).  There are 40 conserved genes 
found in all alpha, beta and gamma herpesviruses, these are 
known as the core genes which encode for proteins involved in 
the metabolism of nucleic acid, structure of the virion and DNA 
replication, they are arranged in seven gene blocks (Table 2).  
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Table 2: Conserved gene blocks across all herpesviruses, HHV6 names and 
numbering are used as examples, source: Firyal and Naureen (2007). 
Block Genes Properties 
I U27-U37 Tegument encoding proteins, DNA packing, capsid 
assembly and DNA polymerase gene 
II U38-U41 DNA polymerase gene, glycoprotein B gene and 
capsid assembly 
III U42-U46 DNA binding protein, tegument proteins, 
glycoprotein N gene and DNA helicase complex 
IV U48-U53 Glycoprotein gH, fusion protein, DNA packaging, G 
protein receptor gene, and capsid assembly protein 
gene 
V U56-U57 Major capsid protein 
VI U64-U77 Several virion proteins, helicase primase complex, 
Glycoprotein M and alkaline exonuclease 
VII U81-U82 Uracil-DNA glycosylase and Glycoprotein L 
 
There are a number of genes that are unique to each 
subfamily, including a tegument associated gene and a 
transcriptional regulatory protein which are unique to the 
Alphaherpesviruses. Betaherpesviruses have a unique gene 
block (U2-U19) which is unlike any other within the 
Herpesvirus family; the gene block encodes a group of 14 
proteins (Table 3). Gammaherpesviruses possess a unique 
gene block which encodes proteins essential for maintaining 
latency, whilst the genes for latency are spread throughout 
the genome for Alpha and Beta herpesviruses. There are also 
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a number of unique genes belonging to each viral species, and 
additional ones for the various strains within each species 
(Pellett and Roizman, 2007). These unique genes can be used 
to help identify the viral species and strains. 
 
Table 3: Betaherpesvirus specific genes and their properties, sources: 
Gompels et al. (1995) and Dominguez et al. (1999). 
Gene Properties 
U2 Tegument protein 
U3 Tegument protein 
U4 HCMV Maribavir resistance 
U7 HCMV U22 gene family 
U10 dUTPase family 
U11 Antigenic tegument protein 
U12 Chemokine G protein-coupled receptor 
U13 Represses US3 transcription 
U14 Antigenic tegument protein 
U15 HCMV UL25 gene family 
U17 Tegument protein 
U18 Membrane glycoprotein 
U19 Glycoprotein 
 
The MHV-68 gene is found in Gammaherpesviruses such as 
EBV, it is a unique gene that encodes M2 latency associated 
protein. It may be used as a potential target to disrupt 
/prevent the establishment of latency (Husain et al., 1999). 
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1.5.4      Replication 
1.5.4.1 Early and late phases 
Replication of HSV1 has been studied extensively, and is the 
standard model used for the study of herpes viruses, and has 
been chosen for this review for this reason. However, it is 
likely there are variations in the cycle depending on the 
individual herpesvirus. The replication process will be 
explained for Herpes Simplex Virus 1 as it is a highly studied 
virus. Attachment to the host cell occurs when the herpesvirus 
glycoprotein spikes bind to the host cell receptors; the viral 
envelope then fuses with the cell plasma membrane (Pellett 
and Roizman, 2007). The envelope opens, and the capsid 
containing viral DNA is released and transported to the 
nucleus, via the nuclear pores. When viral DNA enters the 
nucleus, it causes host-cell macromolecule synthesis to stop.  
During the early phase, two different mRNA’s are then 
transcribed to form α and β proteins, which are DNA binding 
proteins and enzymes. Firstly, α proteins are produced; this 
then initiates the transcription and translation of β proteins. 
Viral replication occurs using both the α and β proteins. In the 
late phase, γ proteins are produced after DNA synthesis has 
been initiated; these γ proteins are structural (Boehmer and 
Nimonkar, 2003, Pellett and Roizman, 2007, Cecil et al., 
2008). 
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1.5.4.2 Viral DNA replication 
DNA replication occurs within the nucleus. HSV has seven core 
genes essential for replication (Table 4): this includes UL9, a 
gene which is only found in alpha herpesviruses. 
 
Table 4: Core HSV genes which are essential for DNA replication. 
Gene Abbreviation Function Present in 
UL29 ICP8 Single stranded DNA-binding 
protein 
All known 
herpesviruses 
UL42  Processivity subunit of DNA 
polymerase 
All known 
herpesviruses 
UL5  Subunit of helicase/primase; 
contains helicase motifs 
All known 
herpesviruses 
UL8  Subunit of helicase/primase; 
interacts with other proteins 
All known 
herpesviruses 
UL52  Subunit of helicase/primase; 
contains primase motifs 
All known 
herpesviruses 
UL30  DNA polymerase All known 
herpesviruses 
UL9 OBP Origin-binding protein, helicase Alpha 
herpesviruses 
 
Replication is initiated at one of the three viral origins of 
replication (Ori 1, Ori2 and Ori 3) which are specific areas 
within the genome. UL9 an origin binding protein which 
contains DNA helicase motifs and an ATP binding site then 
unwinds and binds to the DNA (Taylor et al., 2002). ICP8 a 
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major single stranded DNA binding protein is attached to the 
unwound DNA. HSV1 Helicase/primase complex a complex 
heterodimer, and a DNA polymerase holoenzyme (a 
heterodimer) is then recruited to the replication forks, and 
bind to DNA (Taylor et al., 2002). Synthesis of DNA proceeds 
via a theta replication mechanism. During the replication to a 
circular DNA molecule, a theta structure is formed. Two 
replication forks are formed; these are created from helicases 
breaking bonds holding the double stranded DNA together, 
this results in a section of double stranded DNA with two 
single stranded DNA prongs at the end. The prongs serve as 
the leading strand template and the lagging strand template 
(Waga and Stillman, 1998, Johnson and O'Donnell, 2005). 
Replication then switches to a rolling circle replication 
mechanism, which is a unidirectional process of nucleic acid 
production, where synthesis occurs rapidly. It is thought that 
replication is swapped to the rolling circle mechanism to 
enable to majority of progeny genomes to be synthesised 
(Jacob et al., 1979) (Figure 7).   
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Figure 47: HSV DNA replication adapted from Taylor et al. (2002). There are 
five main stages of HSV DNA replication: 1, UL9 (blue circle) binds to the DNA and 
begins to unwind it, this occurs at a specific site at an origin of replication, 2, ICP8 
(orange circle), a single stranded binding protein is then recruited to the unwound 
DNA, 3, IPC8 and UL9 then recruit the helicase/primase complex (purple circle) and 
DNA polymerase holoenzyme (green circle) to the replication forks, 4, DNA 
synthesis begins via a theta replication mechanism, 5, replication then switches to 
a rolling circle mechanism. 
 
1.5.4.3 Viral protein production 
For viruses to be able to reproduce, they must produce 
proteins, and therefore they must transcribe and translate 
mRNAs from their genomes. The mechanism used varies 
depending on the viral family. Important proteins made by 
viruses include viral immunomodulatory proteins which are 
used to evade the immune response (Husain et al., 1999). 
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1.5.4.3.1      Viral immunomodulatory proteins 
Virokines (ligand like) and viroreceptors (receptor-like) are 
immunomodulatory proteins which are encoded by some large 
DNA viruses, including herpesviruses (Husain et al., 1999, 
Lucas and McFadden, 2004). They are produced by the host 
cell, and are used by the virus to evade the host’s acquired 
and innate immune response. Virokines are able to occupy the 
binding site, this process uses competitive inhibition of host 
signalling molecules, the result of this means signalling 
molecules are then unable to access their target site. The 
virokine is then sequestered by the cytokine binding protein, 
obstructing the binding site.  The host’s immune response can 
be reduced as interaction with receptors has been interrupted 
(Reddacliff et al., 1997). Another way in which viruses are 
able to evade the host’s immune system is the modulation of 
chemokine activity through the expression of type 1 
transmembrane proteins called viral chemokine binding 
proteins. The viral chemokine binding proteins bind to 
chemokines and are then able to modulate their activity 
(González-Motos et al., 2016). 
1.5.4.4 Virion assembly and egress 
In the generic herpesvirus replication cycle, assembly of the 
new virion occurs within the nucleus of the host cell. The 
newly replicated viral DNA is packaged into a new capsid and 
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matures; infectivity is acquired via budding through the 
nuclear membrane (Pellett and Roizman, 2007). The new 
virion is transported through the Golgi apparatus, where 
glycosylation occurs: glycans are attached to the lipid 
envelope, creating glycoprotein spikes (Cecil et al., 2008). 
Finally, egress occurs when the virion is transported to the cell 
membrane; the progeny exit the cell via the exocytosis 
pathway. When viral exit or egress occurs, progeny are 
released and subsequently cause host cell death (Hunt, 2013) 
(Figure 8). 
 
Figure 48: Herpes virus replication cycle adapted from Cecil et al. (2008). 
The herpesvirus enters the host cell; the capsid disintergrates releasing viral DNA, 
which is then transported to the nucleus where transcription occurs. The viral DNA 
is encapsulated within a capsid, and the virion is transported through the 
endoplasmic reticulum and golgi apparatus. Within in the Golgi apparatus, the 
virion undergoes glycosylation, which is a process where glycans are attached. The 
virion is then transported to the cell membrane inside Golgi derived vesicles. The 
new virion progeny is then released from the cell, and the host cell subsequently 
dies. 
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1.5.5      Latency and reactivation 
All herpesviruses are capable of maintaining latency within the 
host’s cells; where this occurs depends upon the species of 
herpesvirus. Alphaherpesviruses, such as HSV and VZV in 
humans, establish and maintain latency within neurons, which 
are non-dividing cells. This is achieved as the virus migrates 
into the neurons in the peripheral tissue. The virus then 
invades the nucleus and becomes circularized; the genome is 
then maintained in this form (Gupta et al., 2008). HSV 
remains completely inactive during latency, whereas VZV does 
not, some proteins are still able to be detected, these include 
intermediate-early and early proteins. During an active 
infection these proteins are intranuclear, whereas during a 
period of latency these proteins accumulate in the cytoplasm 
of the infected neurons (Van Eys et al., 1989). It is thought 
that HSV1 avoids cell death by restricting viral gene 
expression; the only gene transcribed during HSV latency is 
latency associated transcript (LAT). LAT is RNA which 
accumulates within the nuclei of infected cells. LAT is able to 
interfere with the normal function of the infected cell, it also 
regulates viral gene expression (Block and Hill, 1997).  
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Infection with a herpesvirus can result in a lifelong infection 
with long periods of viral latency; viral reactivation may occur 
during stress or low immunity and result in clinical disease.  
 
When reactivation of the herpesvirus occurs through events 
such as stress, lytic replication is resumed, and the infected 
cell and its membrane is destroyed. The virus reactivates 
within the neuron, and is transported to the skin or mucosal 
surface. Lesions caused by herpesvirus infection are not 
limited to the initial site of infection, as the virus is able to 
travel along the axon and exit the nerve at any branch of the 
axon (Gupta et al., 2008). 
1.5.6      Herpes induced disease 
Herpesviruses cause a wide range of symptoms and diseases 
in both humans and animals (Table 5). Humans are currently 
the only host species that can be infected with herpesviruses 
from all subfamilies, there are eight species known to infect 
humans. Human herpesviruses include HSV1 and HSV2, both 
belonging to the subfamily Alphaherpesvirinae, and known to 
cause ulceration on the genitals or oral mucosa, though an 
attack of genital herpes is more commonly associated with 
HSV2 (Fleming et al., 1997, Lafferty et al., 2000, Pellett and 
Roizman, 2007). Varicella Zoster virus is also an 
alphaherpesvirus and is the causative agent of chicken pox 
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and shingles, also common among humans (Pellett and 
Roizman, 2007). Symptoms of chickenpox are commonly a 
pruritic vesicular rash which can be located in widespread 
areas on the body. Reactivation of VZV leads to shingles, the 
rash is localised and painful (Arvin, 1996).  
 
Epstein-Barr virus (EBV) is a gammaherpesvirus which is 
thought to be associated with carcinomas and lymphomas 
such as Burkitt’s lymphoma (zur Hausen et al., 1970, Lindahl 
et al., 1974, Pellett and Roizman, 2007). Patients infected 
with EBV may show symptoms such as fever, cough, rashes, 
and lymphadenopathy (Ellis, 2014). EBV has also been 
associated with infectious mononucleosis (glandular fever) and 
tonsillitis, the symptoms of which include pharyngitis, malaise, 
splenomegaly, hepatomegaly and jaundice (Shigeta et al., 
1983, Kleymann et al., 2002, Bailey, 1994, Rothman, 2002). 
 
Human cytomegalovirus (HCMV) is a betaherpesvirus found in 
up to 90% of adults, most adults are asymptomatic and 
people rarely experience fever and/or mild hepatitis (Staras et 
al., 2006). Reactivation of the virus and a recurrent infection 
are rare unless the person is immunocompromised, where the 
following symptoms may be observed: retinitis, nephritis and 
cystitis (Ljungman et al., 2002). Human herpesviruses 6, 7 
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and 8 are less studied.  HHV6 and 7 are members of the 
betaherpesvirus subfamily, HHV6A has been associated with 
multiple sclerosis, HHV6B and HHV7 have been associated 
with exanthema subitum also known as sixth disease, clinical 
symptoms include rashes on the trunk spreading to other 
parts of the body and fever (Yamanishi et al., 1988, Tanaka et 
al., 1994, Challoner et al., 1995, Amo et al., 2003). The 
eighth human herpesvirus is HHV-8, has been associated with 
Karposi’s sarcoma (Gillison and Ambinder, 1997). 
  
There are a large number of important herpesviruses in 
animals, of which only some will be discussed (Table 5). A 
number of domestic species such as cattle, horses and dogs 
can be affected. Cattle can be infected with Bovine 
herpesvirus 1 (BVH1) known to cause rhinotracheitis, vaginitis 
and abortions (National Research Council Committee on 
Methods of Producing Monoclonal Antibodies, 1999, Quignot et 
al., 2014). Equid herpesvirus 1 (EHV1) affects both domestic 
and wild equids, and is known to cause abortions and 
neurological problems (Edington et al., 1991, Mumford et al., 
1994, Borchers et al., 2006). Canine herpesvirus 1 affects 
both domestic dogs and wild canines, and was first associated 
with fatal haemorrhagic disease in 1965, it has since also been 
associated with fertility disorders such as embryonic 
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reabsorption and neonatal mortality (Carmichael et al., 1965, 
Ronsse et al., 2002, Ronsse et al., 2004, Ronsse et al., 2005). 
Alcelaphine Herpesvirus 1 (AIHV1) is associated with bovine 
malignant catarrhal fever, the clinical signs of which include 
fever, ocular and nasal discharge, lesions in the mouth and 
vasculitis, death may occur within several days (Liggitt and 
DeMartini, 1980, Schultheiss et al., 1998, Schultheiss et al., 
2000). Neurological signs may also be present in some 
animals including ataxia, corneal opacity may occur which can 
lead to blindness (Albini et al., 2003, Mitchell and Scholes, 
2009). Whilst the natural host for AIHV1 is cattle, wildebeest 
act as an asymptomatic reservoir host and AIHV1 is thought 
to derive from the Wildebeest (Wambua et al., 2016). Another 
virus which is associated with malignant catarrhal fever is 
Ovine Herpesvirus 2 (OVHV2) which is thought to cause sheep 
associated malignant catarrhal fever. OVHV2 is contracted via 
contact with sheep; the primary mode of transmission is 
thought to be via nasal secretions (Li et al., 2004, Berezowski 
et al., 2005). 
 
A number of different animal species such as pigs, cattle and 
bison have been known to be infected with the virus, which 
can cause large outbreaks (Reid and Pow, 1998, Schultheiss et 
al., 2000, Simon et al., 2003). 
                                                                   Literature review 
 
73 
     
Table 5: Important herpesvirus of humans and animals including disease 
association, this list is not exhaustive. Information sourced from (Braun et al., 
1997, Pellett and Roizman, 2007, Ernest et al., 2000). 
 
1.5.7      Cross species transmission of herpesviruses 
Many herpesviruses are host specific; however, a few are 
epizootic and zoonotic. Equine herpesvirus 1 and 9 are 
examples of such; both are alphaherpesviruses and are 
members of the Varicellovirus genus. Equine herpesvirus 1 
(EHV1) is the causative agent of respiratory illnesses in 
Herpesvirus Primary host Disease association 
Human Herpesvirus 1 (HSV-
1) 
Humans Oral/genital herpes 
Human Herpesvirus 2 (HSV-
2) 
Humans Genital herpes 
Human Herpesvirus 3 (VZV) Humans Chicken pox and shingles 
Human Herpesvirus 4 (EBV) Humans Associated with Burkitt’s 
lymphoma and 
nasopharyngeal carcinoma 
Human Herpesvirus 5 (HCMV) Humans Major cause of deafness and 
retardation 
Human Herpesvirus 6A (HHV-
6) 
Humans Possible association of HHV-
6A and multiple sclerosis. 
HHV-6B is associated with 
exanthema subitum 
Human Herpesvirus 7 (HHV-
7) 
Humans Associated with exanthema 
subitum 
Human Herpesvirus 8 (HHV-
8) 
Humans Associated with Karposi’s 
sarcoma 
Bovine Herpesvirus 1 (BHV-1) Cattle Rhinotracheitis, vaginitis and 
abortion 
Equine Herpesvirus 1 (EHV-1) Equids Respiratory disease and 
neonatal mortality 
Alcelaphine Herpesvirus 1 
(AIHV-1) 
Wildebeest 
and 
Hartebeest 
Bovine malignant catarrhal 
fever 
Canine herpesvirus 1 (CHV-1) Canines Fatal haemorrhagic disease 
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horses, and is associated with abortion or neurological 
disease. EHV1 has been isolated in a number of other species, 
including other equids such as various subspecies of Zebra 
(Equus quagga, Equus quagga boehmi, Equus quagga 
burchellii and Equus grevyi ) and Persian onager all of which 
were isolated from captive animals (Borchers et al., 2005, 
Ghanem et al., 2008, Ibrahim et al., 2007, Guo et al., 2014). 
Many cases of fatal encephalitis linked to the presence of 
EHV1 have occurred in non-equids, including guinea pigs 
(captive), Thompson’s gazelle (captive), Indian rhinoceros 
(captive), black bears (captive), camels (captive) and llamas 
(experimental captive infection) (House et al., 1991, Bildfell et 
al., 1996, Wohlsein et al., 2011, Abdelgawad et al., 2013). 
There are also cases of zoonotic transmission of Herpes simian 
B virus, the natural host of which is macaque monkeys. 
Herpes B virus is also an alphaherpesvirus, in the genus 
Simplexvirus. Since the discovery of Herpes B virus in the 
1930’s there have been around 40 documented human 
infections (Fu and Fu-Liu, 2002). Clinical signs in macaques 
include conjunctivitis, genital ulcers and gingivostomatitis 
causing mild disease; in humans, signs can include weakness, 
numbness, dizziness, conjunctivitis, flu-like symptoms, 
headache, and burning dysesthesia, and in some cases fatal 
encephalomyelitis can occur (Davenport et al., 1994). 
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A number of cases have been reported in those that have 
close contact with macaques, such as veterinary and 
laboratory staff. Transmission in these cases has occurred by 
needlestick injury, bites and scratches (Sabin and Wright, 
1934, Breen et al., 1958, Davenport et al., 1994, Artenstein et 
al., 1991).  
1.5.8      Herpesvirus infections during pregnancy 
In humans, acquiring a herpesvirus infection during pregnancy 
can have major health consequences; it has been associated 
with spontaneous abortion, congenital herpes, neonatal herpes 
and prematurity. It has been reported that 2% of women 
acquire HSV infections during pregnancy (Brown et al., 1997). 
The time of acquisition may also be significant: acquisition 
within 6 weeks of labour is often associated with neonatal 
herpes (Brown et al., 1997). There is some evidence of low 
birth weight and prematurity if HSV1 or 2 is acquired during 
the third trimester. Caesarean section is recommended for 
women with genital herpes to prevent the new-born coming 
into contact with lesions during birth (Tsara et al., 2009).  
1.5.9      Diagnostic methods 
Herpesvirus infections can be diagnosed by a variety of 
methods, including: direct detection of viral proteins or DNA 
through ELISA and PCR, detection of the host’s immune 
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response to the virus, and viral culture. Viral culture is used in 
the detection of genital HSV, and is described as the gold 
standard method, whereas PCR is used for HSV of the central 
nervous system (Frantz et al., 2003). However, it can be 
difficult to amplify DNA in some samples using PCR due to the 
presence of inhibitors, such as faecal and blood samples 
(Monteiro et al., 1997, Al-Soud et al., 2000). 
For culture, a wide variety of samples can be used such as 
swabs of skin lesions, vesicular fluid from a lesion or a 
mucosal sample of an area with a lesion. However, culturing 
the virus is less sensitive than other methods, such as PCR, 
and results can take up to 7 days. Cultures must also be 
conducted in specialised laboratories, sample transport 
conditions and storage can affect the sensitivity (Yeager et al., 
1979). Molecular methods can be used to detect viral DNA of 
HSV, including PCR. The advantage of using PCR is its high 
sensitivity, but it is not quantitative and cannot measure the 
amount of virus present unless qPCR is used (Slomka et al., 
1998, Ryncarz et al., 1999, Engelmann et al., 2008). 
Several serological methods for the detection of antiviral 
antibodies have been used in detecting HSV, including 
Western blotting for HSV1 (University of Washington, 2017).  
This is the gold standard test proposed by some institutions, 
but it is not commercially available.  ELISA may also be used 
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on serum samples, but in some circumstances there may be 
issues with both sensitivity and specificity (Baker et al., 1989, 
Turner et al., 2002, Elshal and McCoy, 2006). 
.  
1.5.10  Treatment 
Several drugs are available for the treatment of Herpesvirus 
infections; these include nucleoside analogues such as 
famciclovir, aciclovir, ganciclovir, vidarabine, valganciclovir 
and valaciclovir, cidofovir, trifluridine, and idoxuridine. Other 
drugs include foscarnet which is derived from phosphoric acid 
and fomivirsen a synthetic oligonucleotide. Administration of 
antivirals is achieved via a variety of routes including oral, 
intravenous, topical and as eye drops, this varies depending 
on the drug (De Clercq, 2004) (Table 6). 
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Table 6: Drugs used to treat Herpesvirus infections. Information sourced from 
(De Clercq, 2004) . 
 Orally Intravenous Topical Eye drops 
Penciclovir   Yes  
Famciclovir Yes    
Ganciclovir Yes Yes   
Aciclovir Yes Yes Yes Yes 
Valalciclovir Yes    
Valganciclovir Yes    
Cidofovir  Yes   
Vidarabine  Yes  Yes 
Trifluridine    Yes 
Idoxuridine    Yes 
Foscarnet  Yes   
Formivirsen  Yes   
 
1.5.10.1      Nucleoside analogues  
Nucleoside analogues include vidarabine, aciclovir, penciclovir, 
famciclovir, ganciclovir, valaciclovir, valganciclovir, cidofovir, 
trifluridine, and idoxuridine. They are initially phosphorylated 
by a nucleoside kinase such as herpesvirus thymidine kinase, 
which leads to the production of a monophosphate metabolite. 
A nucleoside monophosphate kinase then performs a second 
phosphorylation; a final third phosphorylation step is then 
completed by a nucleoside diphosphate kinase. The 
triphosphates can either inhibit essential enzymes which then 
inhibit nucleic acid synthesis, or they can be incorporated into 
the nucleic acids, where there is then competitive inhibition 
with their normal counterparts, which then prevents the virus 
from replicating (Jordheim et al., 2013) (Figure 9). 
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Figure 9: The mechanism of action of nucleoside analogues. Image 
adapted from Jordheim et al. (2013). The process of the cellular uptake of 
nucleoside analogues involves concentrative nucleoside transporters (CNT’s) and 
equilibrative nucleoside transporters (ENT’s). When the nucleoside analogue is 
within the cell it undergoes phosphorylation step where a phosphate is added this is 
performed by a nucleoside kinase, this leads to a monophosphate metabolite. A 
second phosphate is added, this is performed by a nucleoside monophosphate 
kinase, and a third phosphate is added this is performed by a nucleoside 
diphosphate kinase. An enzyme called Ribonucleotide reductase 1 (RRM1) is 
involved in nucleotide metabolism, dephosphorylated and triphosphorylated 
analogues can inhibit RRM1. The amount of active metabolites can be reduced by 
catabolic enzymes such as deaminases and 5’-nucleotidases. 
 
1.5.10.2      DNA polymerase inhibitors 
The antiviral drug Foscarnet is a DNA polymerase inhibitor 
which structurally mimics the anion pyrophosphate (Meyer et 
al., 2007). This drug works by inhibiting the pyrophosphate 
binding site on the viral DNA polymerases. The concentrations 
do not affect human polymerases, meaning the drug is less 
toxic than nucleoside analogues. There are advantages when 
using this drug: as it is not activated by viral protein kinases 
such as thymidine kinase, making it useful in the treatment of 
immunocompromised patients and in aciclovir or ganciclovir 
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resistant herpesvirus infections  (Trial, 1989, Safrin et al., 
1991, Jacobson et al., 1991, Morfeldt and Torssander, 1994, 
Mylonakis et al., 2002). However, mutants may also be 
resistant to Foscarnet (Weinberg et al., 2003).  The major 
disadvantage of Foscarnet in the treatment of HCMV infections 
in transplant patients, is its renal toxicity, which can lead to 
renal impairment (Lischka and Zimmermann, 2008).  
1.5.10.3      Synthetic oligonucleotide 
Fomivirsen is a synthetic oligonucleotide, and is also resistant 
to degradation by nucleases. It blocks the translation of viral 
mRNA by binding to the complementary sequence of mRNA 
(Malik and Roy, 2008). It is currently used in the treatment of 
HCMV, especially in immunocompromised patients as this drug 
does not target viral DNA polymerases. 
1.5.10.4      Vaccines 
For most herpesviruses, vaccines are not available; however, 
in humans, a successful vaccine has been created for VZV. 
The vaccine has been considered a success in both Germany 
and the USA. In Germany, between 2005 and 2009, there was 
a reduction in the number of chicken pox cases by 55% in all 
age groups (Siedler and Arndt, 2010). Between 1995 and 
2005 at two sites in the USA, varicella incidence decreased by 
90%; reductions were observed in all age groups (Guris et al., 
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2008). The herpes zoster vaccine ZOSTAVAX (Merck) is 
available in a number of countries including the UK.  
 
There have been a number of attempts to develop vaccines for 
other herpesviruses, specifically HSV1 and 2. One of these 
was Herpevac, a proposed vaccine against HSV2; in 2002 it 
was reported to be effective in women who were seronegative 
for HSV1 (Jacob et al., 1979). In 2010, a phase 3 trial for 
Herpevac conducted a study of 8323 women aged between 
18-30 and free of both HSV1 and 2. Each participant was 
vaccinated at the beginning of the study, and again 6 months 
later. After the initial injection participants were followed for 
20 months, and were evaluated for the presence of both HSV-
1 and 2. The study concluded that the vaccine was not 
commercially viable, as it was only effective in certain women 
and designed for a very narrow market (Galimand et al., 
2006). 
1.5.11  Control strategies 
A number of herpesviruses are classed as notifiable diseases, 
and the correct authority must be notified when a case occurs. 
Herpesviruses of animals are also included on the notifiable 
list in England/Wales and Scotland, with Koi herpesviruses 
needing to be reported in both England, Wales and Scotland, 
and Ostried herpesvirus in Scotland.  
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Vaccination against VZV at an early age can prevent the 
number of cases of chicken pox. Other advice is given to those 
with active herpesvirus infections to prevent the spread of the 
virus to others. This includes not taking children infected with 
VZV to school whilst they have weeping pustules, and for 
people infected with HSV, not sharing utensils or kissing 
others whilst they have a cold sore. A vaccine is also available 
for the prevention of equine herpesvirus 1 (EHV1) and 4 
(EHV4), it is suggested that vaccination should begin when 
foals are between 3-4 months old, second and third doses are 
also required at one month intervals, however, this may be 
different if the mare was not vaccinated (McCue, No date). 
Another vaccine is usually recommend for EHV1, an 
inactivated vaccine is given at 3, 5, 7, 9 months through 
pregnancy, this is to prevent EHV1 related abortion (McCue, 
No date). 
1.6      Herpesviruses of elephants 
Based on current literature three herpesviruses have been 
found in elephants, including bovine herpes, Elephant 
Gammaherpesvirus (EGHV) and EEHV (Metzler et al., 1990, 
Ossent et al., 1990, Latimer et al., 2011).  
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1.6.1      Bovine herpes 
Serological techniques have been used for the detection of 
Herpesvirus antibodies in elephants. Metzler et al. (1990) 
studied 17 captive Asian elephants for the presence of bovine 
herpesvirus antibodies using a number of serological tests. 
Sera used included pericardial fluid, blood and lyophilized 
serum samples. Samples were tested for antibodies to BHV1, 
BHV2 and BHV4. Serological tests included a 
seroneutralisation test, radio-immunoprecipitation and sodium 
dodecyl sulphate – polyacrylamide gel electrophoresis (SDS-
PAGE), and antibodies for 3 bovine herpesviruses were found 
in all elephants tested. The titres for bovine herpesvirus were 
at low levels, the study also suggests that this level was 
potentially low due to the serology being conducted with 
heterologous viruses, which potentially meant only cross-
reacting antibodies were detected. However, the evidence 
from this study may not be robust and is limited as the study 
highlights that there may be a limitation as BHV2 may have 
been neutralized by the generation of antibodies from a HSV 
infection (passed from humans) however, this is unlikely, 
repeat or duplicate samples are also not described which limits 
the validity of the results. The study included samples from 21 
captive Asian elephants, sera would need to be obtained from 
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more captive and free ranging Asian and African elephants to 
provide conclusive evidence. 
1.6.2      Elephant gamma herpesviruses 
There are six Elephant Gammaherpesviruses: Elephant 
Gammaherpesvirus 1 (EGHV1), EGHV2, EGHV3, EGHV4, 
EGHV5 and EGHV6. There are two strains of EGHV3: EGHV3A 
and EGHV3B. EGHV3B is found in African elephants and 
EGHV3A is found in Asian elephants. These have been 
detected (in conjunctival and genital secretions of 
asymptomatic animals) using PCR to amplify the DNA 
polymerase gene (Wellehan et al., 2008, Latimer et al., 2011). 
EGHVs have not been associated with clinical disease, and 
their prevalence among different elephant populations is 
unknown. However, Latimer et al. (2011) reported cases in 
which there was a co-infection of EEHV and EGHV, and  
Masters et al. (2011) documented a case in which EGHV5 was 
detected by PCR in a biopsy sample from a mass in the nostril 
of a 26 year old female Asian zoo elephant. 
1.6.3      Elephant Endotheliotropic Herpesvirus (EEHV) 
1.6.3.1 EEHV phylogeny 
EEHV is a virus of both African and Asian elephants. It was 
previously suggested that EEHV originated in the African 
elephant and spread when African and Asian elephants came 
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together or were co-housed in a zoo environment (Richman et 
al., 1999, Richman et al., 2000b). This is no longer the 
accepted theory, as EEHV has been found in Asian elephants 
with no previous contact with African elephants, and at high 
prevalence rates in Asian elephant range countries (Stanton et 
al., 2014). 
1.6.3.2 Variants 
There are thought to be several variants of EEHV. Two of the 
variants, EEHV1 and 2 have been identified based on sections 
of the U60 terminase gene and the U38 DNA polymerase 
gene. Further analysis has shown two chimeric variants of 
EEHV1, named EEHV1A and 1B. Although much of their 
sequence is very similar, differences can be seen in the 
glycoprotein B, O and H genes and the thymidine kinase gene 
(Ehlers et al., 2001, Fickel et al., 2001, Ehlers et al., 2006). 
EEHV3A and 3B are within a GC rich (67%) branch of the 
Probosciviruses, this is contrasted with the AT rich branch 
which includes EEHV1, 2, 5 and 6 (Latimer et al., 2011).  
It is thought that EEHV1,3,4, and 5 are all present in Asian 
elephant populations and EEHV 2,3,6 and 7 are present in 
African elephant populations (Hayward, 2012). For reasons 
that are poorly understood, most fatal cases of EEHV have 
been linked to EEHV1; deaths relating to EEHV4 and 5 have 
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also been reported but are thought to be rarer (Richman et 
al., 2000a, Denk et al., 2012, Sripiboon et al., 2013). 
1.6.3.3 EEHV in African elephants 
Nodular lesions associated with herpesvirus infection were first 
detected in African elephants in 1971 (McCully 1971); more 
recent research has identified multiple EEHV’s within the lung 
and splenic tissue of asymptomatic African elephants in South 
Africa, USA, Kenya and Spain. Samples from two wild 
elephants in South Africa were both positive for EEHV2.  Of 
the elephants located in the USA, one was positive for EEHV6, 
one for EEHV3, one for EEHV2 and one for EEHV7. Of the four 
animals located in Kenya, each of the animals tested positive 
for EEHV, EEHV2, EEHV3, EEHV6 or EEHV7. Samples from 3 
African elephants located in Spain each tested positive for a 
different EEHV: EEHV2, 3 or 6 (Centers for Disease Control, 
2015).  
1.6.3.4 EEHV in Asian elephants 
1.6.3.4.1      Clinical disease 
EEHV has a mortality rate of 85% in calves that develop 
clinical signs (Latimer et al., 2011). From 1992-2012, 24% of 
elephant calves in the USA were affected by EEHV (Hayward, 
2012). 
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EEHV is associated with haemorrhagic disease in Asian 
elephants. The onset of clinical disease is extremely rapid. 
There are a number of clinical signs including: lethargy, 
oedema of the face, neck and trunk, oral ulceration, cyanosis 
of the tongue, reluctance to eat, depression, decreased stool, 
tachycardia and anorexia (Ossent et al., 1990, Richman et al., 
1999, Richman et al., 2000a, Ehlers et al., 2001, Garner et 
al., 2009, Sripiboon et al., 2013, Atkins et al., 2013). Post 
mortem examinations have revealed a number of anomalies 
including: pericardial effusion, haemorrhages (in the small 
intestine, large intestine, heart, stomach, lungs, trunk, 
tongue, lymph nodes and kidneys), pulmonary oedema, 
congestion, ulceration and cyanosis of the tongue (Ossent et 
al., 1990, Richman et al., 1999, Reid et al., 2006, Garner et 
al., 2009, Sripiboon et al., 2013, Zachariah et al., 2013).  
1.6.3.4.2      Reported cases to date 
Up to January 2016 22 cases have been reported this includes 
19 deaths and 3 survivors, 13.6% of the cases have occurred 
in Europe, 27.3% in USA and 59.1% in Asia, the greatest 
number of deaths (63.2%) occurred in those aged below 5. 
Ten of the cases used multiple diagnostic methods, including 
PCR, serology, pathology and histology, whereas 12 cases 
were diagnosed using PCR only. 
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A point of interest from the data gathered in Table 7 is that 
there are no deaths below the age of 1 year, it is uncertain if 
this related to the presence of maternal antibody during the 
first year, it is not currently known if primary exposure occurs 
when the juvenile has maternal antibodies, are they then able 
to develop their own immunity to the virus in later life.
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Table 7: Reported cases of EEHV infection in Asian elephants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Species Status Date of death Method of diagnosis EEHV variant Age Location Reference 
Asian Survived N/A PCR, serology, pathology N/A 17 months USA (Richman et al., 2000a) 
Asian Survived N/A PCR, serology, pathology N/A 16 months USA Richman et al., 2000a 
Asian Survived N/A PCR EEHV 5 42 USA (Atkins et al., 2013) 
Asian Deceased N/A Histology and pathology N/A 3 Switzerland Ossent 1990 
Asian Deceased Apr-95 PCR, serology, pathology N/A 16 months USA Richman 2000a 
Asian Deceased Aug-98 PCR EEHV 1 11 Germany Ehlers 2001 
Asian Deceased Unknown PCR, pathology, histology EEHV 3 5 USA Garner 2009 
Asian Deceased Unknown PCR, pathology, histology EEHV 3 6.5 USA Garner 2009 
Asian Deceased Unknown PCR, pathology, histology EEHV 5 20 months UK Denk 2012 
Asian Deceased Jan-05 PCR, pathology, histology EEHV 1A 2 Thailand Siripboon 2013 
Asian Deceased Apr-11 PCR, pathology, histology EEHV 4 3 Thailand Siripboon 2013 
Asian Deceased May-04 PCR EEHV 1 3 Cambodia Reid 2006 
Asian Deceased 2005 PCR EEHV 1 12 India Zachariah 2013 
Asian Deceased 2007 PCR EEHV 1 5 India Zachariah 2013 
Asian Deceased 2007 PCR EEHV 1 2 India Zachariah 2013 
Asian Deceased 2007 PCR EEHV 1 2 India Zachariah 2013 
Asian Deceased 2008 PCR EEHV 1 6 India Zachariah 2013 
Asian Deceased 2009 PCR EEHV 1 8 India Zachariah 2013 
Asian Deceased 2010 PCR EEHV 1 8 India Zachariah 2013 
Asian Deceased 2011 PCR EEHV 1 18 months India Zachariah 2013 
Asian Deceased 2011 PCR EEHV 1 7 India Zachariah 2013 
Asian Deceased Feb-11 PCR, pathology, histology EEHV 1A 30 months Laos Bouchard 2014 
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1.6.3.4.3      Current recommendations and treatment 
There are no set guidelines for treating EEHV; however, there 
are published protocols available. A protocol from the United 
Kingdom Elephant Health Programme was created in response 
to an EEHV related death in the UK, and was used globally 
(Cracknell, No date). Another protocol is available from the 
Houston Zoo. Both recommend treatment with anti-herpetics, 
antibiotics, analgesics, fluid therapy and oxygen therapy. 
However, The Elephant Health Programme recommends 
vasoconstrictors in the management of circulatory failure and 
the use of diuretics, whereas the Houston Zoo recommends 
plasma transfusion when the sick animal blood type is 
matched with a correct donor, and a blood transfusion when 
haematocrit levels fall below 14% (Table 8) (Houston Zoo, 
2010). 
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Table 8. A comparison of two EEHV treatment protocols. 
Recommendations: United Kingdom 
Elephant Health 
Programme EEHV 
protocol (Cracknell, 
No date) 
Houston Zoo EEHV 
protocol (Houston 
Zoo, 2010) 
Diagnostic testing PCR or ELIZA Complete blood count,  
Serum biochemical 
analysis, and PCR 
Antiherpetic drugs 
suggested 
Famciclovir – orally or 
rectally 
Famiciclovir (orally or 
rectally), or Ganiciclovir 
(orally) 
Antibiotics Recommended to 
prevent infection, a 
number of drugs are 
available for use in 
elephants: Amoxicilin, 
Ampicillin, Ceftiofur, 
Doxycycline, Enrofloxcin, 
Marbofloxacin, Procain 
pencillin and Benzathine 
penicillin 
Recommended to 
prevent infection and to 
be instigated 
immediately (list of 
antibiotics in protocol) 
Analgesia Non-steroidal anti-
inflammatories and 
opioids may also be used 
Non-steroidal anti-
inflammatories and 
opioids may also be used 
Fluid therapy Yes recommended Rectal or intravenous 
fluid therapy 
recommended 
Oxygen therapy Yes recommended – flow 
rate of 5 litres 
Administered where 
possible 
Diuretics Flurosemide  N/A 
Pericardial tap Yes recommended N/A 
Vasoconstrictors Can be used where blood 
pressure can be 
measured or as a last 
resort 
N/A 
Daily herd management Oral examination (ulcers, 
tongue lesions), general 
assessment and faecal 
ball temperature 
Oral examination, 
general inspection of the 
animal, appetite 
assessment, 
temperature, and blood 
pressure assessment 
(twice for all elephants 
and daily for calves) 
Daily monitoring of an EEHV 
case 
N/A Blood samples to be 
taken daily during the 
first week of treatment, 
daily urine samples and 
faecal samples 
Plasma transfusion N/A If available 
Blood transfusion N/A Should be considered if 
haematocrit falls below 
14% 
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The EEHV Advisory Group is a group of EEHV specialists 
consisting of zoo staff, veterinary surgeons and scientists. 
Their mission is to “decrease elephant mortality and morbidity 
due to EEHV” (Hájková et al., 2006). Their goals are to 
recommend treatment and management protocols, coordinate 
research samples and fund-raising (Hájková et al., 2006). The 
group has produced a document stating the minimum 
standards of care for elephant calves in relation to EEHV 
preparedness. Recommendations are made for calf training to 
enable successful sample collection for EEHV detection and 
monitoring. By the age of one year, calves should be trained 
for voluntary blood collection, trunk wash collection, standing 
on scales, oral exam, ocular exam, faecal bolus temperature 
measurement, blood pressure and standing for monitoring of 
the pulse. Calves should also be trained by one year of age to 
be separated from the dam, restrained, be able to receive 
medications orally and rectally, accept fluids rectally and orally 
from a bottle and be able to receive medications via injection 
(EEHV Advisory Group, No date).  
 
Anti-viral therapy is currently recommended, but it is unknown 
if current medications are effective for the treatment of EEHV; 
a number of animals treated with anti-viral medication have 
survived, and a number have also died. Factors indicating 
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whether an animal will survive or not have not been 
determined.  A previous case study on the use of the anti-viral 
drug famciclovir in two cases of clinical EEHV determined that 
both elephants were viremic prior to treatment (based on 
PCR). Both elephants survived; the first case was given 
famciclovir orally and showed decreasing amounts of viral DNA 
in blood samples which also coincided with levels of 
famciclovir in serum. In the second case, famciclovir was 
administered rectally, decreasing amounts of viral DNA were 
observed  - this may suggest an alternative route for 
administering antivirals to elephants (Schmitt et al., 2000).  
 
The nucleoside analogue famciclovir is a prodrug which is then 
converted into penciclovir the active drug through 
phosphorylation by the viral thymidine kinase.  Therefore, in 
order for nucleoside analogues to be effective, the virus must 
have a thymidine kinase (TK) gene. EEHV is the first 
betaherpesvirus discovered to have a TK gene, and there is 
evidence suggesting that the TK gene present in the EEHV 
genome is homologous to the one present in 
gammaherpesviruses. The TK found in EEHV is similar in 
structure to the TK found in HSV-1 (Ehlers et al., 2006). In 
addition to thymidine kinase, there is a serine/threonine PK 
gene in EEHV (Ehlers et al., 2006). This is a type of kinase 
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that possesses ganciclovir-phosphorylating activity. The 
results from this study suggest that the use of famciclovir in 
the treatment of clinical cases of EEHV may be effective due to 
the presence of viral TK; however, the presence of the PK 
gene would also suggest that other drugs such as ganciclovir, 
aciclovir and penciclovir may also be effective (Ehlers et al., 
2006).   
1.6.3.4.4      Diagnostic methods 
Initial detection of herpesviruses in Asian elephants was 
achieved by electron microscopy and histopathology from 
necropsy samples (McCully et al., 1971). Inclusion bodies 
could been seen within the nuclei of capillary endothelial cells 
and sinusoidal cells (Ossent et al., 1990). To determine the 
type of herpesvirus present in Asian elephant samples, a PCR 
was developed to detect EEHV DNA. This was developed using 
EEHV terminase gene primers, and resulted in a 163bp PCR 
product from 7 deceased animals diagnosed with EEHV.  
However, this method only detected the presence of EEHV and 
did not determine which variant was present (Richman et al., 
1999). A more sensitive and specific qPCR method was 
subsequently developed to determine sites of viral shedding in 
asymptomatic animals.  This provided information on which 
samples can be tested to detect virus in both symptomatic and 
asymptomatic animals (Stanton et al., 2010). More recently, a 
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SYBR green qPCR assay was developed by Sariya et al. (2012) 
to test tissue from tongue, heart, kidney, spleen and liver 
samples. Samples which can be used for testing asymptomatic 
animals include oral-nasal secretions, conjunctival swabs, oral 
swabs and vaginal vestibule samples including swabs and 
biopsies. However, there is disagreement about which site 
provides the highest viral DNA yield; Hardman et al. (2011) 
suggested conjunctival swabs were more likely to yield viral 
DNA. Other studies have reported successful viral DNA 
detection from trunk washes (Stanton et al., 2010, Stanton et 
al., 2014). 
 
Other methods have been developed to detect the host’s 
immune response to EEHV. A recent study of 125 captive 
Asian elephants in the USA and Europe used an ELISA to 
detect IgG antibodies to EEHV in serum or plasma samples, 
multiple samples were used to ensure reproducibility (van den 
Doel et al., 2015). However, there are several disadvantages 
to this assay including the failure of this ELISA to detect 
certain antibodies conformational epitopes of gB, and a poor 
sensitivity due to high background. High background can be 
due to excessive colour development which leads to the 
obscuring of the true signal. Specificity testing was conducted 
using rabbit sera, a reaction with the antigen was not 
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observed. However, a positive response was observed when 
EEHV-gB specific sera were used, and this would suggest 
EEHV specificity. 
1.6.3.4.5      Epidemiology 
Most captive adult animals in the US and Europe that have 
been tested on a regular basis appear to intermittently shed 
EEHV. It is unknown if latency occurs, or if animals continue to 
actively shed the virus chronically. Evidence suggests that 
certain stressors may increase viral shedding similarly to other 
herpesviruses (Padgett et al., 1998, Freeman et al., 2007). In 
a study by Stanton et al. (2010), two pregnant animals were 
found to shed more often than other animals within the herd; 
an increase in the frequency of viral shedding during 
pregnancy was also suggested by Hardman et al. (2011). 
However, preliminary work conducted at The University of 
Nottingham suggested there is no link between Herpesvirus 
shedding and pregnancy in Asian elephants (Kenaghan, 2012).  
 
Studies have concluded that most captive adult Asian 
elephants in the USA and Europe are infected with at least one 
EEHV subtype. A study in India found at least one EEHV 
variant present in 35% (16/46) of captive Asian elephants.  
EEHV5 was the most prevalent, and was detected in 20% 
(9/46) of trunk wash samples; EEHV 3/4 was in 9% (4/46), 
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EEHV1 in 7% (3/46), and EEHV2 and EEHV6 were not 
detected at all. In camp elephants, EEHV1 was the most 
prevalent at 14%, whereas in temple and orphanage 
elephants EEHV5 was more commonly seen at 37% and 20% 
respectively (Stanton et al., 2014). EEHV has also been found 
in wild elephants in India;  it was suggested that EEHV was 
involved in the death of a two year old male calf (Press Trust 
Of India, 2014). Detection of EEHV1 has been confirmed in 
Laos, where a captive 2.5 year old male Asian elephant died, 
the only clinical sign observed before death was swelling the 
intermandibular region (Bouchard et al., 2014). It has also 
been confirmed in Cambodia, where a wild caught captive 3 
year old female Asian elephant was found dead at a 
sanctuary, no clinical signs were observed (Reid et al., 2006). 
Lertwatcharasarakul et al. (2015) determined strains of EEHV 
in 8 samples from Asian elephants in Thailand; 75% (6/8) 
samples were positive for EEHV1 (of which 5 were EEHV1A 
and 1 sample was EEHV1B). Twenty-five percent (2/8) tested 
positive for the presence of EEHV4. It is currently unknown if 
the virus has an impact on wild populations.   
 
EEHV has been detected intermittently in most captive 
European and North American asymptomatic adult animals. 
That have been tested using PCR to detect the virus, Hardman 
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et al. (2011) found a 100% prevalence of EEHV in a herd of 6 
asymptomatic elephants in a UK collection, samples from a 
number of collection sites were used including trunk washes, 
oral swabs, conjunctival swabs and vulval swabs. Trunk 
washes are the sample most commonly used to detect the 
presence of EEHV in asymptomatic animals. A study of 5 Asian 
zoo elephants in the USA confirmed the presence of EEHV1 in 
3 of the 5 elephants over a 15 week period (Stanton et al., 
2010). By conducting longitudinal studies of virus shed from 
elephant populations, it can be determined if social and 
environmental stressors affect EEHV viral shedding. By 
contrast, the only published serology study, of 125 Asian 
elephants in USA and Europe, demonstrated 18% 
seropositivity and 19% were borderline for EEHV IgG 
antibodies (van den Doel et al., 2015).  It is unclear how 
serum antibody titres vary with respect to viral latency, or 
whether antibody may vary relative to time since the last 
active infection. 
1.6.3.4.6      Early detection and management 
A number of suggestions have been made on how to manage 
elephant herds to improve early detection and treatment of 
EEHV. This includes daily checks by keepers: oral examination 
for ulcers and tongue lesions, monitoring of faecal bolus 
temperature and a general assessment of the animal. If a case 
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of EEHV is suspected, the current recommendation is that the 
attending veterinarian should complete a physical examination 
and collect a blood sample. If no other disease is diagnosed, 
treatment with famciclovir should commence. If the treatment 
is not successful, and the elephant dies, the veterinarian 
should submit post mortem tissues for further testing for 
EEHV (Lehman and Boehmer, 1999). Advice on the movement 
of captive elephants into a new collection includes: 
performance of an EEHV ELISA two weeks and one week 
before shipment, a PCR one week before, Packed Cell Volume 
/Complete Blood Count taken on the day of shipment along 
with a full medical examination. Risk periods should also be 
highlighted to keeping staff, such as pregnancy, weaning, 
transportation, introduction of new animals, social stressors, 
and sickness. It is currently unknown what/if risk periods are 
linked to development of symptomatic EEHV, or to viral 
shedding (Lehman and Boehmer, 1999). Attempting to control 
EEHV spread through preventative measures may not be 
possible as it is thought that the majority of the captive Asian 
elephant population are already infected with the virus. 
1.6.3.4.7      Potential Co-infections in EEHV disease 
There are a limited number of studies investigating co-
infection with other pathogens in EEHV cases. It is not clear if 
the presence of co-pathogens affects the progression or 
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clinical signs of EEHV related haemorrhagic disease in clinical 
cases. A previous study investigated the potential presence of 
four other viruses which similarly target cardiovascular tissue, 
including: bluetongue virus (BTV), encephalomyocarditis virus 
(EMCV), haemorrhagic disease of deer, and equine arteritis 
virus. One animal tested positive for a co-infection, with both 
EEHV and EMCV being present in tissues (Richman et al., 
1999). As there are a number of pathogens that can be 
transmitted to elephants in both wild and captive 
environments, many other pathogens could be investigated for 
their involvement in EEHV related deaths. 
 
1.7      Final summary 
The literature suggests that there is a current downward trend 
in the population of captive Asian elephants, therefore the 
sustainability of the captive population may still be 
questionable even with further research into EEHV. However, 
from the information reviewed there appears to be a number 
of gaps within the EEHV literature. It has been suggested that 
EEHV is the causative agent of a rapidly fatal haemorrhagic 
disease in Asian elephants, with the most fatalities occurring 
in juveniles aged below 5, though it is not understood why it 
mostly affects this age group. There is limited information 
within the literature on EEHV tissue tropism, further research 
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into this area would provide information as to where damage 
from EEHV infection may occur, which tissues contain the 
highest amount of EEHV, if EEHV is able to be present in a 
broad range of tissues and to determine which tissues support 
the growth of the virus. 
There is a no research that has investigated the potential for a 
familial or genetic component to lead to an increased 
incidence of EEHV related death; this would provide further 
information on the possibility of EEHV being inherited, or if 
there is some inherited genetic susceptibility.  
Currently there is no vaccine for the prevention of EEHV 
infection and there is limited information on the efficacy of 
anti-viral drugs. To enable further research into the efficacy of 
antiviral drugs, and for potential vaccine development, it will 
be necessary to develop a cell culture system which could be 
used to culture the virus, with Asian elephant cells the most 
likely to be able to grow the virus; at present, no such culture 
system exists for Asian elephants.  
 
A limited number of studies have investigated the potential for 
co-infection with other pathogens in clinical EEHV cases, 
consequently it is unknown if co-pathogens may be involved in 
EEHV related deaths. 
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 The aims and objectives for this PhD are therefore as follows: 
1.8      Aims and objectives 
This thesis contains a number of different studies with 
different aims and objectives: 
 
Chapter 3: 
The aim is to determine if there is a link between pregnancy 
and EEHV viral shedding, and this will be achieved by 
conducting the following objectives: 1. use qPCR to analyse 
trunk wash samples obtained over a 3 year period, 2. compare 
the data with glucocorticoid data to look at stress levels and 3. 
determine whether the presence of other potential stressors 
are present by looking at keeper records. 
 
Chapter 4: 
The aim is to culture endothelial cells from Asian elephant 
umbilical cord samples by conducting the following objectives: 
1. isolate cells from umbilical cords obtained at birth from 
Asian elephants and 2. revive cells and attempt cell culture. 
 
Chapter 5: 
The aim is to determine the tissue tropism of EEHV1 in two 
Asian elephants whose deaths were associated with EEHV, and 
this will be achieved by conducting the following objective: 
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analyse and compare viral DNA loads from samples associated 
with EEHV deaths using qPCR. 
 
Chapter 6: 
The aim is to determine if there is a potential genetic or 
familial link between EEHV associated deaths, and this will be 
achieved by conducting the following objectives: 1. create a 
genogram of related Asian elephants located in North America 
and Europe, 2. calculate inbreeding coefficients and 3. conduct 
microsatellite analysis on samples obtained from Asian 
elephants in the UK. 
 
Chapter 7: 
The aim is to detect the potential presence of co-pathogens in 
EEHV infected Asian elephant samples using microarray 
technology, and this will be achieved by conducting the 
following objective: develop and optimise primers to detect 
EEHV and EMCV using microarray technology to determine the 
presence of co-pathogens.
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2      Materials and methods 
2.1      Ethical approval 
Ethical approval for this project was granted by the School of 
Veterinary Medicine and Science, The University of 
Nottingham’s non-animal scientific procedures act (ASPA) 
ethics committee. All samples were collected by trained 
keepers and staff at the establishment.  
2.1.1      Elephant trunk wash collection and preparation 
Fifty millilitres of sterile saline was poured into the nares of 
the elephant; the trunk was elevated for 20-30 seconds. The 
elephant was then instructed to blow the contents of the trunk 
into a bag. The fluid was then poured into a 60ml pot. This 
procedure is routinely used for TB testing. Samples were 
stored at 4°C or -20°C until transported to Nottingham on ice 
or ice packs. Samples were stored in -20°C freezer until 
processing. 
 
Trunk washes were filtered to remove debris such as sand and 
hay. Non-woven gauze was attached to the bottom of a 25ml 
pipette; the sample was then strained through the gauze into 
a 50ml Falcon tube. The samples were then centrifuged for 10 
minutes at 1,500xg. The supernatant was then removed, and 
the cell pellet was stored at -20°C until DNA extraction. 
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2.1.2      Post mortem tissue 
Post mortem tissue was collected from five Asian elephants, 
the cause of death for four of the elephants was haemorrhagic 
disease, and EEHV was confirmed in these animals by qPCR. 
One of the elephants was negative for EEHV, and the cause of 
death is not determined. Samples were collected from each 
tissue using a borer and placed into a 7ml bijou tube. All 
samples were stored at -20°C until DNA extraction. 
2.2      Nucleic acid extraction 
2.2.1      Trunk wash and tissue DNA isolation 
DNA was extracted using a Macherey-Nagel tissue kit following 
the manufacturer’s instructions for buccal swabs and an extra 
step to elute highly pure DNA. To elute highly pure DNA the 
spin column was placed into a 1.5ml microcentrifuge tube, 
50µl of preheated (70°C) buffer EB was applied to the column. 
Tubes were centrifuged for 1min at 11,000xg. A further 50µl 
of preheated buffer BE was added to the column and again 
centrifuged for a further 1min at 11,000xg. DNA extractions 
were stored at -20°C. All DNA extractions were conducted in 
carried out in a class II laminar flow hood to minimise 
contamination. 
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2.3      Samples used in this study 
A number of different samples from Asian elephants have 
been used throughout this study including tissue samples from 
five elephants, trunk washes from nine elephants and faeces 
from seven elephants (table 9). The ID of the animals have 
been anonymised at the request of the collections. 
 
Table 9: A list of samples used throughout this study. Asian elephants 
included have been anonymised. 
ID Samples used in this study 
UON_1189 
Kidney, tongue, lung, heart, liver, aorta, spleen, bone 
marrow, trunk lining and lymph node 
UON_1329 
Kidney, tongue, lung, heart, liver, aorta, spleen, pancreas, 
trunk lining and lymph node 
UON_1002 Heart, liver and lung 
UON_1490 Liver, lung, and kidney 
UON_1149 Heart, liver, lung and kidney 
UON_1140 Trunk wash 
UON_1093 Trunk wash 
UON_1625 Trunk wash 
UON_1089 Trunk wash 
UON_1175 Trunk wash 
UON_1543 Trunk wash 
UON_1579 Trunk wash 
UON_1309 Trunk wash 
UON_1353 Trunk wash 
UON_1091 Faeces 
UON_1285 Faeces 
UON_1626 Faeces 
UON_1027 Faeces 
UON_1094 Faeces 
UON_1405 Faeces 
UON_1627 Faeces 
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2.4      Statistics 
All statistics were performed using GraphPad version 7.01. 
Tissue samples were analysed and compared in chapter 5 
using a one way ANOVA, and a Pearson product-moment 
correlation was used in chapter 7 to determine if there was a 
correlation in the presence of EEHV using PCR and microarray.
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3      Longitudinal study of Asian elephants Elephas 
maximus indicates no link between Elephant 
Endotheliotropic Herpesvirus-1 shedding and 
pregnancy 
 
Please note this chapter includes the following publication:  
(Bennett et al., 2015)(Bennett et al., 2015)Bennett, Laura, et 
al. "Longitudinal study of Asian elephants, Elephas maximus, 
indicates intermittent shedding of elephant endotheliotropic 
herpesvirus 1 during pregnancy." Veterinary Record Open 2.1 
(2015): e000088. 
 
Text in italics indicates new text added which was not included 
in the original publication. Viral load has also been changed to 
virus DNA load throughout this chapter and EEHV-1 has been 
changed to EEHV1. 
 
Author list and role: 
Laura Bennett – Prepared the manuscript, analysis and 
conducted laboratory work 
Stephen Dunham – Contributed to the manuscript and 
supervision 
Lisa Yon – Contributed to the manuscript and supervision 
Sarah Chapman – Sample collection 
Megan Kenaghan – Laboratory work 
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Laura Purdie – Laboratory work 
Rachael Tarlinton – Contributed to the manuscript, supervision 
and lead contact 
3.1      Abstract 
Introduction: EEHV1 is a viral infection of elephants that has 
been associated with a fatal haemorrhagic syndrome in Asian 
elephants. Previous studies have suggested that pregnant 
animals may shed more virus than non-pregnant animals. 
Methods: This study examined whether pregnancy affected 
the frequency or magnitude of shedding of elephant 
endotheliotropic herpesvirus 1 (EEHV1) using Taq man real-
time PCR on trunk washes from four female elephants from a 
UK collection over three time periods between 2011 and 2014. 
These periods included pregnancies in two animals (period 1 
and period 3). Behavioural observations made by keepers 
were also assessed. 
Results: During period 1 there was a high degree of social 
hierarchical instability which led to a hierarchy change, and 
was associated with aggressive behaviour. Also during period 
1 EEHV1 shedding was of a higher magnitude and frequency 
than in the latter two time periods. 
Conclusions: These results suggest that there is no clear 
relationship between shedding and pregnancy, and that 
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behavioural stressors may be related to an increase in EEHV1 
shedding. 
3.2      Introduction 
Elephant endotheliotropic herpesvirus 1 (EEHV1) is a 
betaherpesvirus associated with a fatal haemorrhagic 
syndrome in juvenile Asian elephants (Elephas maximus) 
(Davison et al., 2009). Clinical EEHV disease can be very 
rapid, beginning with oedema of head and thoracic limbs, 
lethargy, anorexia and reluctance to drink, and progressing to 
ulceration and cyanosis of the tongue, and internal organ 
haemorrhage. Death can occur between one and seven days 
from onset of clinical signs (Ossent et al., 1990, Richman et 
al., 1999, Richman et al., 2000a, Richman et al., 2000b, Reid 
et al., 2006, Garner et al., 2009, Denk et al., 2012). More 
than 60 cases have been reported worldwide, with a mortality 
rate as high as 85 per cent (Latimer et al., 2011). There is no 
vaccine or other preventive measures for EEHV infection, but 
treatment with intensive care and famciclovir has been used, 
and in some cases, the animal has survived (Schmitt et al., 
2000). This treatment is expensive: a course of famciclovir 
can be in excess of £10 000 per animal (US$17 000) (Redrobe, 
2012). EEHV is currently not able to be cultured though qPCR 
of viral DNA in trunk washes, which are an established way of 
detecting EEHV viral shedding (Stanton et al., 2010). It has 
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recently been discovered through studies of zoo animals that 
many, perhaps most, captive adult Asian elephants 
intermittently excrete EEHV1 from oronasal mucosa (Stanton 
et al., 2010, Hardman et al., 2011), suggesting that 
subclinical infection is widespread. Viral DNA shedding can be 
detected using conjunctival swabs, buccal swabs, trunk swabs 
and trunk washes (Hardman et al., 2011, Stanton et al., 2013, 
Stanton et al., 2014). It is not clear why some animals 
develop fatal haemorrhagic disease and others only have 
latent or asymptomatic infections. The route of transmission of 
the virus is also currently unknown though transmission via 
nasal secretions from the trunk has been suggested (Stanton 
et al., 2010). 
 
Herpesviruses exhibit both latent and lytic (active) phases. In 
the betaherpesvirus family, latency has been reported in 
lymphoreticular cells, secretory glands, kidneys and other 
tissues (Knipe and Howley, 2007). Reactivation of human 
herpesviruses from latency is thought to occur as a result of 
immunosuppression during stressful physiological states such 
as occurs in: pregnancy, organ transplant and chemotherapy 
patients (Sakamoto et al., 1982, Greenberg et al., 1987, Dahl 
et al., 1999). In a study by Dahl et al. (1999), blood samples 
were taken from 104 pregnant women at 3, 5 or 6-8 months 
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during pregnancy, and a blood sample was also taken at the 
time of birth. During pregnancy, HHV6 DNA was present in 
158/416 (38%) of leukocyte samples collected from 104 
women, which was significantly higher than at delivery in 
those same women, at which time 26/104 (25%) of the 
samples were positive, in comparison 5/21 (24%) of control 
samples tested positive for HHV6 DNA. This compares to 24% 
of women who tested positive for HHV6 in the control group. 
Sakamoto et al. (1982) investigated reactivation of the 
Epstein Barr virus in immune supressed pregnant women, the 
results suggested antibody titres were higher in those women 
in contrast to non-pregnant controls. 
 
However, a reactivation during pregnancy is not needed to 
transmit herpes virus to the infant; indeed, it has been 
suggested that most cases of vertical transmission of herpes 
viruses (such as HSV2) during pregnancy, are transmitted 
during asymptomatic or unrecognized viral shedding episodes 
(Zuckerman, 2009). Transmission often occurs when a herpes 
infection is acquired during pregnancy, thus transmission to 
the infant may occur before symptoms occur from the primary 
infection or transmission occurs and the mother may remain 
asymptomatic (Brown et al., 1997, Whitley, 2004). 
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Many healthy non-immunosuppressed individuals continuously 
or sporadically shed various herpesviruses such as Epstein-
Barr virus and herpes simplex virus 1 (Junker et al., 1991, 
Kaufman et al., 2005, Pierson et al., 2005). In healthy 
individuals, stress is a known factor in the reactivation of 
herpesviruses, stress can occur in many forms including 
loneliness and examination stress. Using the loneliness scale 
developed by Bissinger et al. (2002), Glaser et al. (1985) 
investigated the stress of loneliness as a trigger. Virus capsid 
antigen antibody titres were used to determine the level of 
herpesvirus in each of the 30 participants, significant changes 
were observed between low and high loneliness groups. Those 
in the high loneliness group had higher antibody titres 
compared to those in the low loneliness group, higher titres 
were observed for EBV, HSV and HCMV, and however, 
changes were not seen in antibody titres for poliovirus type 2. 
Glaser et al. (1999) investigated the impact of final 
examination stress on military cadets in the USA, EBV 
antibody titres were higher in blood samples obtained during 
examination week in comparison to samples taken 6 weeks 
previously, significant changes were not observed in the 
antibody titres for HSV-1 or HHV-6. However, in contrast, a 
study of 308 immunocompetent adults, investigated potential 
stressors for herpes simplex virus eye infections. Potential 
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stressors investigated included: wearing contact lenses, 
psychological stress, exposure to sunlight, eye injury, and 
menstrual periods. It was concluded that there was no 
evidence to suggest psychological stress and other stressors 
investigated were triggers of ocular HSV (Cohen et al., 2000). 
 
Physiological measurement of stress levels in animals can be 
difficult; however, measurement of cortisol levels is usually 
accepted as an indicator of stress levels. Cortisol is a product 
of the hypothalamic–pituitary–adrenal axis, which is activated 
at times of physical or psychological stress (Foley et al., 2001, 
Möstl and Palme, 2002, Millspaugh et al., 2007). In many 
wildlife species, measurement of serum cortisol levels is 
impractical; obtaining blood from the animal can be stressful, 
and would interfere with the study as this handling could in 
itself increase cortisol levels. Faecal glucocorticoid metabolites 
(breakdown products of cortisol excreted in the faeces) are, 
therefore, used as a non-invasive measurement of stress in 
elephants (Millspaugh et al., 2007). 
Several recent reports from longitudinal studies of EEHV 
shedding in zoo herds (Stanton et al., 2010, Hardman et al., 
2011). Hardman et al. (2011) indicated that EEHV1 shedding 
detected by trunk washes may be increased during 
pregnancy; this trunk secretion could present a possible 
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transmission route to juveniles and neonates. Hardman et al. 
(2011) reported that pregnancy may affect the amount of 
EEHV virus shed; the pregnant animal in their study had a 
higher level of virus detected in trunk washes during the third 
trimester of pregnancy, compared with other stages of the 
pregnancy, or to the rest of the herd throughout the 
pregnancy. Investigating EEHV during pregnancy is important 
as it is currently accepted that it is common for there to be an 
increase in herpes viral shedding, or a reactivation of the virus 
during pregnancy or birth in humans. A number of studies 
have been conducted on the reactivation of HSV2, especially 
in asymptomatic seropositive pregnant women. (Frenkel et al., 
1993) suggested HSV2 is common among pregnant women.  
The study investigated antibodies (using western blot 
analysis) of pregnant women 439/1355 (32%) tested 
positively for HSV2. Infection was recognised as a first 
exposure based on antibody titres in 43/264 seropositive 
women during the study. This suggests there was a high 
amount of seropositivity due to a reactivation, the remaining 
396 women had previously been infected with HSV2, and 
therefore a high prevalence of seropositivity was as a result of 
reactivation. The researchers noted that viral shedding 
occurred at a similar rate in both asymptomatic and 
symptomatic women. Co-infection with other viruses such as 
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HIV has also been suggested to increase the chance of a 
herpesvirus reactivation during pregnancy.  A study was 
conducted in which 60 HIV-positive and 8408 HIV-negative 
pregnant women were screened for genital herpes; 48/60 
(75%) were found to be seropositive, in contrast to only 
2709/8408 (32%) of HIV-negative pregnant women. The 
study further determined that 8% of HIV positive women and 
2% of HIV negative women had a reactivation of herpes 
during labour (Hitti et al., 1997). 
 
The current study is the first longitudinal cohort study of a 
group of four elephants that were studied over a period of 
three years. Samples were examined from 2011 to 2014 over 
three periods: during pregnancies in two animals that 
occurred at separate times (sample period 1 and sample 
period 3), and during a period when no animals were pregnant 
(sample period 2). Faecal glucocorticoid levels (for those time 
periods for which they were available) and behavioural records 
were also examined to analyse physiological or behavioural 
indicators of stress that may be linked with EEHV1 shedding. 
This permitted investigation of the suggestion that pregnancy 
may increase EEHV1 shedding frequency and magnitude 
(Stanton et al., 2010, Hardman et al., 2011). The current 
study used qPCR on trunk wash samples to examine EEHV1 
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shedding in an all-female closed herd at a European zoological 
collection.  
 
3.3      Materials and methods 
This study was approved by the School of Veterinary Medicine 
and Science (University of Nottingham) non Animals Scientific 
Procedures Act Committee, September 13, 2011. 
Samples were collected from four female Asian elephants at a 
UK zoo. The elephants are referred to as elephant A, B, C and 
D. Samples were collected during two separate pregnancies, 
and one period where no animal was pregnant. Both 
pregnancies were the result of artificial insemination. Elephant 
hierarchical ranking was reported by the keepers, and was 
based on observations of dominant and submissive behaviours 
seen in interactions between the animals over time. A 
hierarchy change was observed on November 20, 2011 (Table 
10). 
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Table 10: Elephants included in the study, showing keeper estimated rank, 
age and detailing pregnancies during three sample periods. Pregnancy 
status of each elephant is also shown, + = pregnant and - = not pregnant. 
Elephant Hierarchy 
rank before 
20/11/2011 
Hierarchy 
rank after 
20/11/2011 
Age ‘Sample 
period one’ 
(07/09/2011–
26/03/2012) 
pregnancy 
status 
‘Sample 
period two’ 
(27/03/2012- 
22/05/2012) 
pregnancy 
status 
‘Sample 
period three’ 
(23/05/2012-
20/03/2014) 
pregnancy 
status 
A 2nd 3rd 16 - - - 
B 1st 1st 29 - - - 
C 4th 4th 30 + - - 
D 3rd 2nd 19 - - + 
 
Time period 1 (pregnancy 1) was from September 7, 2011 to 
March 26, 2012 (samples were taken for seven months during 
this period). Time period 2 (no animal pregnant) was from 
March 27, 2012 to May 22, 2012 (two months), and time 
period 3 (pregnancy 2) was from May 23, 2012 to March 20, 
2014 (samples were taken for 11 months during this period). 
Sampling was not continuous during period 1 and period 2. 
One hundred and thirty-seven trunk washes were tested from 
the four animals over the three sample time periods. Trunk 
washes were collected by having the elephant draw up 50 ml 
of saline into its trunk, the trunk was then elevated for 30 
seconds, and the elephant then forcefully expelled the saline 
into a plastic freezer bag. The contents were then transferred 
into a 60 ml plastic container, and were stored at −80°C until 
transport and processing of samples could be arranged. All 
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samples were treated alike. Before processing, trunk wash 
samples were thawed and filtered through gauze to remove 
sand and feed material, and were then centrifuged at 458 g 
for 10 minutes. The supernatant was discarded, and cell 
pellets were stored at −20°C until further processing. 
DNA was extracted from trunk wash cell pellets, using a 
NucleoSpin Tissue Kit (Machery Nagel), as per manufacturer's 
instructions. To avoid cross-contamination, all work was 
conducted in a class II laminar flow hood, and a separate 
plastic opener was used for each 1.5 ml microcentrifuge tube. 
Quantitative PCR analysis was conducted using a modified 
version of the protocol described by Stanton et al. (2010).  
However, alternatively sourced primers and probes and 
equipment brands were used, and the quencher dye on the 
probe was modified from MGB-NFQ to Eclipse. 
EEHV viral shedding was normalised against interferon-γ (IFN-
γ) using a standard curve; the qPCR cycle threshold value was 
converted into a copy number (the number of EEHV and IFN 
copies within each sample), and the number of EEHV copies 
was divided by the number of IFN-γ copies in each sample to 
obtain a ratio. 
Freidman tests with Dunn's multiple comparison test as a 
post-hoc test, were performed in GraphPad Prism V.5.04 
(GraphPad Software) for comparative virus DNA load (a) 
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between animals and (b) median virus DNA loads during each 
sampling period. 
Faecal samples were opportunistically collected at irregular 
intervals from all animals. An aliquot of faeces was collected 
from the centre of the faecal bolus, and the material was 
manually broken apart and transferred into a 60 ml universal 
container. Faecal samples were stored at −20°C until analysis. 
Faecal glucocorticoid and progesterone analyses were 
performed using the protocol described by Watson et al. 
(2013). 
Elephant keepers maintained records of the animal's 
behaviour; events recorded included submissive behaviour, 
aggressive behaviour, management changes, foot care and 
medical observations. Records were stored on the MedARKS 
database. Foot care events occurred at the same incidence 
throughout the study, and no major illnesses or injuries were 
sustained during the study period. 
3.4      Results 
During ‘sample period 1’ (pregnancy 1), all samples from all 
animals (61) tested positive for the presence of EEHV, with 
normalised virus DNA loads between 0.1 and 10.5. During 
‘sample period 2’ (non-pregnant period), all samples (12) also 
tested positive for EEHV1 though at a lower magnitude of 
normalised virus DNA load (below 3.1). During ‘sample period 
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3’ (pregnancy 2), EEHV1 was detected in 8 out of 63 samples 
(12.69 per cent) though these samples had an even lower 
normalised virus DNA load of below 2.0 (Figure 10).
 
Figure 49: EEHV viral shedding in four female elephants, EEHV was 
normalised against IFNγ. Elephant endotheliotropic herpesvirus (EEHV) viral 
shedding in four female elephants. EEHV was normalised against interferon-γ (IFN-
γ). Red squares=elephant A, blue diamonds=elephant B, green inverted 
triangles=elephant C, purple triangles=elephant D. Green arrow=elephant C gave 
birth, purple arrow=elephant D gave birth, black star=switched to protected 
contact, black X=change in hierarchy, grey inverted triangle=change in keeping 
staff and red horizontal bar=periods of pregnancy. The y axis is the amount of 
EEHV normalised against IFN-γ. EEHV was normalised against IFN-γ. EEHV copy 
number was divided by IFN-γ copy number to give a ratio. On the x axis is the 
date; note that dates were not continuous, as sampling periods were irregular. 
 
From August 2011 until October 2011, before the change in 
hierarchy, elephants B, C and D showed elevated levels of 
EEHV. There was a drop in EEHV shedding in all animals in 
November 2011. This was then followed by a period of 
consistent shedding in all animals from December 2011 until 
June 2012. From August 2012 until March 2014, EEHV1 was 
detected in 81 out of a total of 137 samples (59.56 per cent) 
(Figure 10). 
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The median magnitude virus DNA load for each elephant was: 
elephant A, 1.28; elephant B, 1.17; elephant C, 1.18 and 
elephant D, 1.21. Elephant D had the highest frequency of 
positive samples at 61.7 per cent (22 out of 34). All samples 
were positive in sample periods 1 (pregnancy 1) and 2 (non-
pregnant period). In sample period 3 (pregnancy 2), elephant 
D had the highest frequency of positive samples at 18.7 per 
cent (3 out of 16) (Table 11). 
No significant differences were apparent in normalised virus 
DNA load between animals. However, median virus DNA load 
during time period 1 and 3 were significantly different 
(Freidman test P value 0.0046, Dunn’s multiple comparison 
test time period 1 v time period 3 P<0.05). 
 
Table 11: Percentage of positive samples for each elephant 
Sample period Elephant A Elephant B Elephant C Elephant D 
1 100%(15/15) 100%(15/15) 100%(16/16) 100%(15/15) 
2 100%(3/3) 100%(3/3) 100%(3/3) 100%(3/3) 
3 13.3% (2/15) 6.3%(1/16) 15.5%(2/16) 18.7%(3/16) 
Total 60.6%(20/33) 55.8%(19/34) 60%(21/35) 61.7%(22/34) 
 
A total of 50 incidents of aggression were recorded by 
keepers. During sample period 1, there were a total of 14 
incidents. Over the five months of this period, this equated to 
an incident rate of 2.8 per month. During this time period, 
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elephant A suffered three injuries from aggressive behaviour 
from elephant D, and overall, injuries were most common 
during this sampling period. This is also the time during which 
the first pregnancy occurred. During sample period 2, 13 
incidents of aggression were observed, and one injury was 
sustained by elephant A. The rate of incidents during this time 
equated to 6.5 incidents per month. During the third sample 
period, the second pregnancy occurred. There were a total of 
23 incidents in this sampling period; the incident rate was 2.9 
per month, with one incident causing an injury to elephant A 
(Figure 11). Incidents involving more than one elephant were 
classed as 1 occasion, aggressive behaviour may also only 
involve a single animal where an animal exhibited aggressive 
behaviour, but other animals were not involved. 
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Figure 50: EEHV viral shedding and incidents of aggression in four female 
elephants. EEHV viral shedding and incidents of aggression in four female 
elephants. Red squares=elephant A, blue diamonds=elephant B, green inverted 
triangles=elephant C, purple triangles=elephant D, green arrow=elephant C gave 
birth, purple arrow=elephant D gave birth, black star=switched to protected 
contact, black X=change in hierarchy, grey inverted triangle=change in keeping 
staff, orange diamond=injury/reopened injury from aggression, purple inverted 
triangle=incidents of aggression/tension (aggressor) and pink inverted 
triangle=incidents of aggression/tension (victim).  
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Faecal glucocorticoids were monitored for short periods, which 
only partially overlapped with trunk wash sampling. No 
patterns of variation in glucocorticoid levels versus normalised 
virus DNA load were evident (Figure 12). 
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Figure 51: Glucocorticoid (corticosterone) levels versus normalised virus 
DNA load. Corticosterone levels (round yellow points) from faeces were compared 
to EEHV virus DNA load levels (elephant A = red squares, elephant B = blue 
diamonds, elephant C = green inverted triangles and elephant D =purple 
triangles). Specific changes are also highlighted in each graph, switched to 
protected contact (black star), change in hierarchy (grey cross), elephant D gave 
birth (purple arrow) and elephant C gave birth (green arrow). 
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A number of samples were Sanger sequenced (Source 
BioScience), and the presence of EEHV1 DNA was confirmed. 
 
3.5      Discussion 
In this study, EEHV was detected in four out of four elephants 
though results suggest that pregnancy did not result in 
increased EEHV1 shedding; indeed, median normalised load 
during the second pregnancy was significantly lower than 
during the first, which was not the case for the difference 
between normalised virus DNA loads for either pregnancy and 
the non-pregnant period in this study. Freeze thawing of the 
trunk wash samples may have resulted in some cell lysis and a 
reduced sensitivity of the present assay; however, all samples 
were positive for IFN DNA, indicating that cellular DNA was 
present, and have been presented as a ratio of viral to cellular 
DNA to compensate for variation in input DNA. During the first 
pregnancy, all four elephants shed EEHV1 consistently. During 
the second pregnancy, shedding was quite sporadic. 
Furthermore, during the period when no animal in the group 
was pregnant, shedding was continuous. This is in contrast to 
herpesvirus reactivation during human pregnancy, which has 
been reported for both human herpesvirus 6 and 
cytomegalovirus (Dahl et al., 1999).  
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In the current study, the study herd was closely monitored, 
and data were available for a number of other factors that 
might be linked to stress in the animals (and EEHV1 
shedding). The faecal glucocorticoid results are difficult to 
interpret without previously defined baseline levels, but no 
clear patterns emerged between faecal glucocorticoid levels 
and EEHV1 shedding. However, because there were a limited 
number of samples used for hormone measurements during 
the sampling periods for EEHV1 testing, these results must be 
interpreted with caution. All faecal glucocorticoid samples 
were taken post management change, so it was not possible 
to look at the effect this had. There are a number of 
limitations in using faecal glucocorticoids as a measure of 
stress, they may not be reliable as an animal can become 
used to a stressor and this may reduce the level of cortisol in 
faeces when exposed to that stressor (Möstl et al., 2002). 
There may be a link between diet and levels of glucocorticoids 
in faeces, as a diet that is high in fibre takes longer to pass 
through the gut which may result in less reabsorption of 
glucocorticoids. These factors may limit the reliability and the 
usefulness of using glucocorticoids as a measure of stress 
(Lewis et al., 1997, von der Ohe et al., 2004). There is limited 
information in the literature to determine if the levels in this 
study are reflective of the “normal” range. 
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Keeper reports of behaviour were used to identify aggressive 
behaviours throughout the study period. Dominance-related 
aggression relating to hierarchy change has been observed in 
many other species, and incidents of aggression may occur for 
several days until a hierarchy is established (Houpt, 2011). 
Studies in other species have also indicated that 
corticosterone measures are more strongly linked with 
intensity of aggression than with frequency of incidents 
(Marsteller et al., 1980). 
 
In this study, the highest level of EEHV shedding occurred 
during sample period 1 (pregnancy 1). This is the period 
during which keepers reported that a hierarchy change 
occurred on November 20, 2011. Elephant A also sustained an 
injury on this date due to aggressive behaviour. Analysis of 
the behavioural records showed that a large number of 
incidents involved elephant D as the aggressor and elephant A 
as the victim. This was not unexpected as these were the two 
elephants that the keepers reported had switched in their 
hierarchical ranking. Although there were not as many 
aggressive incidents during sample period 1 compared with 
other sample periods, the intensity appears to be greater as 
indicated by the higher number of injuries or reopened injuries 
that resulted during this period. This period of hierarchical 
                                                                             Chapter 3 
 
131 
     
instability could have led to higher levels of stress in the herd, 
and suggests that EEHV shedding may be linked to 
behavioural stress in these animals.  
 
It has been suggested that psychological or social stress is 
linked to the development of disease; this may be due to the 
onset of anxiety and depression due to the occurrence of 
stressful events. When stressful events occur they put the 
body into a negative state which affects biological processes, 
which in turn influences disease (Cohen et al., 2007). Social 
stress has also been suggested as a precursor to increases in 
asymptomatic shedding and the reactivation of herpesviruses; 
different stressors have also been shown to have different 
effects on reactivation. To investigate the relationship between 
social stress and the reactivation of HSV1, Padgett et al. 
(1998) investigated two potential stressors in mice: restraint, 
and social disruption. There was little evidence of HSV1 
reactivation in mice that underwent restraint stress. By 
contrast, there was significant evidence that social disruption 
resulted in the reactivation of HSV1: In 15/37 (40.5%) mice, 
reactivation occurred in mice that experienced social 
disruption. Results also suggested that dominant mice were 
more likely to show a reactivation of HSV1; this may be 
because they were more likely to be involved in social conflict 
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and therefore experiencing more stress.  A number of different 
psychological stressors have been shown to cause a 
reactivation of EBV in humans, including: experiencing 
spaceflights (for an astronaut) and undergoing academic 
examinations  (Glaser et al., 1985, Glaser et al., 1999, 
Kennedy et al., 2000, Kim et al., 2002)  
 
During the current study, elephant management practices at 
the facility also changed. Until September 11, 2012 (during 
sample period 2), the herd was managed using a ‘free contact’ 
approach (where keepers have direct physical contact with the 
animals). After this date, the management style changed to 
‘protected contact’ (where there is always a physical barrier 
between the keeper and the elephant (Association of Zoos and 
Aquariums, 2011b). There was no clear connection between 
shedding and management methods, as frequency of viral 
shedding and magnitude of virus DNA load were already 
decreasing by this time, and decreased to negligible levels 
after these management changes. There is no information 
currently available on the impact of management changes and 
EEHV. 
 
The results from this study suggest that that there is no clear 
relationship between shedding of EEHV1 in captive Asian 
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elephants and pregnancy. However, behavioural stressors may 
be related to an increase in EEHV1 shedding. It is also possible 
that EEHV shedding is affected by other, as yet unidentified 
factors, or that the animals may have been newly infected 
when the first sample set was taken. Further longitudinal 
studies on greater numbers of elephants, targeted monitoring 
of glucocorticoid levels, detailed behavioural observations and 
more detailed data on any behavioural indications of stress 
would add further support to the findings suggested by this 
study. However, the small sample size is a limitation of this 
study, this is due to the small herd at the establishment, and 
as such it is not possible to draw any conclusions as to the 
significance of the observations. Future longitudinal cohort 
studies would help to determine how EEHV shedding varies 
with time in individual animals and whether any increase in 
virus DNA loads are seen in associated pregnancies or 
parturition, or other factors such as management 
interventions.  
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4      Asian elephant (Elephas maximus) endothelial 
cell culture from umbilical cord 
 
 
4.1      Introduction 
The ability to culture cells to support a viral infection in vitro is 
important in establishing a laboratory grown viral stock. A cell 
culture system has not currently been established for EEHV, 
and viral isolation has also not yet been possible; this has 
resulted in difficulties in attempting to develop a vaccine or 
test drug efficacy. 
 
Viral culture is a laboratory technique where samples of a 
particular virus are cultured within a cell type that they are 
able to infect. Visible changes in the cell morphology due to 
viral invasion may occur known as cytopathic effects (CPE) 
(Leland and Ginocchio, 2007). An example of herpesvirus CPE 
is the presence of inclusion bodies. Viral inclusion bodies can 
occur in liver cells infected with HSV, VZV and CMV. An 
example of an inclusion body are Cowdry type A bodies, which 
are composed of protein and nucleic acid, and can be seen 
using light microscopy (Tselis and Booss, 2014). 
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4.2      Use of viral cultures 
4.2.1      Diagnostics 
Viral cultures have been a traditional method of diagnosing 
disease, with the virus being isolated in the culture process. 
HSV is commonly detected in cell culture using primary rabbit 
kidney, mink lung or enzyme-linked virus inducible system 
(ELVIS) culture systems. Such systems are unable to detect 
VZV, but using a mixture of CV-1 and MRC-5 cells allows both 
HSV and VZV to be detected simultaneously (Huang et al., 
2002b). However, using cell culture for diagnosis is slow, 
expensive and requires trained technicians. With the 
development of new technologies allowing for rapid detection 
of viruses, the use for viral culture in diagnostics has 
decreased. However, a large number of viruses have been 
propagated in cell cultures to allow for the development of 
vaccines, including small pox, yellow fever, flu and hepatitis A  
(Provost et al., 1986, Weltzin et al., 2003, Ehrlich et al., 
2008).   
4.2.2      Cell culture derived vaccines 
Prior to development of cell culture methods, many viruses 
were propagated in embryonic chicken eggs. Advancing to cell 
based methods provides benefits such as the ability to 
produce vaccines rapidly during an outbreak, producing 
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vaccines which avoid egg based methods is important, 
especially as egg is a known allergen. Animal serum can also 
be avoided, as viruses can be grown in a synthetic media; this 
may prevent transmission of spongiform encephalopathies. 
There are also some disadvantages to this method: cells must 
be free from viruses, and virus yields may be low.  
Mammalian cell culture systems have been used to produce 
influenza vaccines, of which three are currently licensed by the 
Food and drug administration (FDA).  
 
There are three types of inactivated vaccine: whole virus, split 
virus vaccine and subunit vaccine (Zuckerman, 2009). There 
are several stages in the preparation and production of a cell 
based vaccine: firstly, a high density cell culture of the 
appropriate cell type must be made; the cells are then 
infected with the virus. After viral propagation the culture is 
centrifuged and residual virus is removed. The virus is then 
inactivated; this may be done using several methods, 
including the use of solvents or detergents, pasteurisation or 
acidic pH inactivation. The virus can then be purified and used 
in a whole virus vaccine (Milián and Kamen, 2015). To 
produce a split vaccine, the virus particles are disrupted; to do 
this the inactivated virus is treated with detergents. 
Inoculation with a split virus produces fewer adverse reactions 
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than using whole virus (Zuckerman, 2009).  The third type is 
the subunit virus vaccine; this type of vaccine stimulates an 
immune response by presenting the immune system with an 
antigen from the target virus. Hepatitis B vaccine 
RECOMBIVAX HB is an example of a subunit virus vaccine, the 
vaccine is made by cloning the Hepatitis B virus gene which 
codes for Hepatitis B antigens in yeast, the antigen can then 
be harvested from the cultures (MERCK, No date)   For the 
influenza vaccine, for example, surface glycoproteins HA and 
NA are the antigens used, and the vaccine is purified by the 
removal of other viral components (Zuckerman, 2009, Milián 
and Kamen, 2015). 
4.2.3      In vitro drug testing 
In vitro cell cultures are used for initial testing on the efficacy 
of new drugs new compounds to treat viruses prior, to the use 
of animal models (in vivo). The testing of drugs for use in 
treating HSV in humans has mostly used rabbit and murine 
models (Brandt et al., 1992). There are advantages and 
disadvantages to both in vitro and in vivo methods. The main 
disadvantage using the in vitro method is that drug candidates 
that are successful in preventing viral replication in a 
laboratory setting do not always work when transferred to an 
in vivo trial (Rothman, 2002, De Clercq, 2005). Many drug 
candidates used for in vivo trials prove to be ineffective, 
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usually due to drug toxicity or failure to achieve therapeutic 
levels (De Clercq, 2005). However, there are advantages to 
using in vitro methods. It can be species specific (human cells 
can be used for drug candidates for human infections). In vitro 
methods are also automated and are simpler than in vivo 
methods, as they do not require the maintenance and care of 
live animals (Quignot et al., 2014).  
4.2.4      Anti-herpetic drug candidate testing 
When conducting drug testing there are welfare and ethical 
considerations to consider. Research conducted using 
endangered species presents with a number of other issues 
such as small sample sizes, which may limit the statistical 
robustness of the data (Hilton and Richardson, 2004). If living 
animals are used for essential experimental research, 
guidelines for animal welfare need to be followed. Workman et 
al. (2010) suggest that to ensure the welfare of the animals, 
the use of replacement, reduction and refinement should be 
incorporated into experiments; thus, researchers must ensure 
that other methods have been explored (replacement), the 
number of animals used remains as low as possible 
(reduction) and that the experiment is refined and optimised 
(refinement). Other studies have shown that to improve the 
welfare of test animals, environmental enrichment should be 
used as this led to an improved wellbeing. Enrichment is used 
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to create a more stimulating environment and can include toys 
in the environment, rodent wheels for mice, plastic tubes, 
gnawing blocks, and different nesting materials (Van Loo et 
al., 2002, Frick and Fernandez, 2003, Wolfer et al., 2004). 
Proxy species may be used in replacement for endangered 
species in research; however, a proxy species for either the 
African or Asian elephant has not yet been determined. There 
are limitations when using a proxy species that would need to 
be considered; for example, any results which are then trialled 
on the target species would need to be done so with caution, 
and proxy species may not be found for more unique animals  
 
A number of studies have used both in vitro and in vivo 
methods to investigate drug candidates in the treatment of 
herpes infection. A previous study by Shigeta et al. (1983) 
investigated a number of anti-herpetic compounds to 
determine their inhibitory activity against VZV. Ten isolates of 
VZV (five clinical isolates and five laboratory strains) cultured 
in Human Embryo Fibroblast (HEF) cells were infected after 
three days of incubation. Three compounds were identified as 
potent VZV inhibitors. The study authors highlighted that to 
fully investigate the therapeutic potential of the compounds 
would require further investigation in an animal model 
(Shigeta et al., 1983). The need to find new drug candidates 
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has meant cell culture methods continue to be used. A more 
recent study by Kleymann et al. (2002) investigated the 
potential use of helicase-primase inhibitors as a new drug 
candidate in the treatment of HSV. This study however, tested 
the compounds on HSV-1 infected Vero cells. To investigate 
compounds further this study also included a murine challenge 
model. HSV-1 or HSV-2 was applied to the nares of female 
mice, they were then subsequently given an oral suspension 
of treatment compounds. The study concluded that the 
compound BAY 57-1293 both in vitro and in vivo, was found to 
be superior in the treatment of HSV in comparison to 
acyclovir, valaciclovir and famciclovir (Kleymann et al., 2002) 
 
There is difficulty in using antivirals for the treatment of EEHV. 
Ultimately anti-viral drugs have not been tested in Asian 
elephants, therefore therapeutic levels are not known. The 
most appropriate and effective route of delivery is also 
unknown for antivirals in Asian elephants, however, levels of 
the drug in blood could be established with minimal invasion, 
this can be difficult in elephants as blood samples would need 
to be taken. 
 
                                                                           Chapter 4 
  
143 
     
4.3      Cell lines used for the culture of herpesviruses 
A number of cells have been used to culture herpesviruses 
including ovine fetal lung cells, mink lung cells, ferret lung 
cells, potoroo kidney cells, turkey embryo kidney cells, equine 
dermal cells, bovine turbinate cells, and porcine kidney cells 
(PK15); all were shown to be sensitive to a number of animal 
herpesviruses  (Peterson and Goyal, 1988). Other cells such 
as marmoset B lymphoblastoid cells (B95-8), Vero cells, 
Human Fetal Lung Fibroblast cells (MRC-5), Cyprinus carp 
brain, human peripheral blood Mononuclear cells, guinea pig 
embryo cells, baby hamster cells, and rabbit kidney cells, have 
also been used (Landry et al., 1982, Gleaves et al., 1985, 
Shaw et al., 1987, Archer et al., 1999, Hukkanen et al., 
1999). 
4.4      Previous attempts at EEHV culture 
Being able to culture EEHV would enable the potential 
development of a vaccine and the testing of anti-herpetic 
drugs for efficacy against the virus, as well as fundamental 
studies of the virus lifecycle and transmission route that are 
essential background information for the development of 
diagnostics, treatment and control strategies for the virus.  
 
Several attempts have been made to isolate and culture EEHV 
in a variety of cell lines (Table 12). A previous attempt to 
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culture primary placental endothelial cells for an attempt at 
viral culture by Richman (2003) was unsuccessful.  
 
Table 12: Previous attempts to culture EEHV in a variety of cell lines 
Cell line Source 
Primary bovine lung cells Metzler et al. (1990) 
Chicken Embryo Fibroblasts Metzler et al. (1990) 
Madin Darby Bovine Kidney Cells 
(MDBK) 
Metzler et al. (1990) 
Rabbit Kidney 13 cells (RK13) Metzler et al. (1990) and Richman et al. 
(1999) 
Vero cells Richman et al. (1999) 
MARC African Green Monkey Kidney cells Richman et al. (1999) 
Embryonating chicken eggs Richman et al. (1999) 
Baby Hamster Kidney cells (BHK) Richman et al. (1999) 
Equine Epidermal cells Richman et al. (1999) 
Human Foreskin Fibroblasts Richman et al. (1999) 
Asian Elephant Fibroblasts Richman et al. (1999) 
African Elephant Fibroblasts Richman et al. (1999) 
Primary Placental Endothelial cells Richman (2003) 
 
4.5      Culture of endothelial cells 
Primary cell cultures include fibroblasts, melanocytes and 
endothelial cells. Endothelial cells are derived from the 
endothelium of veins, commonly obtained from the umbilical 
vein, as this vessel is more easily available. Endothelial cells 
have been cultured to study blood pressure homeostasis and 
permeability. Human umbilical vein endothelial cells (HUVEC’s) 
are frequently used as a model system, especially for the 
study of pathology and function of endothelial cells including 
physiological processes such as angiogenesis.  
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This study describes two methods used in attempts to culture 
Asian elephant endothelial cells. Endothelial cells were 
selected for culture for two reasons: they are undifferentiated 
cells, and EEHV has been previously been detected in 
haematoxylin and eosin stains in endothelial cells from clinical 
cases.  
 
4.6      Materials and methods 
Ethical approval for the procedures was granted by the School 
of Veterinary Medicine and Science, through their non-Animal 
Scientific Procedures Act (ASPA) ethics committee 
13/09/2011. A total of seven attempts were made to culture 
endothelial cells; two methods were trialled during this study. 
4.6.1      Method one 
The first umbilical cord was collected on 12/10/2013 by 
elephant keepers and staff at a UK zoo. Small pieces of 
umbilical cord were washed twice in phosphate buffered saline 
(PBS) and transferred into pots containing Dulbecco’s Modified 
Eagle Medium (DMEM). The DMEM contained 20% fetal calf 
serum, 5% Penicillin-Streptomycin, 5% Amphotericin B and 
5% Fungizone. Cord blood was collected in a blood bag 
containing anticoagulants. Placenta and cord blood were 
transported to Nottingham at room temperature to minimise 
cell death. 
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4.6.2      Method two 
Samples were derived from umbilical cord material from a 
natural birth following a normal 22 month gestation in a 
female Asian elephant in a UK zoo, which resulted in a live 
born female calf. The expelled placenta was collected, and a 
section of elephant umbilical cord was clamped.  Artery clamps 
were attached to the free end of both umbilical arteries and 
the umbilical vein, and clamps were then attached 30cm 
further along the cord (Figure 13). The cord section was cut 
away from the remaining cord and placenta using a dissection 
knife. The cord section was washed once in lukewarm water to 
remove external debris, and a second time in phosphate 
buffered saline (PBS). The sample was then transferred into a 
sterile plastic transport box containing rinsing solution (1% 
penicillin/streptomycin, 1% heparin (138.8mg per 5ml PBS)) 
in PBS). Overalls, masks and gloves were worn by the 
investigators throughout sample handling. 
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Figure 52: Asian elephant umbilical cord prior to separation of both 
arteries and the umbilical vein. Arteries and the umbilical vein were clamped 
using artery clamps. 
 
Cord processing was conducted in a laminar flow hood to 
minimise contamination. Both arteries and umbilical vein were 
separated using a surgical blade (Figure 14). 
 
Figure 53: Elephant umbilical cord, artery and vein separation. A = artery, 
B = umbilical vein and C = artery. Both arteries and the umbilical vein were 
separated from each other using a surgical blade. Clamps remained attached to 
minimise external contamination. 
 
Blood was washed from the vessels with phosphate buffered 
saline (PBS) through a 4-French canine urinary catheter. 
Twelve millilitres of pre-warmed collagenase (Sigma-Aldrich, 
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Dorset, UK) at a concentration of 1mg/1ml was injected into 
each artery and vein, and the sample was incubated for 15 
minutes at 37ᵒC. Twenty millilitres of endothelial media [10% 
foetal calf serum, 0.01% human Epidermal Growth Factor 
(hEGF) (BD biosciences, Bedford UK) in 400ml human 
endothelial serum free media (Life technologies (Thermo 
Fischer), UK)) was used to wash cells from each artery and 
vein into a 50ml centrifuge tube and to inactivate collagenase. 
The harvested cell suspension was centrifuged at 484xg 
(Thermo Scientific Sorvall Legend RT centrifuge) for 5 
minutes; the supernatant was then discarded, and the cell 
pellet resuspended in endothelial media. 
 
Cell culture flasks were coated in fibronectin (0.1% fibronectin 
in RPMI media), and the cell suspension was added and 
incubated at 37°C and 1% CO2 until cells were 50-70% 
confluent. Media was changed every other day and cells were 
passaged twice a week. 
4.6.3      Immunohistochemistry 
Cultured cells were transferred onto microscope slides using 
cytospin (All cytospins in this thesis were performed using a 
Thermo Shandon cytospin 4 machine); cells were first 
suspended in 100µl human endothelial media, 100µl of the cell 
suspension and 50µl foetal calf serum were put into each 
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cytospin funnel. Samples were spun at 500rpm for 5 min and 
air dried for 30 minutes. Cells were fixed using acetone, 
wrapped in foil and stored at -20°C overnight and then 
transferred to -80°C until further processing. The cells were 
then stained using a protocol for visualising cells, using von 
Willebrand factor (VWF) as a biomarker for endothelial cells 
(Robinson et al., 2006). The primary antibody used was 
polyclonal rabbit anti-human VWF (Dako, High Wycombe, UK) 
diluted in PBS with 2% Normal Goat Serum. Normal rabbit IgG 
diluted in 2% normal goat serum was used for negative 
controls, and the secondary antibody was biotinylated goat 
anti-rabbit IgG (Vector Labs, Peterborough, UK). Primary 
antibodies were detected using Vectorstain ABC and 
visualisation was performed using diaminobenzidine (Vector 
Labs) as described by Robinson et al. (2006). 
 
Aliquots of cultured cells from each passage were stored in 
freezing media (Lonza, Slough, UK) and in liquid nitrogen for 
future use.  
4.6.4      DNA barcoding 
DNA was extracted from the cultured cells using a commercial 
kit following the manufacturer’s instructions for extracting 
DNA from cultured cells (Machery Nagel Tissue kit). Cells used 
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for DNA extraction were at a concentration of 20x106/ml, of 
which 100µl was used. 
 
DNA barcoding primers were used to confirm the origin of the 
cells.  Primers were as follows: forward primer C 5’-
TTTCAACCAACCACAAAGACATCGG-3’ and reverse 5’-
TATACTTCAGGGTGTCCAAAGAATCA-3’ (Bitanyi et al., 2011). 
The sample was amplified using PCR; this included 35 cycles 
of 94°C for 30 secs, 55°C for 30 secs and 72°C for 1 min 
(Bitanyi et al., 2011). DNA bands were visualised using gel 
electrophoresis and Nancy 520 fluorescent stain, and the PCR 
product was then sent to Eurofins for Sanger sequencing using 
the same primers to confirm the identity of the product. 
 
4.7      Results 
4.7.1      Method one 
Two attempts were made to isolate endothelial cells; method 
one was unsuccessful, as only fibroblast like cells were present 
in both cultures. The cells derived from attempt one survived 
until passage 3, and attempt two until passage 1; at this time 
both became contaminated with bacteria and yeast. 
4.7.2      Method two 
A total of five attempts were made using method two. Attempt 
3 using method two was successful, and endothelial cells were 
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present; this will be discussed in more detail below. Attempts 
5, 6 and 7 all became contaminated on the 4th, 2nd and 3rd 
day respectively. Three umbilical cord samples were between 
4-6 days old on arrival; the cord used for attempt one was 
three days old and the one for attempt two was 2 days old. 
The umbilical cord used for attempt 3 was processed within 2 
hours from the time of parturition, and attempt 7 was within 
10 hours (Table 13).
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Table 13: A brief account of each EUVEC attempt. 
 Method Age of cord Survival time Cell growth 
Attempt 1 One A few days To passage 3 Fibroblast like cells 
Attempt 2 One 2 days To passage 1 Fibroblast like cells 
Attempt 3 Two Within 2 
hours 
To passage 8 Endothelial cells present 
Attempt 4 Two 6 days Contamination 
on day 2 
No significant growth 
Attempt 5 Two 4 days Contamination 
on day 4 
No significant growth 
Attempt 6 Two 5 days Contamination 
on day 2 
No significant growth 
Attempt 7 Two Within 10 
hours 
Contamination 
on day 3 
No significant growth 
 
Cultured cells from attempt three survived until passage 8, 
and they appeared to be morphologically similar to endothelial 
cells with a “cobblestone” effect (Figure 15). After passage 2 
there began to be a mixed population of cell types. 
 
 
Figure 54: Cultured cells at passage 2 40x resolution. Cultured cells appeared 
morphologically similar to endothelial cells with a “cobblestone” effect. 
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The cells were stained for the presence of VWF to determine 
cell type, VWF was chosen as a biomarker as VWF lines the 
internal surface of both bone marrow cells and blood vessels, 
VWF is made within endothelial cells.  Cultured cells from 
passage 2 stained positively for VWF (Figure 16).  
 
 
Figure 55: Visualisation of passage 2 endothelial cells using von 
Willebrand Factor as a biomarker on cultured cell cytospin. A= passage 2 
elephant cells negative control, B = positive elephant endothelial cells showing the 
presence of von Willebrand Factor and C = positive control bovine corpus luteum. 
Cells were stained using a protocol for visualising cells, using von Willebrand factor 
(VWF) as a biomarker for endothelial cells. 
 
 
Cells from passage 6 also stained positively for VWF, but the 
negative control for this passage was also mildly positive 
(Figure 17). By passage 6 cells appeared less morphologically 
like endothelial cells. 
 
 
Figure 56: Visualisation of passage 6 cultured cells using von Willebrand 
Factor as a biomarker on cultured cell cytospin. A= passage 6 elephant cells 
negative control, B = positive elephant endothelial cells showing the presence of 
von Willebrand Factor and C = positive control bovine corpus luteum. 
 
 
Sequencing and DNA barcoding results confirmed that the 
cultured cells were of Asian elephant origin (sequence not 
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shown) and the sequence was deposited on Genbank 
(KP233819). Comparing the sequence obtained from the 
cultured cells to the mitochondrial complete genome of each 
species, the sequence was 99% identical to Elephas maximus, 
95% identical to Mammuthus primigenius, 95% identical to 
Loxodonta cylotis and 94% identical to Loxodonta africana. 
 
4.8      Discussion 
This study demonstrated the successful culture of elephant 
endothelial cells obtained from an Asian elephant umbilical 
cord. The cells cultured survived to passage 8; the passage 1 
cell population appeared to be predominantly endothelial cells, 
while from passage 2 onwards there appeared to be a mixed 
cell population. This is similar to results from previous 
unpublished attempts by other researchers (Paul Ling, 
personal communication).  
 
Endothelial cells may play a role in EEHV pathogenesis; this is 
suggested by the presence of haemorrhages observed in 
various tissues in acute cases. Endothelial cell dysfunction has 
been related to viral haemorrhages, as viral infection of the 
endothelium can alter the function of endothelial cells, such as 
their ability to control permeability resulting in vascular 
leakage. The endothelium also controls platelet interactions; 
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during viral infection of the endothelium, platelets may 
become aggregated or sequestered which can also result in 
thrombocytopenia (Krishnamurti et al., 2002, Carr et al., 
2003, Dewi et al., 2004, Chen et al., 2007). However, herpes 
viruses such as cytomegalovirus are thought to infect 
endothelial cells; this could play a key role in the spread of 
HCMV throughout the body. HCMV may therefore infect 
endothelial cells without causing vascular leakage or 
thrombocytopenia. Endothelial cells are also thought to play a 
role in HCMV latency (Ho et al., 1984, Grefte et al., 1993, 
Jarvis and Nelson, 2002, Jarvis and Nelson, 2007). Similarly, it 
has been suggested that endothelial cells may also serve as 
the site of EEHV latency (Seilern-Moy et al., 2016). A recent 
study suggested that due to the large number of basophilic 
intranuclear inclusion bodies in Asian elephant deaths 
associated with EEHV, endothelial cells located in the 
endocardium and the myocardial arteries were more severely 
affected. This was compared to those in the: kidney, lung, 
liver, skeletal muscle and bladder (Seilern-Moy et al., 2015).  
Despite the successful outcome of this study, several further 
attempts to culture elephant endothelial cells from other 
umbilical cord samples were not successful. An attempt was 
also made to revive cell stocks from liquid nitrogen; this was 
unsuccessful.  There are a number of challenges to performing 
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this type of culture.  One of the key considerations is the age 
of the umbilical cord; efforts to isolate EUVECs from umbilical 
cords which were collected more than 4 hours after parturition 
were unsuccessful. Contamination is another common 
problem; this type of culture is highly prone to contamination 
with environmental contaminants such as bacteria and yeast. 
One of the other considerations in conducting this type of 
work is the difficulty in obtaining Asian elephant umbilical 
cords; as pregnancies do not occur frequently in captive 
elephants, the availability is limited.  
 
There are also a number of other challenges in obtaining Asian 
elephant umbilical cords such as, animals may be kept in 
protected contact conditions this may make it difficult for 
keeping staff to enter the enclosure. If the animals are kept in 
free contact conditions, it may be dangerous to enter the 
enclosure following a recent birth. The animals may also 
consume or damage the umbilical cord prior to retrieval.  
Due to potential difficulties in retrieval, the umbilical cord 
sample may be in the enclosure for several hours before it is 
collected and prepared for shipping, thus collection conditions 
are not always known.  However, in future attempts to culture 
EEHV, other sources of elephant endothelial cells may be 
used; endothelial cells are also found in bone marrow and 
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blood vessels (Shi et al., 1998, Crosby et al., 2000). It would 
however, be difficult to obtain bone marrow or blood vessels 
from a living Asian elephant.  Samples could be obtained after 
death, but post mortem examinations usually take place 
several days after the elephant has died. Samples obtained 
after several days would not necessarily be viable for cell 
culture as prompt sample collection is important to allow 
successful cell culture. Samples could be obtained after death, 
but post mortem examinations often take place several days 
after the elephant has died. This may be due to a number of 
reasons, including the size of the animal, availability of 
suitable transportation, specialist staff availability and whether 
the death was expected or sudden.  
 
The first steps in the development of a vaccine for EEHV or 
testing antivirals are to develop the ability to culture the 
correct cell type (susceptible to infection with EEHV), isolate 
EEHV, and attempt a viral culture. However, there are a 
number of factors that need to be considered when attempting 
to develop vaccines or test drugs in endangered animals. 
There are difficulties in the ethics of treatment; both drug and 
vaccine trials would require experiments on Asian elephants, 
as there is no animal model for this species. It would also be 
difficult to perform both vaccine and drug tests in the natural 
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host, as Asian elephants are a protected species. The testing 
of drugs in a sick animal would also be difficult, or even the 
possibility of not treating with anti-virals to determine if the 
animal would survive without treatment, as not providing any 
form of treatment may be determined as unethical.  
It is the responsibility of the zoo to provide care for all animals 
and to provide treatment for any clinically ill animals and is 
covered under the Zoo Licensing Act 1981 (DEFRA, 2012). 
 
BIAZA state that one of their main priorities is the promotion 
of zoo animal welfare, and that the needs of the animals must 
be met; this includes medical treatment (BIAZA, No date). 
 
In the UK every zoo is required to have a license under the 
Zoo Licensing Act 1981, mistreatment or not providing good 
care to zoo animals could result in the revocation of the 
establishment’s license, an example of this is South Lakes Zoo 
in the UK, whose owner had the renewal of their zoo license 
refused due to the deaths of 486 animals within four years 
(BBC News, 2017). 
 
In the case of EEHV, treatment has included treating with 
anti-viral drugs of unknown efficacy in the Asian elephant. 
Attempting treatment of EEHV in Asian elephants can be seen 
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as justifiable as zoos are required to treat a sick animal to try 
and improve their health, even if there has been no evidence 
to prove the medication is successful. However, this may also 
be seen as inappropriate as zoos may be driven to treat EEHV 
in Asian elephants with drugs not proven to improve their 
health due to legal/ethical requirements. As zoos are not 
currently releasing Asian elephants into the wild and 
contributing to the survival of wild populations it may be 
suggested that keeping and treating animals in captivity is not 
ethically justified. But whilst Asian elephants are in captivity in 
the UK, zoos are required by law to provide care and 
treatment for medical conditions. However, developing a 
vaccine for EEHV may not be justifiable for a number of 
reasons including cost, unknown potential side effects and it is 
not known if it will have an effect on increasing the numbers 
of captive elephants. It is also unknown if a vaccine is 
developed how or if it would be possible to vaccinate wild 
Asian elephants and what impact this would have on wild 
populations if any. 
 
Future work should build on the results from this study; this 
could include further attempts to revive endothelial cells from 
storage and attempting an EEHV infection. Cell to cell 
transmission could be investigated using infected post mortem 
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tissue placed onto cells in cell culture. The identification of 
other cells present within the population of mixed cells after 
passage 3, could be determined using other antibodies which 
have been developed for the identification and detection of 
endothelial cells. A number of antibodies (cell markers) have 
been developed in other species; however, their use in 
elephant studies is currently unknown. A number of existing 
antibodies which could be tested include the mouse 
monoclonal (RECA-1) to endothelial cells (anti-endothelial cell 
antibody), which has been shown to react with cells in the 
vascular endothelium; it has been successfully used in rat 
endothelial cell studies (Duijvestijn et al., 1992, Kang et al., 
2001). Mouse monoclonal (BW-200) to endothelial cell anti-
endothelial cell antibody, which reacts with the endothelium of 
the renal glomerulus in humans could also be tried (Abcam, 
n.d). Testing cell markers that have reactivity for a wide 
number of species could also be attempted. For example, 
VEGF R3, a mouse monoclonal antibody, has been developed 
for the identification of endothelial cells; VEGFR-3 mRNA is 
expressed in most endothelial cells, such as those found in the 
placenta, brain, intestine and lung. VEGF R3 antibody is 
reactive in a number of animals including bovines and canines 
(Neuromics, n.d-b). EMAP II antibody has shown reactivity in 
a large number of species, including cattle, cats, chickens, 
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horses, primates, rats and rabbits. It is a tumour derived 
cytokine that inhibits endothelial proliferation and can 
potentially induce apoptosis (Neuromics, n.d-a). This list, 
however, is not an exhaustive list as there are a large number 
of antibodies available; one of the major limitations in testing 
a large number of antibodies is cost. 
 
If attempting a culture of cells for use in EEHV 
experimentation, another possibility would be to investigate 
the potential use of endothelial cells from other species such 
as horses or humans.  Using elephant EGF or elephant foetal 
calf serum could be tested; this may aid in the growth of cells, 
and may provide more natural conditions for cell growth. A 
viral infection could also be attempted in other cell types. 
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5      Tissue tropism of EEHV1 and clinical disease 
5.1       Introduction 
Tissue tropism can be determined using the measurement of 
viral DNA or RNA present (viral load) in tissues; viral load can 
also be measured in blood, or other body fluids, and can be 
used to diagnose or monitor the progression of clinical 
disease. A number of previous studies have investigated the 
correlation between disease severity and higher virus DNA 
loads for a number of different viruses. Zink et al (1999) 
concluded that the severity of Simian Immunodeficiency Virus 
encephalitis was linked with higher viral loads in both the 
brain and cerebral spinal fluid. Higher levels of HSV2 viral 
loads in the autonomic ganglia have also been correlated with 
an increased severity in clinical disease (Weinberg et al., 
2003).  Similar results were also found by Malavige et al. 
(2008), who investigated the relationship between viral load 
and disease severity in primary infections of VZV. Blood 
samples were obtained from 34 patients with varicella 
infection. The severity of disease was determined by the 
presence of fever, and the number and character of lesions. 
Viral load was measured for each patient using qPCR. Those 
patients who had more than 500 lesions had higher viral loads 
when compared to those with less than 500 lesions. The 
findings suggested patients with a mild infection presented 
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with lower viral loads than those with moderate to severe 
infections (Malavige et al., 2008).  
 
One of the current problems facing the management of 
captive elephants is the prediction of which animals might 
develop disease due to EEHV.  A number of previous studies 
have measured virus DNA loads in asymptomatic animals 
using trunk washes, it remains unclear whether levels of viral 
DNA present in trunk washes can be used to predict or even 
diagnose clinical disease.  
 
Virus DNA loads have also been measured in the blood of 
Asian elephants. In an animal determined to be clinically ill, a 
virus DNA load of 1,464 viral genome copies was present per 
ml of whole blood 2 days before the onset of clinical signs. A 
blood sample was also taken from the same animal on day 8 
of clinical signs, and showed an increase in the virus DNA 
load, which peaked at 635,992 viral genomes/ml blood 
(Stanton et al., 2013).  Another previous study reported the 
range of viral genomes per ml of blood at 6.4 X 105 – 2.6 X 
107, however, elephants’ whose deaths were associated with 
EEHV1 presented with higher virus DNA loads. This would 
suggest higher amounts were present in the animals that are 
clinically ill.  However, it is difficult to be certain, as samples 
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were not obtained from the elephants before they became 
clinically ill, and a virus DNA load range was not determined 
for “healthy” elephants. Using blood to detect EEHV in 
asymptomatic animals is not recommended, as obtaining 
blood samples from ‘healthy’ asymptomatic animals can be 
difficult and is invasive. Another consideration is that blood 
samples are only recommended if the elephant is in the 
viremic stage where EEHV can be detected in blood (Hardman 
et al., 2011). Whereas trunk washes are less invasive, and 
have successfully been used to determine asymptomatic virus 
DNA loads (Stanton et al., 2010), however, trunk washes may 
be less useful during active infections when a blood sample 
may provide more valuable information. When EEHV is present 
in blood it is considered a clinically active infection, and higher 
levels of the virus are present in blood. 
 
The presence of EEHV1 has been detected using a variety of 
methods including histology, serology and conventional PCR. 
5.2      EEHV detection and presence of inclusion bodies 
Basic methods to detect EEHV include using histopathology to 
examine post mortem samples. This includes looking for the 
presence of inclusion bodies, which are an indication of 
infection with a herpes type virus. Inclusion bodies are 
aggregates of proteins in cells, which are usually sites of viral 
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transcription and replication (Augenbraun et al., 1995, Jarvis 
and Nelson, 2002, Lahaye et al., 2009, Hoenen et al., 2012). 
A number of diseases are diagnosed on the basis of inclusion 
bodies, such as lewy body inclusions in Parkinson’s disease 
and neuronal inclusion bodies in frontotemporal dementia 
(Gibb and Lees, 1989, Englund et al., 1994, McKeith et al., 
1996, Gelb et al., 1999, McKeith et al., 2005). There are a 
number of different types of inclusion bodies currently 
identified for different diseases; some inclusion bodies form in 
the cytoplasm and others in the nucleus. These include: 
intracytoplasmic eosinophilic, intranuclear acidophilic and 
intranuclear basophilic (Table 14).  
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Table 14: Viral inclusion bodies and virus association 
Inclusion body type Inclusion body and 
association 
Reference 
Intracytoplasmic 
eosinophilic 
Negri bodies (Rabies) (Gupta and Varshney, 
2000) 
 Guarnieri bodies (Vaccinia) (McCouch et al., 1997) 
 Paschen bodies (Variola/small 
pox) 
(Clayton et al., 1995) 
 Bollinger bodies (Fowlpox) (Cambon-Thomsen, 
2004) 
 Henderson-Patterson bodies 
(Molluscum contagiosum) 
(McGuire and Beskow, 
2010) 
Intranuclear acidophilic Cowdry type A (HSV/VZV) (Parsons et al., 2005, 
Bayes et al., 2000) 
 Torres bodies (Yellow fever) (Bowkett et al., 2009) 
 Cowdry type B (Adenovirus) (Kierepka et al., 2016) 
Intranuclear basophilic Cowdry type B (Adenovirus) (Kierepka et al., 2016) 
 Owl’s eye appearance inclusion 
bodies (CMV) 
(Stanton et al., 2016) 
Intranuclear and 
intracytoplasmic 
Warthin-Finkeldey bodies 
(Measles) 
(Brown et al., 2007) 
 
Inclusion bodies have been found in proliferative cutaneous 
lesions of captive African elephants in the USA. Jacobson et al. 
(1986) investigated elephants from two groups: 33 animals 
from an animal importer (group one), and group two which 
were 63 elephants collected in Zimbabwe. Animals in both 
groups exhibited lesions; seven animals from group one had 
fibrous growths on their trunk which were present on arrival, 
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whereas fibrous growths did not appear on the trunks of 
animals in group two until three months after arrival. Biopsies 
from the lesions were taken at various stages, which showed 
younger nodules were inverted papilloma’s, whereas older 
lesions were composed of fibroblasts, collagen and mixed 
cells. Electron microscopy also confirmed the presence of 
inclusions in the centre of early lesions. Lesion samples 
showed mature virus particles in the cytoplasm and in the 
intercellular space. The study concluded that the cutaneous 
papilloma lesions were associated with a herpes like infection. 
 
Inclusion bodies have also been found in studies of EEHV; 
Richman et al. (2000a), found lesions in a number of target 
organs (including heart, liver and tongue), and the capillary 
endothelial cells also contained amphophilic to basophilic viral 
inclusion bodies. Further investigation of the inclusion bodies 
by electron microscopy revealed viral capsids of 80-92nm in 
diameter which were consistent with the morphology of 
herpesviruses. Similar results were suggested by Sripiboon et 
al. (2013), who noted the presence of cowdry type A inclusion 
bodies in epithelial cells within heart tissue samples from an 
EEHV associated death, this was determined by the use of 
haematoxylin and eosin staining.  
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The first discovery of a herpes like virus in African elephants 
was in 1971. For histology, lung samples were stained with 
haematoxylin and eosin, and for electron microscopy thin 
sections were stained with uranyl acetate. Lymphoid nodules 
associated with cowdry type A inclusion bodies were observed 
in the lungs of 37/50 (74%) wild African elephants, while 
inclusion bodies were found in both epithelial and syncytial 
cells, limited information was given about elephants such as 
gender, age etc. (McCully et al., 1971). Twenty-eight years 
later a PCR based assay was then developed to determine the 
presence of EEHV; however, this assay could not detect 
specific variants and was not quantitative (Richman et al., 
1999).  
5.3      EEHV tropism 
The name ‘elephant endotheliotropic herpes virus’ suggests 
the virus has a tropism for endothelial cells; this is similar to 
HCMV which also has endothelial cell tropism (Jarvis and 
Nelson, 2007). Indeed, it appears that EEHV has a primary 
tropism for endothelial cells, especially those of the heart, 
liver and tongue (Brock et al., 2012). 
 
However, it has been suggested that EEHV has a broader 
tropism than previously suggested, as it has been associated 
with both mild mucosal lesions and more severe haemorrhagic 
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disease (Schaftenaar et al., 2010). Tissue tropism of EEHV can 
vary case by case, as was observed by Sripiboon et al. 
(2013); in one of two fatal cases attributed to EEHV infection, 
tissue tropism was more specific, with mainly the 
cardiovascular system being affected, whereas in the other 
case, haemorrhages were noted in most organs. Tissue 
tropism also appears to differ depending on the variant of 
EEHV present; in fatal cases involving EEHV1, the 
cardiovascular system appears to be more severely affected. 
However, there appears to be less selective organ tropism for 
EEHV3, 4 and 5 (Garner et al., 2009, Sripiboon et al., 2013). 
Infection with EEHV3 has been associated with retinal damage 
and renal medullary haemorrhages; EEHV3 also appears to 
have a tropism for larger veins and arteries (Garner et al., 
2009). Sripiboon et al. (2013) noted EEHV4 infection appears 
to be linked with multiple organ haemorrhages, including 
respiratory, cardiovascular and gastrointestinal systems. It 
was also noted that EEHV4 appears to have less selective 
organ tropism in comparison to other EEHV variants. In a case 
of EEHV5, widespread haemorrhages and oedema were found 
(Wilkie et al., 2013). 
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5.4      EEHV virus DNA loads 
A number of previous EEHV studies have used qPCR to detect 
viral DNA; those developed have either used probe based or 
SYBR green technology. The first probe based qPCR for 
specifically detecting EEHV1 was developed in 2010 by 
Stanton et al. (2010). The PCR was used to detect EEHV1 in 
oronasal secretions of five asymptomatic animals; the assay 
detected up to 1,200 copies/ml in whole blood. The detection 
method, which was designed to detect a segment of the U38 
(POL) gene, incorporated a separate qPCR assay for cellular 
IFNƴ DNA in order to confirm the presence of cellular DNA in 
the samples and absence of PCR inhibitory factors. 
Subsequently, several probe based qPCR assays were 
described which were developed to specifically amplify EEHV 
2, 3, 4, 5 and 6. However, discrimination between EEHV 3 and 
4, was not possible as primers specific to each variant could 
not be developed (Lischka and Zimmermann, 2008). A SYBR 
green based qPCR assay has also been developed to detect 
EEHV1 from trunk swabs, with the primers based on the 
terminase gene sequences of EEHV 1-4. The assay detected 
low levels of EEHV1 DNA (276 copies/µl). The primers used for 
this assay were not tested on other sub types of EEHV (2-6), 
as positive control material was not available. The 
disadvantages of using a SYBR green assay is that non-
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specific binding of primers may occur (resulting in false 
positives), and the PCR reaction may be inhibited by some 
dyes (Smith, 2010). The advantage of this method is that it is 
quantitative; the number of viral copies present in a sample 
can be calculated. In this method, virus DNA load is measured 
against a standard curve. A standard curve is a quantitative 
graph; it is created using a serial dilution of multiple samples, 
of which the properties such as the number of molecules is 
known. These samples are known as standards, the number of 
molecules in each dilution can then be calculated using 
Avogadro’s number. Avogadro’s number is the number of 
molecules in one mole of a substance. The sample used for a 
standard curve is usually a dilution series of an appropriate 
cytokine such as interferon or tumour necrosis factor alpha 
(TNFα), or beta actin. It is then transformed into a plasmid, or 
genomic DNA (from a host tissue sample) can also be used. 
The standards are run alongside the unknown samples in a 
qPCR reaction; the cycle threshold value (the cycle number at 
which the fluorescence generated crosses the fluorescence 
threshold) of the unknown samples which can then be 
compared to that of the known standards by interpolation on 
the graph.  
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Understanding the amount of virus present in both 
asymptomatic and symptomatic animals is important in the 
study of EEHV. The level at which an asymptomatic case 
becomes a clinical case is currently unknown. Therefore, 
further investigation into tissue tropism, and determining 
levels of the virus in tissues from animals whose deaths are 
associated with EEHV, would provide further evidence of how 
much virus is present in symptomatic animals. This study used 
a probe based qPCR assay to measure the virus DNA load in 
different Asian elephant tissues, obtained from two deaths 
associated with EEHV. 
 
5.5      Materials and methods 
Ethical approval for the procedures was granted by the School 
of Veterinary Medicine and Science, through their non-Animal 
Scientific Procedures Act (ASPA) ethics committee 
13/09/2011.  
5.5.1      Samples 
Ten post mortem tissue samples were received for each of the 
two juvenile Asian elephants who presented with clinical signs 
consistent with EEHV disease; their deaths were attributed to 
haemorrhagic disease. The juveniles in this study included a 
two-year-old female who died on 03/07/2013 and a 3-year-old 
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male who died on 29/07/2013. All tissues had been stored at -
20°C prior to arrival were stored at -20°C until processing.  
5.5.2      DNA extraction 
See materials and methods section 2.2.1 
5.5.3      DNA content 
The amount of DNA in each sample was determined using a 
nanodrop machine (Thermo Fischer nanodrop 8000) (see 
Table 15). 
Table 15: Samples analysed for the presence of EEHV1 and the amount of 
DNA present. 
UON_1189 DNA ng/µl UON_1329 DNA ng/µl 
Kidney 147.6 Kidney 35.76 
Tongue 40.6 Tongue 24.59 
Lung 176.3 Lung 14.17 
Heart 39.7 Heart 235.6 
Liver 181.4 Liver 76.3 
Aorta 136.6 Aorta 19.73 
Spleen 136.7 Spleen 77.9 
Bone marrow 277.1 Pancreas 456.1 
Trunk lining 169.6 Trunk lining 25.99 
Lymph node 254.3 Lymph node 300 
 
5.5.4      Quantification of EEHV1 by qPCR 
To confirm the presence of EEHV1 by qPCR, the method 
described by (Bennett et al., 2015) was used, which was an 
adapted protocol based on the method described by Stanton 
et al. (2010). EEHV primers were used to amplify the U38 
(POL) region; the forward primer was fluorescently labelled 
with FAM. Primers amplifying IFNγ were used to create a 
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standard curve, and the forward primer was also labelled with 
the fluorescent dye HEX. Both set of primers were included in 
each qPCR reaction. 
5.5.5      Data analysis 
Data was analysed using GraphPad Prism 7.01 software.  
 
5.6       Results 
5.6.1       Quality control of tissue DNA samples 
In order to confirm that DNA samples extracted from elephant 
tissues contained DNA of sufficient quality to detect EEHV1, a 
qPCR to detect elephant IFNγ was performed on each of the 
samples. The presence of DNA of sufficient quality and 
quantity allows robust PCR amplification. The cycle threshold 
(Ct) value obtained for IFNγ was then used to normalise the 
qPCR data for EEHV (Figure 18). All samples tested gave a Ct 
value of between 18 and 22; a lower Ct value indicates a 
higher amount of elephant DNA within the sample. There was 
little variation between the IFNƴ present in the samples. This 
would indicate fluctuations in the amount of EEHV1 was not 
due to variation in IFNƴ.  
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Figure 57: Comparison of mean raw threshold (CT) values and error bars. 
Raw IFNƴ values for UON_1329 are dark orange and EEHV1 values are in light 
orange, raw IFNƴ values for UON_1189 are in dark blue and EEHV1 values in light 
blue. Black bars above each column show the standard of error most bars showed 
a small standard of error. 
 
5.6.2      EEHV1 presence in tissues 
Ten tissues from UON_1189 and ten from UON_1329 were 
used in this study, of which 75% (15/20) were positive for 
EEHV viral DNA. Of the ten tissues provided from UON_1189, 
70% (7/10) were positive; 80% (8/10) of 10 tissues from 
UON_1329 were positive. 
5.6.3      UON_1189 
EEHV viral DNA was present in almost all samples provided for 
this animal except the trunk lining; however, the amount of 
viral DNA present in each tissue varied considerably. The 
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tissues containing the highest amounts of viral DNA were the 
heart and liver, there was 10 fold more virus in the heart than 
in the liver. This was also confirmed using a one way ANOVA, 
the result when comparing the amount of EEHV in the heart 
when compared with the liver was statistically significant with 
a P value of 0.008. Lower amounts were found in the tongue 
and spleen, and the lowest amounts were present in the 
kidney, lung, aorta, bone marrow and lymph node. By 
contrast, no viral DNA was present in the trunk lining sample 
(Figure 19). 
 
 
Figure 58: Ten samples from UON_1189 were tested for the presence of 
EEHV1, samples were normalised against IFNγ, and are displayed as a 
ratio of EEHV/IFNγ on the y axis. The highest levels of EEHV1 were present in 
the heart and liver, whilst lower levels were found in the tongue, bone marrow, 
lymph node and lung. The lowest concentrations were present in the kidney and 
lung, whilst no EEHV1 viral DNA was present in the kidney, aorta or the trunk 
lining. 
 
5.6.4      UON_1329 
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EEHV1 viral DNA was present in eight of the samples from this 
animal; 80% (8/10) of the tested samples were positive. 
Varying levels of viral DNA were also observed between the 
tissues examined. The highest viral DNA loads were present in 
the liver and heart, there was 3 fold more virus in the liver 
than in the heart, however, analysis using a one way ANOVA 
showed that the results were not significant with a p value of 
0.4. Lower amounts were seen in the tongue, trunk lining, 
lung, aorta and spleen. EEHV1 viral DNA was detected in all 
samples; however, only very small amounts were detected in 
the kidney, pancreas and lymph node (Figure 20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figu
re 59: Ten samples from UON_1329 were tested for the presence of 
EEHV1, samples were normalised against IFNγ, and are displayed as a 
ratio of EEHV/IFNγ on the y axis. The highest concentrations of EEHV1 were 
present in the liver and heart, whilst lower concentrations were found in the 
tongue, trunk lining, aorta and lung. The lowest concentrations were present in the 
kidney and pancreas, whilst no EEHV1 viral DNA was present in both the kidney 
and pancreas. 
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5.7      Discussion 
There are a limited number of studies within the literature that 
investigate EEHV tissue tropism and virus DNA load. To 
investigate the presence of EEHV1 viral DNA in samples from 
two deaths associated with EEHV1, qPCR was used. This 
method was chosen for this study as it allows the 
quantification of viral DNA in each tissue sample, the detection 
of smaller quantities of viral DNA, increased sensitivity, and 
requires a lower amount of starting material, in comparison to 
conventional PCR. 
 
The tissues which contained the highest level of EEHV1 
differed between the two animals in this study; the heart 
sample from UON_1189 and liver sample from UON_1329 
appeared to have a higher viral copy number in comparison to 
other tissue samples obtained. In contrast, a study by Seilern-
Moy et al. (2015) found the highest levels of EEHV4 in the 
lymph node and lowest in the heart, whereas for EEHV1A, the 
highest levels were in the lymph node and heart and the 
lowest were in the lung. In the Seilern-Moy et al. (2015) study 
EEHV1A and 4 were detected using a qPCR developed to 
detect EEHV1, 3, 4 and 5. Other viruses, such as hepatitis B 
virus, are known to have a tropism for liver (Sung and Lai, 
2002);  herpesviruses are also known to damage both the 
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heart and liver, this has been reported in neonatal EBV 
infection, where a post mortem showed the most damage 
occurred in the heart and liver (Avgil and Ornoy, 2006). The 
findings of the current study, are also similar to, the multi 
tissue tropism of HCMV fatal congenital inclusion disease, 
where a large number of different tissues have shown to be 
positively infected including; brain, placenta, heart, pancreas, 
liver, spleen, lung, bone marrow and small bowel. However, 
significant infections were found in the lungs, pancreas and 
kidneys which differed from the findings in the current study 
(Bissinger et al., 2002) 
 
Clinical viral DNA/RNA load levels have been investigated 
especially in those presenting with a clinical infection. A study 
investigating recurrences of HSV1 and HSV2 and viral DNA 
load in 22 patients, the peak load of viral DNA was 123.6 viral 
genomes per cell (Boivin et al., 2006). A more recent study 
determined the level of HSV viral DNA in the cerebrospinal 
fluid samples of 29 patients with herpes simplex encephalitis. 
Viral DNA loads were between 2 X 102 and 42 X 106 (Schloss 
et al., 2009). Mathematical models have also been used to 
predict herpesvirus transmission, a study by (Schiffer et al., 
2014) used a mathematical model to predict at what level 
HSV2 transmission is more likely to occur. It was predicted 
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that HSV2 was more likely to occur at viral DNA load levels 
greater than 104 viral genomes. 
 
In studies of deaths associated with EEHV, higher levels than 
these have been observed. Latimer et al. (2011) found levels 
of EEHV3/4 at 107 viral copies per ml. The authors of the 
study also suggested that as the levels of EEHV3/4 were high, 
they were likely to be the primary viral agent responsible for 
haemorrhagic disease in the two Asian elephants studied.  
 
Overall the results suggest that EEHV can be present in a wide 
variety of tissues. However, there were a number of 
limitations in this study. Only two animals were studied, as 
tissues from clinical cases of EEHV are difficult to obtain, so a 
limited number of animals is common in the studies of EEHV. 
In this study, only the presence of EEHV1 was determined and 
no other sub types.  
 
Future work investigating virus DNA loads in connection with 
EEHV could provide more information on the levels of the virus 
during clinical disease and during asymptomatic periods. 
However, this would need samples to be taken during an 
asymptomatic period, and again if the animal becomes 
clinically ill. This would also require the same type of sample 
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being taken, allowing for a comparison to be made. 
Understanding the levels of virus DNA load may potentially 
enable elephants to be monitored, and enable determination 
of the appropriate time to administer prophylactic treatment 
when the virus DNA load reaches a pre-determined threshold. 
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6      A preliminary study into a potential genetic or 
familial link with EEHV associated deaths 
 
6.1      Introduction 
There is no current published research exploring the possibility 
of a familial link with EEHV deaths. Most herpesviruses cannot 
be inherited; however recent research has shown that Human 
Herpesvirus 6 (HHV6), is able to integrate into human 
chromosomes. A mother carrying HHV6 DNA integrated at 
chromosome 22 and a father carrying HHV6 DNA at 
chromosome 14 passed this genetically to their daughter, who 
had HHV6 DNA at both locations identical to her parents; this 
would suggest that HHV6 can be inherited (Daibata et al., 
1999). It is unknown if any other herpesviruses, especially 
those of animals, can be transmitted in this way. A link 
between genetics and EEHV may also be possible through an 
inherited susceptibility to infection. Determining if there is the 
possibility of a familial link between EEHV associated deaths 
can be investigated in a number of ways: firstly, looking at 
relationships between the affected animals, and then looking 
at their genetic diversity. 
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6.1.1       Types of genetic testing to determine 
parentage 
Genetic testing can be used to determine the parentage of a 
human or animal; this can be then used to compare levels of 
relatedness and inbreeding between one population and 
another. There are a number of methods that have been used 
to determine parentage. 
6.1.1.1 Blood typing/serology 
The first type of paternity testing was the use of blood types 
in humans; this method compared the specific antigens 
present in the blood which determine the blood type of the 
child and the parent. The blood typing system ABO is the most 
common; parentage can be determined as A and B alleles are 
co-dominant and O is recessive; a child with blood group O 
cannot have a father with AB blood. This method does not 
directly determine if a man has fathered a specific child, it 
only indicates if someone with a specific blood group fathered 
the child. Using the RH, kell and duffy blood grouping antigen 
system has made this type of testing more effective due to 
increased accuracy (Krøjgaard et al., 2009).  
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6.1.1.2 Restriction fragment length polymorphism 
(RFLP) 
Restriction fragment length polymorphism (RFLP) was one of 
the first DNA profiling techniques developed (Murnaghan, 
2016). The process begins with a sample of DNA, which is 
digested into fragments using restriction enzymes.  The 
different sized restriction fragments are then visualised using 
gel electrophoresis, and the sample is then transferred to a 
membrane and further analysed using a Southern blot 
procedure. A labelled DNA probe is then hybridised to the 
membrane; this procedure then determines the length of the 
fragments which are complementary to the probe (Beckmann 
and Soller, 1986, Williams et al., 1990, Nieminen et al., 
2011). Each fragment is considered to be an allele; an RFLP 
occurs when variation in the length of the fragment is 
observed between individuals. 
 
RFLP has applications in genetic linkage, gene mapping and 
the localization of genes in the study of genetic disorders 
(Williams et al., 1990, Hyten et al., 2010, Ku et al., 2010, 
Wang et al., 2010, John et al., 2012). This technique has a 
number of limitations, as it requires a large DNA sample, it is 
a slow procedure, costly, non-automated, technically 
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demanding and there are low levels of polymorphism in some 
species (Cornell University, 2003, Cheriyedath, 2016). 
6.1.1.3 Microsatellites  
Genetic diversity can be measured using microsatellites 
(simple sequence repeats), which occur in non-coding DNA 
regions. They are short segments of DNA which have a 
repeated sequence. Repeats can be di, tri or tetra nucleotide, 
the number of the repeats can be highly variable, this is why 
they are useful as genetic markers. A genetic marker is 
sequence of DNA which can be used to identify individuals as 
its location on the chromosome is a known factor. This type of 
genetic analysis has been used for a number of species, 
including humans. A genetic map of the human genome based 
on 5,264 microsatellites was completed in 1996 (Dib et al., 
1996).  
 
Microsatellites have been used extensively in parentage 
testing in a number of species. Schnabel et al. (2000) 
validated 15 markers for use in parentage testing of American 
bison (Bison bison). Markers were chosen from the USDA 
cattle mapping database, and a number of criteria needed to 
be met for a marker to be selected, which included: suitability 
for multiplex PCR, high heterozygosity, large number of 
alleles, lack of known null alleles and allele size range. Of the 
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15 loci tested, the study found that five had a greater number 
of alleles in bison compared to domestic cattle (Schnabel et 
al., 2000). Parentage testing can be invaluable in certain 
breeding and domestic animal industries. For example, 
Bowling et al. (1997) determined the parentage of 4903 
quarter horses using both blood typing and microsatellites; 
fifteen loci of blood group and protein polymorphisms (blood 
typing) and 11 dinucleotide microsatellites were studied. The 
validation of the techniques showed an effectiveness of 98.2% 
for microsatellite testing and 97.3% for the blood typing 
method.  
 
There may also be evidence for the use of microsatellites 
across other species; for example, human microsatellites may 
also be applicable for investigating genetic variation in apes 
and old world monkeys. Coote and Bruford (1996) selected 85 
microsatellites for determining paternity in apes and old world 
monkeys, the use of markers was previously published during 
the human genome mapping project. The results showed 11 
markers were polymorphic across nearly all the species 
investigated, including: De Brazza’s monkey (Cercopithecus 
neglectus), Diana monkey (Cercopithecus diana), black and 
white colobus (Colobus spp), langur (Semnopithecus spp), 
Sulawesi macaque (Macaca nigra), baboon (Papio spp), 
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Guinea baboon (Papio papio), mandrill (Mandrillus sphinx), 
orangutan (Pongo spp), gorilla (Gorilla spp), chimpanzee (Pan 
spp) and human. A more recent study also found human 
microsatellite markers effective in a study producing a genetic 
linkage map of the baboon (Papio hamadryas) (Rogers et al., 
2000). 
6.1.2       Samples for genetic testing 
For genetic testing the most commonly used sample is blood 
or tissue however, these can be difficult to acquire from 
animals and it is invasive. There is much debate on the ethics 
of conducting genetic research on stored tissue samples 
(Clayton et al., 1995, Cambon-Thomsen, 2004, McGuire and 
Beskow, 2010). There are a wide variety of DNA sources that 
are non-invasive; the most widely used is dung. Genetic 
analysis has been successful using dung in a number of 
species including baboon (Papio spp), mountain lion (Puma 
concolor), Eurasian badger (Meles meles), grey seal 
(Halichoerus grypus), Abbot’s duiker (Cephalophus spadix), 
Harvey’s duiker (Cephalophus harveyi), Blue duiker 
(Philantomba monticola), bushbuck (Tragelaphus spp), wild 
pig (Sus scrofa), and okapi (Okapia johnstoni) (Bayes et al., 
2000, Ernest et al., 2000, Frantz et al., 2003, Parsons et al., 
2005, Bowkett et al., 2009, Kierepka et al., 2016, Stanton et 
al., 2016). 
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Vidya and Sukumar (2005a) reported the development of a 
successful and reliable method for the detection of 
microsatellites from Asian elephant dung. A study from the 
same year investigating microsatellites in the African elephant 
also reports the use of dung successfully (Okello et al., 2005). 
Dung samples are a preferred sample type when conducting 
research in species that are sensitive and at risk of extinction. 
Using dung enables collection of samples with minimal 
disruption to the animals; this is especially useful when 
studying animals in the wild (Okello et al., 2005). 
 
6.1.3      Use of genetic testing in elephants 
A number of studies have used genetic testing for 
phylogenetic analysis, such as determining different sub- 
species of elephants and different populations within the 
species. This has led to an increased understanding of 
differing populations and the possibility of including more 
subspecies of both African and Asian elephants (Fernando et 
al., 2000, Fleischer et al., 2001, Roca et al., 2001, Eggert et 
al., 2002, Rohland et al., 2010).  
 
Genetic testing has suggested that there are two species of 
African elephant; assumptions had previously been based on 
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morphological evidence. The study examined 195 elephants 
from 21 populations looking at nuclear genes which equated to 
1732 base pairs, and this resulted in two distinct groupings, 
the savannah elephant (Loxodonta Africana) and the forest 
elephant (Loxodonta cyclotis) (Roca et al., 2001). Genetic 
testing can be useful in providing information used in 
conservation attempts, mitochondrial DNA obtained from 
Asian elephants in Borneo  has been compared to Asian 
elephants across other range countries (Fernando et al., 
2003). The study determined that Asian elephants in Borneo 
are genetically distinct from those in other range countries 
and it was concluded that they have not been introduced there 
from another location. This highlights the use of genetic 
testing in the confirmation of genetic distinctiveness in certain 
species (Fernando et al., 2003). 
 
6.1.4      Determining parentage of elephants 
Determining parentage of elephants in captivity can be easier 
than those in the wild, as a stud book is available for both 
Asian and African elephants; breeding information is usually 
routinely recorded by zoos. A number of studies have used 
microsatellite markers for determining parentage of both 
African and Asian elephants; this is useful in wild animals as 
parentage is usually not known. A number of microsatellite loci 
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have been identified in the African elephant, whereas a limited 
number have been determined in their Asian counterpart. 
There are a number of examples of loci first being used in the 
African elephant that have then shown to also be useful in the 
Asian elephant (Nyakaana and Arctander, 1998, Comstock et 
al., 2000, Eggert et al., 2000, Comstock et al., 2002). 
Microsatellites have been used to determine the genetics of 
various populations of elephants; this type of study has 
typically been based on 5 or 6 microsatellites (Whitehouse and 
Harley, 2001, Fernando et al., 2003, Vidya et al., 2004, Okello 
et al., 2008). However, to better estimate paternity and 
kinship, additional microsatellites are required. 
 
Understanding more about captive elephant genetics could be 
an important factor when looking at contributors to disease. 
As little is understood about the transmission of EEHV it is also 
important to further investigate other factors that may 
contribute to infection such as genetic susceptibility and 
disease resistance. 
 
6.2        Materials and methods 
6.2.1        Animals in this study 
A total of 16 Asian elephants were used in this study. Tissue 
samples were obtained from five dead Asian elephants located 
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in the UK; three of the deaths were thought to be associated 
with EEHV. Trunk wash samples were collected from four 
living animals located in the UK. Faeces was also collected 
from seven living animals located in Oklahoma, USA (Table 
16). 
 
Table 16: Details of animals used in this study, animal status and age was 
determined at the start of the study (August 2015). 
Animal ID Status Cause of 
death 
Age 
(Years) 
Location Sex Sample 
type 
UON_1329 Dead EEHV 3  UK Male Tissue 
UON_1189 Dead EEHV 2  UK Female Tissue 
UON_1149 Dead EEHV 2  UK Male Tissue  
UON_1490 Dead Unknown 0  UK Female Tissue  
UON_1002 Dead Unknown 0  UK Female Tissue  
UON_1353 Alive N/A 20 UK Female Trunk wash 
UON_1309 Alive N/A 30 UK Female Trunk wash 
UON_1579 Alive N/A 31 UK Female Trunk wash 
UON_1543 Alive N/A 17 UK Female Trunk wash 
UON_1026 Alive N/A 20  USA Female Faeces 
UON_1094 Alive N/A 18  USA Female Faeces 
UON_1285 Alive N/A 4 USA Female Faeces 
UON_1622 Alive N/A 4 
months 
USA Female Faeces 
UON_1405 Alive N/A 46 USA Male Faeces 
UON_1621 Alive N/A 48 USA Female Faeces 
UON_1091 Alive N/A 36 USA Female Faeces 
 
6.2.2        Genogram 
6.2.3        Data collection 
Elephant data was collected until March 2013 from 
http://www.asianelephant.net/database.htm and 
www.elephant.se. This included name, sex, current location, 
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and date of death if applicable, if the death was caused by 
EEHV, name of mother and name of father for 621 elephants.  
6.2.4        Analysis 
Genograms were created using specialised software Cranefoot 
V3.2 (http://www.finndiane.fi/software/cranefoot/); standard 
settings were used, and inbreeding was analysed using 
FSPEED v2.04a (http://fspeed.software.informer.com/) 
standard settings were also used for this software. The 
epidemiology of EEHV related deaths was analysed using 
GraphPad. 
6.2.5        Inbreeding 
The inbreeding coefficient (F) is the probability of 
autozygosity, where both allele copies are identical by 
descent. In this study the F value is expressed as a decimal, it 
may also be expressed as a percentage. If an animal has an F 
value of 0.25 it has been mated to its own parent or is a full 
sibling mating and is 25% homozygous, 0.125 (12.5%) 
suggests a half sibling mating, grandparent/grandchild 
mating, uncle/niece or aunt/nephew mating and 0.0625 
(6.25%) which results from a great-grandparent/great-
grandchild mating, half-uncle/niece, half-aunt/nephew or first 
cousin mating, an F value of 0.031 (3.1%) suggests the 
parents have a common great-grand parent.  
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6.2.6        Microsatellites 
6.2.6.1        Sample collection 
6.2.6.1.1      Tissue 
Tissue samples were collected as described in section 2.1.2 
6.2.6.1.2     Trunk washes 
Trunk wash samples were collected from nine Asian elephants 
as described in section 2.1.1  
6.2.6.1.3     Faeces 
To determine if a non-invasive method is a useful tool, faeces 
was collected from seven animals; faeces were collected from 
the centre of the bolus using a swab, and then smeared onto 
FTA Whatmans cards. Cards were then stored at ambient 
temperature until processing. Faecal samples were collected 
from seven Asian elephants located at Oklahoma City Zoo, 
USA on 23/08/2015. 
6.2.6.2 DNA extraction 
6.2.6.2.1    Tissue 
DNA was extracted from tissue samples as described in 
section 2.2.1 
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6.2.6.2.2    Trunk washes 
DNA was extracted from trunk wash samples as described in 
section 2.2.1 
6.2.6.2.3    Faeces 
Elephant DNA was isolated from faecal samples using QIAamp 
DNA stool mini kit (Qiagen, Germany), following an amended 
version of the manufacturer’s instructions for the isolation of 
DNA from stool for pathogen detection. The following 
amendments were made for a second attempt due no sample 
remaining when adding one inhibitEX tablet: A 3mm punch a 
mat (Harris puncher) was used to remove ten punches from 
the FTA card and these were transferred to a 2ml centrifuge 
tube. The punches were soaked in PBS overnight. To remove 
as much faeces from the card as possible, a steel bead beater 
was added along with buffer ASL, and then incubated at 70°C 
in a heat block; samples were vortexed, at 30 minute 
intervals. The amount of inhibited tablet suggested by the 
manufacturer’s instructions (1x tablet per tube) was reduced 
by half. All samples were centrifuged at 11,000 rpm 10 
minutes prior to after the addition of half an inhibitEX tablet. 
Half the amount of elution buffer AE was used; the elution 
buffer was prewarmed to 70°C before use, to ensure 
maximum DNA yield. 
                                                                                   Chapter 6 
197 
 
6.2.6.3  Trunk wash DNA concentration 
A pooled sample of DNA obtained from trunk washes was 
made for each animal; 5 or 6 samples per animal were pooled. 
Samples were concentrated using vacuum concentration and 
DNA precipitation. For the vacuum concentration method, the 
pooled samples were placed into a vacuum concentrator 
(Barnstead Genevac mi vac concentrator) for 40 mins at 
60˚C; this procedure reduced the volume of the sample by 
half. For the DNA precipitation method, the pooled DNA was 
transferred into a 1.5ml microcentrifuge tube, where it should 
occupy less than one quarter of the total volume (250µl was 
used). To equalize the ion concentration, one tenth of the 
volume of DNA of 3µM sodium acetate buffer was added to the 
tube. Two to three volumes of cold 100% ethanol was then 
added, the samples were then vortexed to mix and placed in a 
-20oC freezer overnight. The following morning, the samples 
were removed from the freezer, thawed at ambient 
temperature and centrifuged at 13,000rpm. The supernatant 
was then removed. To wash the DNA pellet, 250µl of 4oC 70% 
ethanol was added and the contents centrifuged for 5 minutes. 
The supernatant was then removed, and the remaining 
ethanol is evaporated using a 37˚C water bath. The pellet was 
then resuspended in 50ul sterile water. 
                                                                                   Chapter 6 
198 
 
6.2.6.4  DNA and inhibitor check PCR 
PCR was used to determine if the DNA in the samples was 
degraded and to see if there were any inhibitors present that 
would affect the ability of the PCR to amplify DNA in both 
pooled Asian elephant samples and pooled African elephant 
samples. The primers (Forward 5”-3” = 
GCGTGAAGACCCTTGAGGAA and reverse 5”-3” = 
TGTTCATCTGTCGCTTCCTG (Eurofins, Germany)) used were 
expected to amplify IFNγ and produce a PCR product of 100bp 
in size. Each reaction consisted of 1µl of each primer, 0.8µl 
dNTP mix, 0.6µl 50mM MgCl2, 1µl standard 10x buffer (New 
England Biolabs, USA), 0.1µl taq (New England Biolabs, USA) 
and 4.4µl sterile water. Cycling conditions were as follows: 
94oC for 1 min followed by 25 cycles of 94oC for 30 sec, 60oC 
for 30s and 72oC for 1 min, followed by a final extension of 3 
min at 72oC. 
6.2.6.5 Amplification of microsatellites using PCR 
Fourteen microsatellite loci were amplified from elephant DNA 
using amended protocols from previous publications. The 
amendments included labelling forward primers with a 
fluorescent dye, thus replacing the use of radioactively 
labelled primers. This was done to allow the analysis of PCR 
products by length. Primers are detailed in Table 17. Each well 
of a 96 well plate contained three PCR products labelled with 
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either 6-FAM, ROX or HEX; the ladder (LIZ 500) was also 
included. PCR products were sent to Source Bioscience for 
fragment length analysis.
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Table 17: Microsatellite loci used to determine genetic diversity. 
 
 
 
 
 
Well 
number 
Loci Expected 
size (bp) 
Florescent 
dye 
Forward primer Reverse primer Species Reference 
1 EMX-1 152 6-FAM AGGACTTATTTGCTTAGATGG AGGCAATGTTTCGTTCTGT E maximus Fernando et al. (2001) 
1 EMX-3 254 HEX CATGGTTAACTCATTGCTTGC GTGTTCCCTCCCTCTCATCAT E maximus Fernando et al. (2001) 
1 LA2 227 ROX CTTGGTGGGAGTCATGACCT GGAGAAATGACTGCCCGATA E maximus and L africana Eggert et al. (2002) 
2 LA4 130 6-FAM GCTACAGAGGACATTACCCAGC TTTCCTCAGGGATTGGGAG E maximus and L africana Eggert et al. (2002) 
2 FH48 178 HEX GAGTCTCCATAATCAAGAGCG CCTCCCTGGAATCTGTACAG L africana Comstock et al. (2000) 
2 FH60 148 ROX CAAGAAGCTTTGGGATTGGG CCTGCAGCTCAGAACACCTG L africana Comstock et al. (2000) 
3 FH94 229 6-FAM TTCCTCCCACAGAGCAGC ATTGGTTAATTTGCCAGTCCC L africana Comstock et al. (2000) 
3 FH103 154 HEX TGTGCTGCCACTTCCTACAC GATGTTGAGACAGTTCTGTAAG L africana Comstock et al. (2000) 
N/A FH102  ROX CTTCATTACTGACCTAAACGAG GGACAGGGCTGGAGAAATATG L africana Comstock et al. (2000) 
N/A FH127  6-FAM ACTGACCGGGAAGAGGAAGT AGGTTTCTAAGCTGAATTGG L africana Comstock et al. (2002) 
4 FH153 169 HEX CATGGGCCTAAGCTAAAACG GTCACATGGGGTTGCTAC L africana Comstock et al. (2002) 
4 LafMS02 147 ROX GAAACCACAACTTGAAGGG TCGCTTGTAAGAAGGCGTG L africana Nyakaana and Arctander (1998) 
5 LafMS03 144 6-FAM CATATGAACATACCGGAAC GAAACTCCTCGAGTAGTAGAA L africana Nyakaana and Arctander (1998) 
5 LafMS05 158 HEX CCTTAGGCTGGGTTGTAT AATGGACTTGGGACTTGCCAAAATGT L africana Nyakaana and Arctander (1998) 
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6.2.6.6 Optimised reaction and cycling conditions 
Reaction and cycling conditions were amended and optimised 
from published protocols; all loci utilised the same cycling 
conditions (Table 18). The annealing temp was optimised for 
each locus (Table 18). All reaction volumes were 10µl, 
consisting of; 1µl 10x buffer (New England biolabs, USA), 
0.8µl dNTP mix (New England biolabs, USA), and 0.1µl taq 
(New England biolabs, USA) and a variable amount of MgCl2 
(New England biolabs, USA) (Table 18).  
 
Table 18: Optimised cycling conditions for all reactions.  
Step Temperature (
oC) Time 
Initial denaturation 94 4 min 
Denaturation 94 30 sec 
Annealing Variable 30 sec 
Extension 72 1 min 
Final extension 72 3 min  
Final hold 4 Indefinitely 
 
PCR reactions for LA2 and LA4 were conduction in an Applied 
Biosystems 2720 thermal cycler, and the remaining PCRs were 
conducted in a Techne TC-512 thermal cycler Machine. All PCR 
products were visualised using gel electrophoresis on a 2% 
agarose gel using the fluorescent dye Nancy 520.  
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6.2.6.6.1    Reaction conditions 
A number of modifications were made to the primer 
concentration if the amount stated in the original publication 
did not appear to produce a PCR product, this was then 
determined using a concentration gradient. MgCl2 
concentration and annealing temperatures were also 
optimised; the final optimised primer concentrations and 
annealing temperature used in this study can be seen in Table 
19. 
 
Table 19: Concentrations and annealing temperatures used in PCR 
reactions 
Loci Primer 
concentration 
MgCL2 
Concentration 
Annealing 
temperature 
EMX-1 0.25µM 1.5mM 62.2 
EMX-3 0.25µM 1.5mM 66.1 
LA2 0.2µM 2mM 58 
LA4 0.2µM 4mM 54 
FH48 10µM 2mM 58 
FH60 0.2µM 1.5mM 59 
FH94 10µM 1.5mM 61 
FH103 10µM 1.5mM 66.6 
FH153 10µM 1.5mM 58 
LafMS02 0.2µM 1.5mM 54 
LafMS03 0.2µM 4mM 54 
LafMS04 0.2µM 1.5mM 54 
 
6.2.6.7 Analysis of fragment length analysis 
All traces were analysed using GeneMarker (Version 2.6.7) 
software.  
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6.3        Results 
6.3.1        Genogram 
Data from a total of 621 Asian elephants were included in this 
study, including 246 males and 357 females; the sex was 
unknown for 18 Asian elephants. Four animals were of 
unknown location, this was due to the limitations of the 
software, where one parent was known it required both to be 
included, and the sex of the unknown parent was known. 
 
A total of 136 males were located in Europe and 105 in the 
North America, 202 females were located in Europe, 153 in 
North America and four males of unknown location. Sex was 
unknown for a total of 18 elephants, with 13 located in Europe 
and 5 in the North America. A total of 39 deaths were 
recorded as being associated with EEHV, 20 in Europe and 19 
in the North America.  
 
Preliminary data suggests the possibility of a familial link in 
EEHV cases. Certain clusters within the genogram showed a 
number of deaths occurring within the cluster. In a cluster of 
ten Asian elephants of which three were alive and seven were 
dead, five of the deaths were thought to be associated with 
EEHV (Figure 21). However, as the elephants were originally 
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located at the same zoo, location association also needs to be 
considered. 
 
 
Figure 60: A cluster showing a large number of EEHV associated deaths. 
This cluster shows ten related Asian elephants, three alive and seven dead. Of the 
seven that were dead, five were thought to be deaths associated with EEHV. Circle 
= female, and square = male, a line through shape = dead, and black shape = 
death associated with EEHV. 
 
Other clusters of related elephants within the genogram 
showed no deaths associated with EEHV (Figure 22). 
 
 
Figure 61: A cluster showing no EEHV associated deaths. This cluster shows 
nine related Asian elephants, three of which were currently living and six that were 
dead, of which none of the deaths were reported to be associated with EEHV. Circle 
= female, and square = male, and a line through shape = dead. 
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6.3.2        Inbreeding 
Inbreeding coefficients (F) were calculated for 445 animals 
with known parents, this value is the percentage of alleles that 
are homozygous. Of the 445 elephants, 15 had an F value of 
>25% and 19 had a value of >12.5%; the mean F value for 
all elephants was 0.9%. Of the European elephants, eight had 
an F value of >25% and 11 had an F value of >12.5%; and 
the mean for all European animals was 0.9%. A smaller 
number of animals in North America had F values above 
12.5%, with seven animals with F value >25% and eight 
>12.5%; the mean F value for all North America elephants 
was 0.9% (Table 20). 
 
Table 20: Inbreeding coefficients (F) for Asian elephants with known 
parents. 
Total Inbreeding mean 0.0094 (0.94%) 
  >25% 15 
  >12.5% 19 
European Inbreeding mean 0.0093 (0.93%) 
  >25% 8 
  12.5 - 24% 11 
North America Inbreeding mean 0.0097 (0.97%) 
  >25% 7 
  12.5 - 24% 8 
 
6.3.3        Analysis of deaths 
A total of 39 deaths were reported to be associated with 
EEHV; slightly more male deaths were associated with EEHV 
(22) in comparison to females (17). The highest number of 
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recorded deaths occurred in the USA, with 15 being reported 
(38.46%), this is followed by ten (25.64%) in the UK, five 
(12.82%) in Germany, three (7.69%) each in Canada and 
Switzerland, and one (2.56%) each in Denmark, the 
Netherlands and France (Figure 23).  
 
Figure 62: Percentage of EEHV related deaths by country. 
 
The mean age of death was 3.1 years of age, whilst the mode 
was 2 years old. In females, the mean age of death was 3.6, 
while in males, it was 2.7 years old (Table 21). 
Table 21: Mean, median and mode of age at death for deaths reported to 
be associated with EEHV 
 Mean Median Mode 
All animals  3.2 2 2 
Males 2.7 2 2 
Females 3.6 2 2 
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6.3.4        Microsatellites 
6.3.4.1.1     DNA concentration for trunk washes  
6.3.4.1.1.1  Vacuum concentrator method 
A vacuum concentrator uses evaporation to concentrate the 
DNA sample. Concentrations of most samples increased after 
concentration; however, one sample showed an apparent 
decrease from 2.903ng/µl to 1.500ng/µl (Table 22). The 
concentrations measured may not reflect the actual 
concentration, as the Nanodrop machine can be inaccurate or 
affected by sample contamination. 
 
Table 22: DNA concentrations of pooled Asian elephant DNA before and 
after vacuum concentration.  
Animal ID Before (ng/µl) After (ng/µl) 
UON_1140 15.28 35.02 
UON_1093 2.903 1.500 
UON_1625 Undetectable 76.43 
UON_1089 Undetectable 82.85 
UON_1175 0.3316 39.07 
UON_1543 50.04 206.0 
UON_1579 6.181 73.51 
UON_1309 8.899 53.31 
UON_1353 12.71 86.19 
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6.3.4.1.1.2   Precipitation method 
Similarly, the precipitation method in most cases increased 
the amount of DNA present within the sample. All but one 
sample saw an increase in the amount of DNA present; 
however, sample UON_1579’s quantity decreased from 
7.213ug/µl to 1.100ug/µl (Table 23).  
 
Table 23: DNA concentrations before and after concentration by DNA 
precipitation. 
Animal ID Before (ng/µl) After 
UON_1140 4.692 21.62 
UON_1093 3.893 14.08 
UON_1625 7.680 49.67 
UON_1089 4.207 17.44 
UON_1175 5.799 22.45 
UON_1543 34.85 208.8 
UON_1579 7.213 1.100 
UON_1309 9.885 55.72 
UON_1353 16.12 61.02 
 
6.3.4.1.2        DNA quality and inhibitors in pooled 
tissue samples 
A pooled sample (pooled samples were either pooled DNA 
from tissue samples or from trunk washes) was made for each 
group of elephants, one Asian group (nine animals) and one 
African group (five animals); the presence of DNA in the 
pooled samples and the lack of inhibitors was confirmed using 
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PCR to amplify IFNƴ. A product of the expected size (100bp) 
was observed in each sample (Figure 24). 
 
 
Figure 63: Visualisation of a PCR on a 2% agarose gel to confirm the 
presence of Asian elephant and African elephant DNA. Lane A: 100bp ladder, 
B: Asian elephant pooled sample pure, C: Asian elephant pooled sample 1/10 
dilution, D: Asian elephant pooled sample 1/100 dilution, E: African elephant pure, 
F: African elephant pooled sample 1/10, G: African elephant pooled sample 1/100 
dilution and H: negative control. 
 
6.3.4.2 Optimisation of microsatellite PCR’s results 
by locus 
6.3.4.2.1     LA2 PCR 
To initially optimise the LA2 locus, the primer concentration 
was lowered from 10mM to 0.2mM; however, this did not 
result in a product when visualised on an agarose gel (not 
shown). To determine the optimal MgCl2 concentration for this 
locus, an MgCl2 dilution series (1.5mM, 2mM, 3mM and 4mM) 
was performed using pooled Asian and African elephant 
samples. A concentration of 2mM for the Asian elephant 
samples, and 4mM for the African samples produced a PCR 
product of the correct size (Figure 25). 
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Figure 64: Visualisation of a PCR on a 2% agarose gel to determine if 
changing the concentration of MgCL2 optimised the reaction for locus LA2. 
Top image: Visualisation of PCR reaction using primers to amplify the LA2 
microsatellite locus using a 1/10 dilution of pooled Asian elephant sample. Lane A: 
100bp ladder (Promega), lanes B-G are a series of MgCL2 concentrations; B: 
1.5mM, C: 2mM, D: 2.5mM, E: 3mM, F: 3.5mM, G: 4mM and H: negative control. 
A PCR product of the expected band size of 227bp can be seen in lanes C and D, 
lane D also shows some smearing. Bottom image: The reaction is as described 
above but using a 1/10 dilution of the African elephant pooled sample. Lane I: 
100bp ladder (promega), lanes J-O concentrations as described above and lane P: 
negative control. 
 
6.3.4.2.2     LA4 PCR 
Optimisation included performing an MgCl2 dilution series to 
determine the optimal conditions for this PCR reaction. The 
PCR was performed using pooled Asian elephant DNA and 
pooled African elephant DNA. A PCR product of the correct size 
was not visualised for the Asian elephant sample, however, 
there was a product of the correct size (130bp) which 
observed for the African elephants pooled sample; this was at 
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a high concentration (4mM) of MgCl2. The agar gel is heavily 
marked in comparison to the other gels in this study, this may 
be due to the brightness settings on the gel viewer or there 
may have been contamination when preparing the gel (Figure 
26). 
 
Figure 65: Visualisation of a PCR on a 2% agarose gel to determine if 
changing the concentration of MgCL2 optimised the reaction for locus LA4. 
Top image: Visualisation of PCR reaction using primers to amplify the LA4 
microsatellite locus using a 1/10 dilution of pooled Asian elephant sample. Lane A: 
100bp ladder (Promega), lanes B-G are a series of MgCL2 concentrations; B: 
1.5mM, C: 2mM, D: 2.5mM, E: 3mM, F: 3.5mM, G: 4mM and H: negative control. 
Bottom image: The reaction is as described above but using a 1/10 dilution of the 
African elephant pooled sample. Lane I: 100bp ladder (Promega), lanes J-O 
concentrations as described above and lane P: negative control. A PCR product is 
visible on the bottom image at an expected bp size of 130bp and at a concentration 
of 4mM. 
 
This led to further investigation which then included replacing 
the pooled Asian and African elephant samples with DNA 
samples from individual animals, an MgCl2 of 4mM was used. 
PCR products of the correct size were visualised for each 
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animal, suggesting that this locus is present in each animal. 
However, nonspecific products were evident in most lanes, 
and there was also evidence of smearing which could be due 
to high concentrations of DNA present (Figure 27). 
 
 
Figure 66: Visualisation of a PCR on a 2% agarose gel to determine if locus 
LA4 is present in individual animals at an MgCl2 concentration of 4mM. Top 
image: using a 1/10 dilution of DNA from each individual Asian elephant in a 
reaction using primers to amplify locus LA4. Lane A: 100bp ladder (promega) and 
Lane G: negative control. A PCR product of the expected size of 130bp is visible for 
Asian elephant. There are also some other bands present in lanes UON_1329, 
UON_1002 and UON_1490. Bottom image: using a 1/10 dilution of DNA from each 
individual African elephant, lane A: a100bp ladder (Promega) G: negative control. 
A PCR product of the expected size (130bp) was also observed for each animal. 
 
6.3.4.2.3     EMX-1 and subsequent loci PCR 
To optimise this PCR, a temperature gradient and an MgCl2 
series was combined into the same experiment. For the locus 
EMX-1, a primer concentration of 10µm was used as detailed 
in Fernando et al. (2001); a temperature gradient of 61.9-
                                                                                   Chapter 6 
213 
 
66.1°C was performed at three different MgCl2 concentrations: 
1.5mM, 2mM and 4mM. The PCR was visualised using a 2% 
gel; a PCR product of the correct size was present in lane C: 
the reaction contained 1.5mM of MgCl2 and was run at a 
temperature of 62.2oC. Smearing and non-specific binding 
were present in lane D, this temperature was not used in the 
final reaction, this consisted of a temperature of 62.6oC and 
an MgCl2 concentration of 1.5mM (Figure 28). 
 
Figure 67: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus EMX-1 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 61.9, C: 62.2, D: 62.6, E: 63, F: 63.4, G: 63.8, H: 
64.1, I: 64.8, J: 65.1, K: 65.6, L: 66.1 and M: 66.1. The reactions contained 
1.5mM of MgCL2, and a PCR product of the expected size (152bp) was visualised in 
column C. 
 
6.3.4.2.4     EMX-3 PCR 
Optimisation for locus EMX-3 included trialling three different 
MgCl2 concentrations (1.5mM, 2mM and 4mM) and a 
temperature gradient (61.9-66.1oC). The final optimised 
reaction used 1.5mM MgCl2 and a temperature of 64
oC. 
However, all reactions across the different temperatures with 
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an MgCl2 concentration of 1.5mM produced a correct product 
size of 254bp (Figure 29). Bands of the correct size were also 
observed in all lanes when using an MgCl2 concentration of 
2mM and in nine lanes when using a concentration of 4mM; 
however, as the MgCl2 concentration increased so did the 
amount of visible primer dimer (not shown). 
 
Figure 68: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus EMX-3 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 61.9, C: 62.2, D: 62.6, E: 63, F: 63.4, G: 63.8, H: 
64.1, I: 64.8, J: 65.1, K: 65.6, L: 66.1 and M: 66.1. The reactions contained 
1.5mM of MgCL2, a PCR product of the expected size (254bp) was visualised in all 
lanes. 
 
6.3.4.2.5     FH48 PCR 
A PCR using a temperature gradient (55.9-60.1oC) and 
differing MgCl2 concentrations (1.5mM, 2mM and 4mM) was 
performed to optimise the reaction for locus FH48. Using an 
MgCl2 concentration of 2mM resulted in products of the correct 
size (178bp) (Figure 30). A concentration of 58°C was 
selected for the final optimised reaction along with a primer 
concentration of 10µM and an MgCl2 of 2mM. Bands of the 
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correct size were visible in all lanes at an MgCl2 concentration 
of 2mM; at a concentration of 4mM, the reaction did not 
produce any PCR products when incubated above 65oC, and 
primer dimer was visible at lower temperatures (not shown) 
 
Figure 69: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus FH48 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 55.9, C: 56.2, D: 56.6, E: 57, F: 57.4, G: 57.8, H: 
58.1, I: 58.8, J: 59.1, K: 59.6, L: 60.1 and M: 60.1. The reactions contained 2mM 
of MgCL2, a PCR product of the correct size (178bp) was visualised in lanes B, C, E, 
F, H and I. 
 
6.3.4.2.6     FH60 PCR 
PCR optimisation for locus FH60 was unsuccessful; the first 
attempt included both a temperature gradient from 54-64˚C 
and three different MgCl2 concentrations of 1.5mM, 2mM and 
4mM. PCR products were not visualised at any of the 
temperatures within the gradient and at any MgCL2 
concentrations used (not shown). 
 
Further optimisation included reducing the concentration of 
both forward and reverse primers from 10µm to 0.2µm this 
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resulted in a number of non-specific bands at an MgCL2 
concentration of 4mM; no PCR products of the correct size 
were visualised at concentrations of 1.5mM or 2mM (Figure 
31). 
 
 
Figure 70: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus FH60 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in °C of B: 54, C: 54.6, D: 55.6, E: 56.7, F: 57.5, G: 58.5, H: 59.3, I: 
60.9, J: 61.6, K: 62.9, L: 64.1 and M: 64. The reactions contained 4mM of MgCL2, 
a number of non-specific PCR products of the incorrect size were visualised in all 
lanes. 
 
6.3.4.2.7     FH94 PCR 
A temperature gradient (58.9-63.1°C) and 3 different MgCL2 
(1.5mM, 2mM and 4mM) were used to optimise the PCR 
reaction for loci FH94. Bands of the correct size (178bp) were 
visualised in all wells; however, at an MgCl2 concentration of 
1.5mM, there was smearing visible in most lanes, with the 
most occurring in lanes D, E and F (Figure 32). At 
concentrations 2mM and 4mM, there was an increased amount 
of smearing, and primer dimer was also visible (not shown). A 
final primer concentration of 10µl at an MgCl2 concentration of 
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1.5mM and a temperature of 59°C were selected for use in the 
final reaction. 
 
Figure 71: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus FH94 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 58.9, C: 59.2, D: 59.8, E: 60, F: 60.4, G: 60.8, H: 
61.1, I: 61.8, J: 62.1, K: 62.6, L: 63.1 and M: 63.1. The reactions contained 
1.5mM of MgCL2, a PCR product of the correct size (229bp) was visualised in lanes 
in all lanes. 
 
6.3.4.2.8     FH103 PCR 
Both a temperature gradient (55.9-60.1oC) and 3 different 
MgCl2 concentrations (1.5mM, 2mM and 4mM) were used to 
optimise the PCR reaction for loci FH103. A product of the 
correct size (154bp) was observed in one lane at an MgCL2 
concentration of 1.5mM (Figure 33). No bands were visible at 
concentrations of 2mM or 4mM; however, at 4mM primer 
dimer was visible (not shown). A primer concentration of 10µl 
at an MgCL2 concentration of 1.5mM and a temperature of 
56.6oC was used in the final reaction. 
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Figure 72: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus FH103 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 55.9, C: 56.2, D: 56.6, E: 57, F: 57.4, G: 57.8, H: 
58.1, I: 58.8, J: 59.1, K: 59.6, L: 60.1 and M: 60.1. The reactions contained 
1.5mM of MgCL2, a PCR product of the correct size (154bp) was visualised in lane 
D. 
 
6.3.4.2.9     FH102 PCR 
A temperature gradient (57.9-62.1°C) and at an MgCl2 
concentration series (1.5mM, 2mM and 4mM) was performed. 
No products of the expected size (176bp) were seen. PCR 
products present in lanes C, D and E were around 140bp and 
larger bands present in lanes D, E and G are around 200bp 
(Figure 34). Bands were also visualised at MgCl2 
concentrations of 1.5mM and 4mM; a band of around 200bp 
was present at a temperature of 58.6˚C at 1.5mM and a band 
at around 140bp was visualised in all lanes at 4mM (not 
shown). 
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Figure 73: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus FH102 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 57.9, C: 58.2, D: 58.6, E: 59, F: 59.4, G: 59.8, H: 
60.1, I: 60.8, J: 61.1, K: 61.6, L: 62.1 and M: 62.1. The reactions contained 2mM 
of MgCL2, a PCR product of the correct size (179bp) was not visualised. 
 
 
Further optimisation was carried out for this locus, with the 
primer concentration being reduced from 10um to 0.2um 
which was successful in other loci. Non-specific bands of 
around 200bp and 140bp were visualised at concentrations of 
4mM MgCl2 (Figure 35). 
 
 
Figure 74: Visualisation of a PCR on a 2% agarose gel to determine if a 
lower primer concentration produced a PCR product of the correct size for 
locus FH102. Lane A is 100bp ladder (Promega), and lanes B-M show a 
temperature gradient in °C of B: 57.9, C: 58.2, D: 58.6, E: 59, F: 59.4, G: 59.8, H: 
60.1, I: 60.8, J: 61.1, K: 61.6, L: 62.1 and M: 62.1. The reactions contained 4mM 
of MgCL2, a PCR product of the correct size (179bp) was not visualised. 
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6.3.4.2.10     FH127 PCR 
A number of optimisations were made to the PCR for this 
locus; to attempt to determine the optimal conditions, a PCR 
using a temperature gradient (51-61.1oC) and 3 differing 
concentrations of MgCl2 (1.5mM, 2mM and 4mM) were used. 
This resulted in a number of non-specific bands of the 
incorrect product size in lanes B, C, D, E, F and H at an MgCl2 
concentration of 4mM (Figure 36). There were no products 
visualised at MgCl2 concentrations of 1.5mM and 2mM. 
 
 
Figure 75: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus FH127 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in °C of B: 51, C: 51.6, D: 52.6, E: 53.7, F: 54.5, G: 55.5, H: 56.3, I: 
57.9, J: 58.6, K: 59.9, L: 61.1 and M: 61.1. The reactions contained 4mM of 
MgCL2, PCR products of the incorrect size were visualised in lanes B, C, D, E, F, and 
H, the expected product size was 241bp. 
 
An attempt was made to further optimise the PCR conditions: 
the primer was reduced from 10um to 0.2um. This resulted in 
less primer dimer; however, no PCR products were visualised 
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on a 2% agarose gel at MgCl2 concentrations of 1.5mM, 2mM 
or 4mM (not shown). 
6.3.4.2.11     FH153 PCR 
A temperature gradient (55-65oC) and MgCl2 series (1.5mM, 
2mM and 4mM) was performed for the locus FH153, a PCR 
product of the correct size (169bp) was visualised in all lanes, 
there was no evidence of non-specific binding and low levels of 
primer dimer (Figure 37). At an MgCl2 concentration of 2mM, 
faint products of the correct size were visible in most lanes but 
there was evidence of primer dimer; at a concentration of 
4mM multiple PCR products and primer dimer were present 
(not shown). A primer concentration of 10µm, MgCL2 
concentration of 1.5mM and a temperature of 58oC were used 
in the final reaction. 
 
Figure 76: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus FH153 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in oC of B: 55, C: 55.6, D: 56.6, E: 57.7, F: 58.5, G: 59.5, H: 60.3, I: 
61.9, J: 62.6, K: 63.9, L: 65.1 and M: 65. The reactions contained 1.5mM of 
MgCL2, a PCR product of the correct size (169bp) was visualised in all lanes. 
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6.3.4.2.12     LafMS02 PCR 
A temperature gradient and three different concentrations of 
MgCl2, were used to optimise the PCR reaction for loci 
LafMS02. At a concentration of 1.5mM, products of the correct 
size (147bp) were visualised in 6 lanes (B, D, E, F, G and H 
(Figure 38). At a concentration of 2mM products were 
visualised in all lanes except at a temperature of 57.3oC; 
products were visible in all lanes at a concentration of 4mM. 
Primer dimer was visible in all lanes for both concentrations 
(not shown). A final primer concentration of 0.2µM, an MgCl2 
concentration of 1.5mM and a temperature of 54oC were used 
in the final reaction. 
 
Figure 77: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus LafMS02 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 52, C: 52.6, D: 53.6, E: 54.7, F: 55.5, G: 56.5, H: 
57.3, I: 58.9, J: 59.6, K: 60.9, L: 62.1 and M: 62. The reactions contained 1.5mM 
of MgCL2, a PCR product of the correct size (147bp) was visualised in lanes B, D, E, 
F, G, and H. 
 
6.3.4.2.13     LafMS03 PCR 
Three different MgCl2 concentrations and a temperature 
gradient were used to determine optimal PCR reaction 
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conditions. At an MgCl2 concentration of 4mM, products of the 
correct size (144bp) were visualised in seven lanes (B, C, D, 
E, F, H and I) (Figure 39). At concentrations of 1.5mM and 
2mM no products were visible in any lanes. 
 
 
Figure 78: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus LafMS03 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in degrees C of B: 52, C: 52.6, D: 53.6, E: 54.7, F: 55.5, G: 56.5, H: 
57.3, I: 58.9, J: 59.6, K: 60.9, L: 62.1 and M: 62. The reactions contained 4mM of 
MgCL2, a PCR product of the correct size (144bp) was visualised in lanes B, C, D, E, 
F, H and I. 
 
6.3.4.2.14     LafMS05 PCR 
Optimisation of this locus consisted of a temperature gradient 
and an MgCl2 series. This resulted in an optimum temperature 
of 52°C and at an MgCl2 concentration of 1.5mM being 
selected. Nonspecific binding and smearing was observed in 
lane C (Figure 40). PCR products were not visualised at MgCl2 
concentrations of 2mM and 4mM (not shown). 
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Figure 79: Visualisation of a PCR on a 2% agarose gel to determine the 
optimal reaction conditions for locus LafMS05 using pooled Asian elephant 
DNA. Lane A is 100bp ladder (Promega), and lanes B-M show a temperature 
gradient in oC of B: 52, C: 52.6, D: 53.6, E: 54.7, F: 55.5, G: 56.5, H: 57.3, I: 
58.9, J: 59.6, K: 60.9, L: 62.1 and M: 62. The reactions contained 1.5mM of MgCl2, 
a PCR product of the correct size (144bp) was visualised in lanes B, C, D, E, F, and 
G.  
 
6.3.4.3 Final optimisation results 
Twelve loci were successfully optimised; after further 
attempts, optimal conditions were not determined for 2 loci 
(Table 24). 
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Table 24: The final working PCR optimal conditions for each successful 
locus 
Loci Primer concentration MgCl2 Concentration Temperature (
oC) 
EMX-1 0.25µM 1.5mM 62.2 
EMX-3 0.25µM 1.5mM 64 
LA2 0.2µM 2mM 58 
LA4 0.2µM 4mM 54 
FH48 10µM 2mM 58 
FH60 0.2µM 1.5mM 59 
FH94 10µM 1.5mM 61 
FH103 10µM 1.5mM 66.6 
FH153 10µM 1.5mM 58 
LafMS02 0.2µM 1.5mM 54 
LafMS03 0.2µM 4mM 54 
LafMS05 0.2µM 1.5mM 54 
FH102 N/A N/A N/A 
FH27 N/A N/A N/A 
 
6.3.4.4 Fragment length analysis traces 
Fragment length analysis was performed on tissue samples 
from five Asian elephants (UON_1329, UON_1189, UON_1149, 
UON_1490 and UON_1002). All traces were analysed using 
GeneMarker, but no samples showed peaks at the expected 
size. For example, the trace for UON_1329 did not show a 
peak at the correct size for any of the three loci in the specific 
well. Three peaks should be visible, one for each locus in the 
well, EMX-1 labelled with 6-FAM (blue) at 152bp, EMX-3 
labelled with HEX (green) at 254bp and LA2 labelled with ROX 
(red) at 227bp. None of the correct peaks were present in this 
trace. A red peak was visible in the trace, but it was not at the 
correct size for the locus LA2 (Figure 41). 
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Figure 80: Fragment length analysis trace for UON_1329. The X axis is the 
height of the peak and the top axis is the size of the peak (bp). Loci in this image 
should include EMX-1 labelled with 6-FAM (blue) at 152bp, EMX-3 labelled with HEX 
(green) at 254bp and LA2 labelled with ROX (red) at 227bp. Ladder (LIZ500) 
shown in orange. 
 
6.4     Discussion 
In this preliminary study, we evaluated whether there was any 
indication of a possible genetic or familial link between EEHV 
related deaths. A genogram was successfully created and 
revealed that EEHV deaths appear to group into clusters, 
inbreeding coefficient data suggests that inbreeding is low 
within the elephants in this study. However, microsatellite 
work gave no useful data despite repeated attempts to 
optimise PCR reactions. 
6.4.1     Genogram 
The genogram was created to determine initially if a link could 
be visualised; the data shows that EEHV deaths appear to 
group in clusters, which suggests there may be a link between 
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the cases. However, this may suggest either a genetic 
component or an environmental component, as a number of 
the clusters were based at the same establishment. The 
genogram included a total of 39 EEHV related deaths, analysis 
of these deaths showed a varied geographic location. Twenty-
five deaths were reported in the USA and UK with 38.46% 
(15/39) and 25.64% (10/39) respectively, with the lowest 
reported number of cases being The Netherlands, Denmark 
and France at 2.56%, where one case was reported in each 
country. Underreporting of cause of death and mistaken 
attribution of death to other causes may contribute to these 
geographic variations. 
6.4.2     Inbreeding coefficients 
Inbreeding coefficients were calculated for 445 elephants with 
known parents.  
 
Values greater than 0.25 or 25% are possible, such as the 
field spaniel a pedigree dog breed, which in the UK has an 
average inbreeding coefficient of 0.274 (27.4%), which 
suggests that dogs of this breed born between January and 
December 2015 are highly inbred (The Kennel Club (UK), n.d). 
However, a total mean inbreeding coefficient of 0.009 (0.9%) 
reported in this study is lower than other captive populations 
such as captive scimitar horned oryx (Gilbert, 2010), the 
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studbook reports a mean F value of 0.124 (12.4%), as this is 
reported as an average it does not mean that all animals are 
12.4% inbred. In comparison to wild populations, an F value 
of 0.009 is lower that F values of wild Baird’s tapir (0.11) and 
the Southern Min Mountains population of wild giant panda 
(0.05)  (Ji-En and Dai, 1994, Norton and Ashley, 2004). In 
comparison to other captive species, an F value of 0.009 is 
lower than that of captive Scimitar horned oryx (Oryx 
dammah) with an F value of 0.124. Other animals such as 
domestic horses report low inbreeding coefficients, including 
the domestic thoroughbred horse (1.5%) and the domestic 
quarter horse (0.4%) (McCue et al., 2012) (Table 25). 
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Table 25: Inbreeding coefficients of selected captive and wild species. 
Inbreeding 
coefficient 
(F value) 
Species/breed Ref 
0.009  Captive Asian elephant (Elephas 
maximus) 
This study 
0.274  Domestic dog (Field Spaniel) The Kennel Club (UK) 
(n.d) 
0.124 Captive scimitar horned oryx (Oryx 
dammah) 
Gilbert (2010) 
0.15  Domestic thoroughbred horse McCue et al. (2012) 
0.04 Domestic quarter horse McCue et al. (2012) 
0.11  Wild Baird’s tapir (Tapirus bairdii) Norton and Ashley 
(2004) 
0.05 Southern Min Mountains wild panda 
(Ailuropoda melanoleuca) 
Ji-En and Dai (1994) 
 
As the above describes the average F value of populations, 
this however does not mean that all animals in the study have 
an F score the same as the average. In this study a total of 15 
Asian elephants presented with an F value of >25% (eight in 
Europe and seven in North America) and 19 with a value of 
between 12.5 and 24% (seven in Europe and eight in North 
America); this suggests that 7.6% (34/445) of the Asian 
elephants included in the inbreeding study are inbred at 0.125 
(12.5%) or above.  
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There are a number of limitations to both elements of the 
current study. There may potentially be under reporting of 
EEHV related deaths, as cases pre-1990 may have been 
incorrectly attributed to other causes. The reporting of EEHV 
cases varies by country and institution. There were a limited 
number of elephants involved in the microsatellite study, as 
such only a limited number of good quality samples were 
available; this is a challenge seen in a number of studies 
investigating EEHV in Asian elephants. There were a number 
of difficulties in determining optimal conditions for each 
microsatellite PCR reaction; there are a number of factors that 
may have contributed to this, including amending several 
microsatellite PCR reactions, using fluorescent primers instead 
of radioactively labelled ones, and using different brands of 
reagents.  
 
The study based on data provided from the genogram sets a 
baseline for other studies, but may have little relevance to 
EEHV.  
 
6.4.3     Microsatellites 
To further investigate the possibility of a genetic link, 
microsatellite markers were used to investigate the genetic 
diversity of Asian elephants located in the UK. Previously 
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published markers were used to enable a comparison with 
other populations in range countries. In total 14 loci were 
selected from previously published studies, 12 loci were used 
in the final analysis. 
 
To investigate whether non-invasive samples could be used an 
attempt was made to extract DNA from faeces to be included 
in the microsatellite analysis. This was unsuccessful as with 
the addition of the inhibitEX tablet all the supernatant was 
absorbed. This may suggest a large number of inhibitors were 
present in the sample, but this may also be due to the 
samples being stored on Whatman’s card, which may not have 
allowed for an adequate extraction. Similar difficulties were 
encountered when attempting to extract DNA from elephant 
faeces directly. Previous studies have used DNA extracted 
from faecal samples successfully in microsatellite analysis in 
both African and Asian elephant, and other species including 
mountain lions, Eurasian badgers (Meles meles), and Orang-
utans (Ernest et al., 2000, Goossens et al., 2000, Frantz et 
al., 2003, Vidya and Sukumar, 2005b, Okello et al., 2005, 
Hájková et al., 2006). However, there have also been reports 
of difficulties in using faeces for microsatellite studies; 
Hájková et al. (2006) reported variable success when using 
faecal samples obtained from wild Eurasian otters (Lutra lutra) 
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for microsatellite analysis. They made a number of 
recommendations when collecting faeces for microsatellite 
analysis, including collecting samples during colder months 
and in the early morning. An attempt was also made to 
include DNA extracted from trunk washes, whether trunk 
washes could be used for microsatellite analysis was not 
established due to time constraints. A number of other non-
invasive samples could be used such as plucked hair or skin.  
 
The microsatellite loci selected for this study were chosen as 
they have been previously shown to amplify in the elephant 
(Thitaram et al., 2008). However, a number of the loci 
selected were originally designed for use in the African 
elephant. We were unable to use two of the 14 loci tested in 
this study due to optimisation failure; attempts were made to 
determine the correct temperature and MgCl2 concentration 
for all reactions.  However, this was not successful for loci 
FH102 and FH127, where further modifications were made in 
an attempt to obtain a successful PCR, but without success. 
Reducing the concentration of primers in the reaction was also 
not successful. In the final analysis of 12 loci, fragment length 
information was not obtained; PCR reactions were optimised 
using pooled samples of DNA, however, even with this 
optimisation most reactions produced a poor yield of PCR 
                                                                                   Chapter 6 
233 
 
product when visualised. There are a number of reasons a PCR 
reaction may fail to produce a PCR product including: an 
incorrect master mix, incorrect concentrations of each 
reagent, degenerated or poor quality DNA or machine failure 
(Roux, 1995, Altshuler, 2006, Kennedy, 2011). However, it is 
surprising that the reactions for all 14 loci were not successful. 
To overcome this in future experimentation, further 
optimisation would be needed to ensure good quality bands of 
the correct size were produced; different reagents such as a 
proof-reading Taq polymerase could be used.  
 
A number of changes were made to the original PCR protocols 
for a number of loci; these include changes in primer 
concentration, MgCl2 concentration or annealing temperature. 
A comparison of optimisations used for this study, the original 
publications and those used in another previous study can be 
seen in Table 26.
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Table 26: Optimisations used in the current study compared to PCR protocols in the original publication and a study which also included 
these loci. Original publication refers to: Nyakaana and Arctander (1998) (LafMS02, 03 and 05),  Eggert et al. (2000) (LA2 and LA4), Comstock et al. 
(2000) (FH48, FH60, FH94, and FH103), Fernando et al. (2001) (EMX-1 and EMX-3) and Comstock et al. (2002) (FH153) 
 
  Primer concentration MgCl2 Annealing temperature (°C ) 
Loci 
This 
study 
Original 
publication 
Thitaram 
et al. 
(2008)  This study 
Original 
publication 
Thitaram 
et al. 
(2008)  
This 
study 
Original 
publication 
Thitaram 
et al. 
(2008)  
EMX-1 0.25um 10um 10um 1.5mM 15mM 15mM 62.2 64 60 
EMX-3 0.25um 10um 10um 1.5mM 15mM 15mM 64 64 57 
LA2 0.2um 0.2um 0.2um 2mM 1.5mM 1.5mM 58 58 62 
LA4 0.2um 0.2um 0.2um 4mM 1.5mM 1.5mM 54 54 57 
FH48 10um 10um 10um 2mM 2mM 2mM 58 58 58 
FH60 0.2um 0.2um 0.2um 1.5mM 2mM 2mM 59 61 61 
FH94 10um 10um 10um 1.5mM 2mM 2mM 61 61 61 
FH103 10um 10um 10um 1.5mM 2mM 2mM 66.6 58 58 
FH153 10um N/A N/A 1.5mM 15mM 15mM 58 N/A 50 
LafMS02 0.2um 0.2um 0.2um 1.5mM 1.5mM 1.5mM 54 51 48 
LafMS03 0.2um 0.2um 0.2um 4mM 1.5mM 1.5mM 54 50 50 
LafMS05 0.2um 0.2um 0.2um 1.5mM 1.5mM 1.5mM 54 49 48 
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Overall the results from this study do not provide enough 
evidence to suggest there is a genetic or familial component to 
EEHV. Microsatellite loci were not able to be detected, but a 
significant limitation of this study is that DNA was only 
successfully extracted from five Asian elephants, more 
samples would be needed to enable data obtained to be 
significant.  
 
Future work would include building on the current study; a 
greater number of elephants could be assessed which had 
tested either negatively or positively for EEHV (so that EEHV 
status was known for each elephant). As recent studies have 
shown HHV6 in humans can be transmitted from parent to 
child due to chromosome integration, and Gallid herpesvirus 2 
(GaHV2) the causative agent of Marek’s disease in chickens is 
also able to integrate into the chromosomes (Delecluse and 
Hammerschmidt, 1993, Tanaka‐Taya et al., 2004, Osterrieder 
et al., 2014), it is reasonable to consider that this may also be 
possible for EEHV. The possible heritability and whether EEHV 
integrates into the chromosomes of Asian and African 
elephants has not yet been investigated. This could be done 
by harvesting metaphase cells and then a chromosome 
spread. The technique has previously been used to determine 
the location of viral integration sites on the chromosomes for 
                                                                                  Chapter 7 
 
236 
 
adenovirus and hepatitis B virus (Recchia et al., 1999, Huang 
et al., 2002a). It has also been used to determine integration 
sites of two herpesviruses, GaHV2 and HHV6 (Delecluse and 
Hammerschmidt, 1993, Daibata et al., 1999).  
 
In conclusion the genogram created in this study may be used 
for further studies. Microsatellite analysis may be a useful tool 
in other studies, but techniques need further optimisation. 
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Chapter 7 – The use of microarrays 
to detect potential co-pathogens and 
EEHV 
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7      The use of microarrays to detect potential co-
pathogens and EEHV 
 
7.1      Introduction 
It is not uncommon for humans and other animals to be 
infected with more than one pathogen at a time; these are 
referred to as co-pathogens. Many co-infections do not cause 
any extra problems for the patient; however, some can cause 
complications. Several studies have suggested that HSV 
infection is facilitating the spread of HIV, as patients with HSV 
are more susceptible to acquiring HIV (Augenbraun et al., 
1995, Mole et al., 1997, Weiss et al., 2001, Rodríguez et al., 
2002, Corey et al., 2004, Brown et al., 2007). 
 
The exact mechanism of how HSV2 increases susceptibility to 
HIV is currently unknown, however, Martinelli et al. (2011) 
describe the possible involvement of dendritic cells in the 
process. Dendritic cells are the site of entry, enabling spread 
to the mucosa for both HSV2 and HIV1. Retinoic acid, 
produced by specialized dendritic cells in the gut, is an 
immunomodulator which influences the replication of HIV-1 
and mediates integrin α4β7 expression on lymphocytes. An 
increase in α4β7 expression was seen on CD4+ cells. The study 
suggests HSV2 is able to modulate its environment, this 
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influences the function of dendritic cells, potentially amplifying 
α4β7highCD4+T cells which is a highly susceptible HIV1 target 
cell, playing a role in susceptibility to HIV1 infection.  
 
It has been suggested that promoting treatment of those 
infected with HSV2 may contribute to reducing the 
transmission of HIV (Webster, 2007). To determine if treating 
HIV positive/HSV2 positive patients with antivirals reduced the 
levels of HIV1 RNA, Schacker et al. (2002) administered high 
doses of acyclovir and measured HIV-1 RNA loads at regular 
intervals. A strong correlation was observed between total 
HSV shedding rate and plasma HIV1 RNA loads. When 
acyclovir was administered HIV1 RNA levels were 48% lower 
in comparison to no HSV treatment. The study suggests daily 
treatment for HSV infections may be important in the 
management of HSV/HIV positive people. 
 
Co-infections have also been seen in animals. Post weaning 
multisystemic wasting syndrome (PWMS) seen in pigs, is 
clinically characterized by pallor of the skin, poor body 
condition, jaundice and dyspnoea (Allan and Ellis, 2000, Kim 
et al., 2002). The viral agent associated with PMWS is porcine 
circovirus 2 (PCV2). Infection with the virus by itself usually 
only causes mild disease (Ellis, 2014), however, the presence 
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of co-pathogens such as porcine parvovirus can lead to 
increased replication of PCV2, which induces more serve 
clinical disease and lesions (Ellis et al., 2000, Kennedy et al., 
2000). 
 
Most clinical cases of EEHV in Asian elephants have not been 
investigated for the presence of potential co-pathogens, and 
the role of co-pathogens in clinical cases of EEHV has not been 
established. 
7.2      Emerging diseases 
An emerging infectious disease (EID) is one which appears for 
the first time in a population, or which is rapidly increasing in 
geographic range or prevalence (Morse, 1995, Morse, 2001). 
There are three tiers of emerging pathogens, tier 1 (those 
transmitted from animal to animal), tier 2 (those that are able 
to opportunistically infect humans) and tier 3 (pathogens that 
can be transmitted from human to human without the 
involvement of an animal host) (Rosenberg, 2015). EID’s have 
occurred throughout history, with disease spreading through 
translocation. Translocation is the geographic movement of 
animals and people into new areas; this can potentially 
introduce pathogens into new regions, or expose animals or 
humans to new pathogens. (Guris et al., 2008). Diseases 
spread in this way include the Black Death (plague), which 
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was brought to Europe by ship from Asia, and measles and 
smallpox, which were introduced into the Americas from 
Europe by Spanish conquistadors (Siedler and Arndt, 2010, 
Malik and Roy, 2008). EID’s can present a risk to livestock, 
which can lead to economic loss through the death of saleable 
livestock. An example of this is African swine fever, which was 
introduced into Europe in 2007, when an outbreak occurred in 
Georgia, spreading amongst domestic pigs and wild boar 
(Rowlands et al., 2008). Other factors may influence the 
spread of EIDS, including climate change; this may increase 
the geographic range of arthropod vectors. The transmission 
season for certain diseases may also be extended due to 
climate change, an increase in temperature could mean 
vectors such as Aedes aegypti, the vector for dengue, could 
establish in Southern Europe (Huang et al., 2002b). 
7.3      Monitoring and surveillance 
Monitoring an outbreak can be difficult as it usually takes 
place when an outbreak has occurred, and may not play a 
clear role in the detection of emerging disease as it is usually 
cryptic and spontaneous.  
 
There are a number of monitoring, surveillance and prediction 
methods that have been used to look at emerging diseases 
and outbreaks. The goal when using indicator based evidence 
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is to find increases in cases or clusters of cases that may 
indicate a threat. Indicator based data can be collected from 
various sources including reports from diseases requiring 
mandatory notification, vector surveillance, mortality data, 
hospital/vet admissions, and pharmacy monitoring (Velasco et 
al., 2014). Data may also be collected from field clinical 
observations, reports from clinicians and information from 
agriculture and industry such as epidemiology and risk factors 
(Meerburg et al., 2009, Woolhouse, 2011, Humblet et al., 
2012, Velasco et al., 2014) 
 
There are a number of new technologies that have been used 
to monitor and predict emerging infectious diseases. Internet 
based surveillance is through event-based evidence and 
includes a diverse range of resources including social media, 
news reports, forums and internet searches (Milinovich et al., 
2014). Event-based surveillance systems are present on the 
internet and include Program for Monitoring Emerging Disease 
(ProMED mail) and the Global Public Health Intelligence 
Network (GPHIN) (Yu and Madoff, 2004, Mykhalovskiy and 
Weir, 2006). A large number of news items are reported 
through these systems each day, however, not all the data 
and reports are able to be investigated and verified (Velasco 
et al., 2014). Models can be useful in predicting epidemics and 
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disease spread, Infectious disease modelling enables an 
epidemic simulation, this allows for potential patterns and the 
progression of epidemics to be studied (Christaki, 2015). The 
Global Epidemic and Mobility model is widely used as an 
infectious disease model, it has been used for the modelling of 
influenza, taking into account demographics and air travel 
(Christaki, 2015). 
 
Monitoring and surveillance tools can be useful in the 
prediction and prevention of emerging infectious disease 
however, this requires a large amount of data analysis and 
investigation which may not always take place. Even with 
these tools in place, it is difficult to predict and monitor 
potential outbreaks. 
 
7.4      The relationship of rodents and spread of 
disease  
There are more than 2000 species of rodents, which account 
for 44% of all mammal species (Wolff and Sherman, 2007). 
Rodents have been associated with the transmission of 
diseases to both humans and animals (including pets, 
domestic animals and wildlife) (Frean et al., 1991, Frenkel et 
al., 1995, Gratz, 1999, Davis and Calvet, 2005, Lilenbaum et 
al., 2005, Kijlstra et al., 2008, Backhans and Fellström, 2012). 
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They can act as a liaison host which is a species that acts as a 
link in the chain of transmission between the reservoir host 
and their definitive host. The liaison host may or may not 
show signs of disease. This suggests rodents can transmit 
pathogens from a reservoir species to others (Garnham, 
1971). It is common for pests such as rodents to live in close 
contact to other animal species, including exotic species in 
captive environments (Forthman and Ogden, 1992). This has 
potentially facilitated the spread of diseases in zoo 
environments. One example of this is an outbreak of cowpox 
virus. An outbreak of cowpox virus occurred in a UK zoo in 
1977, which resulted in the death of three Cheetahs. The 
source of this outbreak was undetermined but it was 
suggested that it may have been spread by rodents (Baxby et 
al., 1982). No similar outbreaks had been reported previously 
in the UK, however, rodents were suggested as a source of 
infection due to a similar outbreak in Moscow caused by the 
use of infected white rats used as food for captive cheetahs 
(Baxby et al., 1982). There is also evidence that pathogens 
from rodents can be spread to elephants in captive 
environments. One study reported the transmission of cowpox 
from rat to elephant, and subsequently from elephant to 
human (Kurth et al., 2008). It has been suggested that in 
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order to predict the emergence of disease, the surveillance of 
rodents is important (Meerburg et al., 2009).   
7.5      Pathogens for investigation 
This study has been conducted to explore the possible 
presence of a large number of pathogens, transmitted by 
rodents which might potentially infect elephants in zoos. Using 
a microarray that has been previously been designed to detect 
a number of pathogens present in rodent populations. 
Pathogens were chosen to be included on the microarray 
based on: (1) their similarity to EEHV in their clinical 
presentation in elephants, and (2) whether they could 
potentially be present in the local rodent population resident in 
zoos.  
 
Encephalomyocarditis virus was included as a pathogen in this 
study as animals with this virus present with similar clinical 
signs to those with clinical EEHV. EMCV has been reported in 
both captive and wild populations of African and Asian 
elephants; clinical signs include anorexia, dyspnoea and 
listlessness, but the most common presentation is sudden 
death (Simpson et al., 1977). It has been suggested that 
EMCV is transmitted to elephants via infected rodents, several 
studies have investigated rodent populations to understand 
more about the prevalence of EMCV. A study by Reddacliff et 
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al. (1997) found only one positive rodent out of a total of 54 
rodent samples (1.8%), however, Billinis (2009) was not able 
to isolate EMCV from 42 brown rats but 35 were seropositive 
suggesting a previous exposure. In comparison a more recent 
study found a prevalence rate of 9% (11/125) in rodents 
captured from Swedish pig and chicken farms (Backhans et 
al., 2013). However, lower prevalence rates have been 
reported in other locations, Truong et al. (2013) investigated 
the prevalence of EMCV in 102 rodents from areas 
surrounding pig farms in South Korea, 3.9% (4/102) tested 
positive by PCR. The main route of transmission of EMCV is 
contamination of food/water supplies with faeces from infected 
rodent and/or eating of infected rodents (Maclachlan and 
Dubovi, 2011). Reducing risk factors such as contact with 
infected rodents, contaminated food/drink and contact with 
infected faeces could reduce the amount of transmission 
(Maclachlan and Dubovi, 2011). 
 
EMCV has been identified as a cause of major production 
losses in intensive piggeries. The virus tends to cause 
explosive sporadic outbreaks, which are potentially the result 
of transfer from rodents indirectly due to food/drink 
contamination with rodent faeces or ingestion of rodent 
carcasses (Dea et al., 1991). It is also thought that pig to pig 
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transmission may be possible, this has been investigated in an 
experimental laboratory setting by placing an infected animal 
in close contact with non-infected animals, there is no mention 
in the study if this has also been seen in none experimental 
animals (Maurice et al., 2002). The estimated R0 in the pig to 
pig transmission study was around 1, this would suggest that 
the spread of EMCV pig to pig is limited but may also lead to 
larger outbreaks (Maurice et al., 2002). Previous EMCV studies 
also found transmission of EMCV from pig to pig via a contact 
animal (Foni et al., 1993, Billinis et al., 1999). Non-human 
primates also appear to be highly susceptible to the virus; 
EMCV fatalities have been reported in the  ring-tailed lemur 
(Lemur catta), black lemur (Eulemur macaco), white-headed 
lemur (Eulemur albifrons), red-ruffed lemur (Varecia rubra), 
common marmoset (Callithrix jacchus), Barbary macaque 
(Macaca Sylvanus), squirrel monkey (Saimiri spp), DeBrazza’s 
guenon (Cercopithecus neglectus), baboon (Papio spp), 
mandrill (Mandrillus sphinx) and chimpanzee (Pan troglodytes) 
(Gaskin et al., 1980, Reddacliff et al., 1997, Canelli et al., 
2010). Clinical signs in primates include lack of coordination, 
anorexia, sensory depression, lethargy, and sudden death 
(Reddacliff et al., 1997).  
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EMCV has occurred in mass outbreaks in wild populations of 
African elephants, with 64 elephants dying in the Kruger 
National Park during one such outbreak (Grobler et al., 1995). 
Necropsy samples from this outbreak showed myocarditis 
lesions; other observations made during necropsy include a 
mottled, streaky myocardium, congested lungs, swollen liver 
and brain congestion. EMCV was thought to be the cause due 
to the presence of cardiac lesions (Grobler et al., 1995). 
Similar post mortem findings such as lesions of the heart and 
congestion of the lungs have since been observed in other 
species (Billinis et al., 1999). Specimens from three elephants 
were positive for EMCV when tested with PCR (Grobler et al., 
1995). Four captive African elephants died from EMCV 
infection in years 1976 and 1977 in the USA (Simpson et al., 
1977), whereas the first reported case in a captive African 
elephant in Europe occurred in 2013. The 18 year old female 
was found dead without any prior clinical signs; a post mortem 
examination reported lesions and haemorrhages on mucosa of 
the eyes, mouth, rectum and vagina. Lesions were also 
reported on a number of internal organs; EMCV was then 
isolated from samples obtained from the infected organs using 
BHK-21 cells (Lamglait et al., 2015). Gaskin et al. (1980) also 
reported a suspected case of EMCV in an Asian elephant at a 
zoo in Florida. The animal, aged 10, died suddenly in 1975. 
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Necropsy findings showed myocarditis and a flaccid heart, as 
well as haemorrhages in the lungs, kidneys and intestine.  
 
A number of other pathogens can be transmitted to elephants, 
both from the environment and from other animals. These 
pathogens include Mycobacterium spp, which include 
Mycobacterium tuberculosis and M. bovis. If an elephant is 
infected with either of these species, this may lead to disease, 
however, most animals including elephants with an active TB 
infection show no clinical signs (De Lisle et al., 2002). In cases 
of TB infection in elephants, clinical signs may include weight 
loss, anorexia, weakness, coughing and nasal discharge (Pinto 
et al., 1973, Gutter, 1981, Saunders, 1983, Angkawanish et 
al., 2010). Tubular lesions are also seen in elephants, their 
appearance varies depending on the stage of the disease; 
granulomatous lesions can be observed in the bronchial lymph 
nodes and pulmonary tissue. In >66% of cases where both 
lungs are involved, caseocalcareous and cavitating lesions 
have also been observed; this can then result in the presence 
of large pulmonary abscesses (Mikota et al., 2000).  
 
There are a number of treatment protocols for mycobacterial 
infections in elephants available suggesting both first line and 
second line drugs. First line drugs include isoniazid, 
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pyrazinamide, rifampin, ethambutol and streptomycin, and 
second line drugs include amikacin, ethionamide, quinolones 
and capreomycin, however, there may be multidrug resistance 
(Dumonceaux and Mikota, n.d). 
Anti-tuberculosis treatments are known to affect the 
performance of serological assays, a treated elephant may 
appear positive by Elephant tuberculosis Stat-Pak but will 
eventually become negative (Lyashchenko et al., 2006).  
 
Tuberculosis from elephants can also spread to other animals 
including humans. This could potentially present a major 
health concern for zoo keeping staff and members of the 
visiting public.  
 
A number of other pathogens that have not been previously 
reported in Asian elephants were also included in this 
investigation. These include Rickettsia spp, lymphocytic 
choriomeningitis (LCMV), Puumala Hantavirus and Seoul 
Hantavirus. By contrast, M. tuberculosis, M. bovis, Leptospira 
interrogans, cowpox virus, Yersinia spp, Toxoplasma gondii, 
EEHV and EMCV, which were included in the pathogens to be 
investigated, have been reported in elephants previously.  
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7.6      Assay for the detection of multiple pathogens 
Being able to detect a number of pathogens simultaneously 
can be less time consuming than testing for each pathogen 
individually, and provide a more rapid diagnosis. When a 
number of pathogens are present such as the presence of HIV 
and T.gondii, it can lead to more serious conditions and 
complications. To investigate the presence of multiple 
pathogens or multiple species, a number of different types of 
testing methods can be used.  
7.6.1      TaqMan Array Card (TAC) 
The TaqMan Array Card (TAC), a singleplex real-time PCR 
assay, can detect multiple pathogens simultaneously, 
including a mixture of both DNA and RNA pathogens (Kodani 
et al., 2011, Rachwal et al., 2012, Liu et al., 2013, Weinberg 
et al., 2013). Samples are added to the channels on the card, 
depending on the experiment the cards contain a number of 
channels. Rachwal et al. (2012) used a TAC with 8 channels 
allowing for 24 individual reactions to allow the detection of 
multiple biological agents. There are a number of limitations to 
this type of assay, it is expensive; even when only one or two 
pathogens are of interest, the whole card must still be used.  
Furthermore, duplicates are needed, especially in the case of 
low level infections due to sensitivity. However, such assays 
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are useful as it allows broad range screening (Eisen and Gage, 
2009). 
7.6.2      Next generation sequencing (NGS) 
Next generation sequencing allows for the detection of any 
nucleic acid present in a sample. The most common method of 
NGS is illumina; this has also been used for pathogen 
discovery. Vayssier-Taussat et al. (2013) found bacterial 
pathogens in ticks in Western Europe using NGS. RNA was 
extracted from 1450 Ixodes ricinus nymphs located in France, 
RNA was then pooled and used for NGS. The study identified 
12 different bacteria species including Candidatus neoehrlichia 
mikurensis which had not been previously reported in France. 
The main advantage to using NGS is the production of large 
amounts of DNA/RNA sequences, which can then be analysed 
by a bioinformatician and the species identified. This allows for 
the identification of everything present in the sample, useful 
for pathogen discovery. It is also very sensitive and can detect 
the DNA from pathogens at low levels. The main 
disadvantages include the need for specialised equipment and 
the cost, also the need for specialised bioinformaticians to 
analyse data (Barzon et al., 2013). Using NGS may be useful 
in the detection of multiple pathogens in a single sample, or 
for pathogen discovery in multiple animal samples, it may also 
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be used in the diagnosis of infectious disease (Vayssier-
Taussat et al., 2013).  
7.6.3       Multiplex PCR 
Conventional PCR assays can be developed to allow the 
detection of multiple pathogens in one assay. Multiplex PCR 
allows for a number of pathogens to be detected in a sample 
using primer pairs optimised for each pathogen. A limitation of 
this method is that it can be difficult to combine all the primer 
pairs into a working reaction. This may be due to differences 
in optimal annealing temperatures and reaction conditions; 
there may also be poor sensitivity or specificity, increased 
formation of primer dimers, and non-specific binding. A 
compromise of poorer sensitivity and reduced specificity may 
be made to enable multiple pathogens to be detected 
simultaneously in comparison to singleplex PCR (Koenen et 
al., 1999, Carocci and Bakkali-Kassimi, 2012). Multiplex PCR 
has been used to detect a number of viral pathogens, Elnifro 
et al. (2000) reported the used of multiplex PCR to investigate 
the presence of HSV1, HSV2, CMV, enterovirus, echovirus 
type 22, LCMV, mumps, and measles. This study reported that 
in controlled testing, the sensitivity of this multiplex PCR was 
no different to that of the reactions using single primer pairs. 
This would suggest that a number of pathogens can be 
detected with no compromise to sensitivity. 
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7.6.4       Real-time PCR 
Real-time PCR is a technique that detects the accumulation of 
amplicons in real time, detecting amplicons during the 
exponential phase enables quantification, in comparison to 
conventional PCR where products are detected during the 
plateau phase at the end of the reaction. Real time PCR has 
been used for the rapid detection of multiple pathogens. 
Lehmann et al. (2008) used this type of assay to detect 25 
different type of fungi and bacteria in human blood. Blood 
samples were mechanically lysed using ceramic beads; DNA 
prepared using a commercial kit. PCR amplification was then 
performed using a LightCycler. With the addition of a melt 
curve at the end of the amplification individual bacterial and 
fungal species can be identified as their melting points differ. 
The advantage of using this type of assay is that it is rapid 
compared to NGS, and has an increased sensitivity compared 
to conventional PCR. However, it does require expensive 
equipment compared to conventional PCR. 
7.6.5      Microarrays 
7.6.5.1 Overview 
Microarrays can be used as a diagnostic tool that allows 
samples to be screened for multiple pathogens. A microarray 
platform contains an arrangement of sequence-specific DNA 
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sequences (probes) attached to a solid surface such as a glass 
slide, silicon chip, nylon membrane or tubes, usually 
configured in rows and columns (Bertucci et al., 1999, Lenigk 
et al., 2001, Heller, 2002, Wang et al., 2003, Giles et al., 
2015). Complimentary DNA or cDNA within a sample are 
hybridised to the probes, non-specific sequences are then 
washed off, and then only strongly bonded sequences remain 
hybridized. The total strength of the signal from each 
hybridised spot on the surface is measured, the amount of 
target sample that has hybridised to the probe determines the 
strength of the signal (Blalock, 2003, De Rinaldis and Lahm, 
2007, Nuber, 2007, Wiesinger-Mayr et al., 2007). 
7.6.5.2 Probe development 
Probes designed for use in a microarray experiment should be 
designed to be specific to their target, this increases binding 
efficiency. If the probe is not specific, then cross-hybridization 
may occur. The sensitivity of the probe is also important; they 
should bind to their target even when there is a low 
abundance of the target sequence. Repeated experiments 
should be conducted to determine probe hybridisation is 
consistent (Loy and Bodrossy, 2006, Giles et al., 2015). Short 
or long oligonucleotide sequences can be designed as probes, 
however, longer sequences (50-70bp) may decrease the 
specificity of the array, when specificity is lowered, sequences 
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with reduced homology may be detected (eg. Cross-species). 
Longer probes are preferred in some circumstances, including 
when there is not an existing array available, when detecting 
similar species may be beneficial, this would include the 
detection of novel species/pathogens (Bar-Or et al., 2007). 
However, there are also circumstances when short 
oligonucleotide sequences of 15-30bp, are useful as it allows 
the probe to be highly species-specific. Short sequences may 
be useful in strain identification (Tomiuk and Hofmann, 2001, 
Wang et al., 2003, Liu et al., 2010). Array sensitivity is 
determined by the intensity with which the probe binds to its 
target sequence (Lemoine et al., 2009). Probe sensitivity is 
affected by: the concentration of the probe on the surface, 
thermodynamic properties of each probe, and the availability 
of the target sequence (Draghici et al., 2006). The 
hybridisation process may also be affected by certain factors 
which may affect the annealing of the probe with the target 
sequence, including the concentration of salt and 
temperatures, used a series of washes ensures that any non-
specifically bound DNA is washed away from the array surface. 
A larger amount of wash buffer is used in comparison to the 
amount used during the hybridisation step, this is to ensure 
impurities and contaminants are diluted. Washing reduces the 
signal caused by any impurities, as they may contribute to the 
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amount of background noise (random signal variation) 
(Russell et al., 2008, Giles et al., 2015, Giles, 2015). 
7.6.5.3 Microarray variability 
There may be an amount of variation in microarray 
experiments, these variations may occur for a number of 
reasons, including small changes in sample labelling or 
processing. Including replicates may reduce some variation. 
The probes attached to the array, may also be a source of 
variation, it is thought that by optimising both the array and 
the hybridisation process this can be reduced (Russell et al., 
2008). Including replicates allows variation to be measured; 
however, this is not always done. There are disadvantages to 
microarray studies without replicates, such as lower sensitivity 
and biological variation (Lee et al., 2000). 
7.6.5.4 Multiple pathogen detection 
Microarrays can be for the detection of pathogens in animals, 
including the simultaneous detection of Newcastle disease and 
avian influenza in birds (Wang et al., 2008). The use of 
microarrays has been valuable in screening rodents for the 
presence of zoonotic pathogens; an assay developed by Giles 
et al. (2015) was used to detect 17 pathogens of rodents 
simultaneously in a sample. Early detection of pathogens may 
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allow for a quicker response and prevention of further spread 
of disease. 
7.6.5.5 The detection of multiple herpes viruses  
Microarrays have been used to detect several human herpes 
viruses (Földes-Papp et al., 2004, Jääskeläinen et al., 2006, 
Zheng et al., 2008). Jääskeläinen et al. (2006) investigated 
samples of cerebral spinal fluid, which were screened for the 
presence of eight human herpes viruses. Target pathogens 
included HSV1, HSV2, CMV, EBV, HHV7, HHV6A, HHV6B and 
VZV. A small number of samples (10/227) tested positive for a 
concurrent infection with two viruses and one sample 
presented with 3 viruses.  A later study by Zheng et al. (2008) 
used amino modified glass slides spotted with a number of 
probes for detecting viral DNA. Pathogens which could be 
detected included HSV1, HSV2, VZV, EBV, CMV, HHV6A and 
HHV6B. One hundred and thirty two blood samples from 
children were tested, of which 49 were positive for herpes 
virus. Five presented with concurrent infections, two EBV and 
CMV, one VZV and CMV, one HSV2 and CMV, and one EBV and 
HHV-6B.  
 
A study by Giles et al. (2015) described the first development 
of an alternative to the glass slide microarray (as this can be 
expensive). The two array platforms used in the study were 
                                                                                  Chapter 7 
 
259 
 
the ArrayTube (AT) platform and the ArrayStrip (AS) platform 
both from Alere Technologies GmbH (Jena, Germany). The AT 
allows up to 225 probe spots whereas the AS platform allows 
up to 600. The probe spots are located on a small array 
surface 4 x 4mm which is located at the bottom of a vial. 
7.6.5.6 Advantages 
There are a number of advantages and disadvantages of using 
microarrays. They are useful in mutation analysis, genotyping 
and detecting bacteria, viruses and parasites (Kumar, 2009). 
Using this technology a large number of samples can be 
screened for multiple pathogens, in comparison to PCR where 
screening large numbers of samples may be difficult (Cannon 
et al., 2010). Previous studies have suggested that 
microarrays are semi-quantitative, if there is more target 
DNA/cDNA within the sample more hybridisation occurs and so 
a stronger signal is then emitted, microarray results can be 
compared to those from qPCRs (Chuaqui et al., 2002, Dallas 
et al., 2005). More recent gene transcription studies have also 
shown a good correlation between microarray results and 
qPCR, further suggesting the semi-quantitative use of 
microarrays (Kouni et al., 2013, Martínez et al., 2015).  
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7.6.5.7 Disadvantages 
There are also a number of disadvantages in developing and 
using a microarray system. The main disadvantage of glass 
slide microarray systems is cost, however, an alternative 
ArrayTube has been developed which uses less specialised 
equipment and is more cost effective (Ehricht et al., 2006). 
 
There can be difficulty in appropriate probe selection, which 
can be a time consuming process. It may also be difficult to 
design probes that are specific to a single organism. Probes 
need to be chosen based on their sensitivity, specificity, high 
coverage to include all strains needed in the experiment, 
however, cross-hybridisation is more likely in sequences that 
provide high coverage (Tomiuk and Hofmann, 2001, Liu et al., 
2010). A number of factors can affect the hybridisation 
process, including probe length and hybridisation temperature, 
hybridisation process optimisation may also be time 
consuming. A number of considerations must be included 
during the optimisation process such as, probe length, 
hybridisation temperature and preparation of the target 
(Schena, 2003). Sensitivity of the assay may also be lowered 
by the presence of nucleic acid from the host within the 
samples, however, there are specialised commercial kits 
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available which can be remove the host nucleic acid prior to 
the initial PCR amplification (Gurrala et al., 2009). 
7.6.6      Conclusion 
Microarray technology has not previously been used to screen 
elephants for multiple pathogens. The current study focused 
on pathogens that are considered zoonotic and are commonly 
found in rodents, as rodents may be present in captive 
elephant environments and able to transmit disease. By using 
an array system developed for screening rodents, the same 
system can be used to screen Asian elephants for potential 
rodent borne pathogens. With further modification of the array 
it could also be used for screening EEHV. 
 
Screening rodents is one method for investigating the 
prevalence of pathogens in a specified area. Screening rodents 
in a zoo setting is important for the health of exotic captive 
species, zoo keeping staff and members of the visiting public. 
Early detection of pathogens may help to prevent a potential 
outbreak.  
7.7      Materials and methods 
7.7.1      Samples 
A total of 18 clinical tissue samples from Asian elephants, and 
trunk wash samples (for sample collection see materials and 
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methods 2.1) from nine Asian elephants, were investigated for 
the presence of multiple pathogens. Tissue samples were 
provided from 4 animals that had previously tested positive 
for EEHV using qPCR, and one which tested negative (Table 
27). RNA and DNA was obtained from tissue, and where tissue 
was not available, previously extracted DNA was used. 
Table 27: List of tissue samples used to investigate the presence of 
multiple pathogens.  
Animal ID Tissue 
Nucleic acid 
sample 
UON_1329 Heart DNA/RNA 
UON_1329 Liver DNA/RNA 
UON_1329 Lung DNA/RNA 
UON_1329 Kidney DNA/RNA 
UON_1189 Heart DNA/RNA 
UON_1189 Liver DNA/RNA 
UON_1189 Lung DNA/RNA 
UON_1189 Kidney DNA/RNA 
UON_1002 Heart DNA 
UON_1002 Liver DNA 
UON_1002 Lung DNA 
UON_1490 Liver DNA 
UON_1490 Lung DNA 
UON_1490 Kidney DNA 
UON_1149 Heart DNA/RNA 
UON_1149 Liver DNA/RNA 
UON_1149 Lung DNA 
UON_1149 Kidney DNA/RNA 
UON_1140 Trunk wash DNA 
UON_1625 Trunk wash DNA 
UON_1089 Trunk wash DNA 
UON_1093 Trunk wash DNA 
UON_1175 Trunk wash DNA 
UON_1309 Trunk wash DNA 
UON_1579 Trunk wash DNA 
UON_1543 Trunk wash DNA 
UON_1353 Trunk wash DNA 
 
                                                                                  Chapter 7 
 
263 
 
7.7.2      DNA extraction 
See materials and methods section 2.2.1 
7.7.3      RNA extraction 
RNA was extracted from tissue samples using a commercial kit 
(Qiagen RNeasy mini kit) and following the manufacturer’s 
instructions. Tissues were initially lysed using a tissue lyser 
(Qiagen TissueLyser II), set at 30Hz for 2 minutes using steel 
beater beads. The supernatant was then used for the 
extraction, 70% alcohol and the supernatant were transferred 
to a spin column, then centrifuged for 15 seconds at 8000xg. 
The membrane was then washed using a series of three 
solutions, the sample was then eluted in 50µl RNase free 
water, and stored at -20oC until use. 
7.7.4      EMCV positive control 
Positive control material (cDNA) was a cell culture adapted 
strain ATCC® VR-129™ obtained from The Veterinary and 
Agrochemical Research Center, Belgium.  
7.7.5      Microarray 
7.7.5.1 Pathogens 
The array system in this study was used to detect a series of 
bacterial and viral pathogens (Table 28). Some of the 
pathogens have previously been detected in rodents within 
zoos in the UK. These include Mycobacterium spp, L. 
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interrogans, Rickettsia spp, LCMV, Cowpox virus, Hantavirus 
spp and Yersinia spp. EMCV was selected due to a similar 
pathogenesis to EEHV in elephants. 
 
Table 28: Pathogens targeted using the ArrayTube (AT) system. A number 
of bacterial and viral targets were used in the microarray. EEHV and EMCV probes 
were also added to the array. 
Type Pathogen 
Bacteria Mycobacterium tuberculosis 
 Mycobacterium bovis 
 Mycobacterium spp 
 Leptospira interrogans 
 Rickettsia typhi 
 Rickettsia spp 
 Yersinia spp 
Virus LCMV 
 Cowpox virus 
 Puumala hantavirus 
 Seoul hantavirus 
 Hantavirus spp 
 EEHV 
 EMCV 
 
7.7.5.2 Layout 
The screening chip had a total of 196 spots, with spot 195 
(biotin marker) repeated twice, in the top right and bottom 
left corners (Figure 42).
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Figure 42: A colour coded layout of the array tube chip. All probes appear once on the chip with the exception of 
the biotin marker (spot 195). Black areas were orientation markers. As a number of pathogens on this chip we used 
previously to screen rodents; Hepatitis E virus was excluded from these experiments, as this has never been reported in 
elephants. 
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7.7.6      Working probes 
Multiple probes were used for each set of primers, a number 
of probes were confirmed to hybridise positively in a previous 
study by Giles et al (Giles et al., 2015), primers and probes 
used are as stated in the study and are highlighted in red text 
in Table 29. Those highlighted in blue in the same table were 
also from this previous study, though positive control material 
was not available, this meant their hybridisation status was 
not confirmed. Those highlighted in purple text were 
developed for this study; positive control material was 
available for both EEHV1 and EMCV to confirm the probes 
hybridise.  
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Table 29: Primer sequences and working probes list.  
* A number of probes were confirmed to hybridise in a previous study by Giles et al (Giles et al., 2015) and are as stated in the study, these are highlighted in red text. 
Those highlighted in blue were also from this previous study, though positive control material was not available, so their hybridisation status was not confirmed. Those 
highlighted in purple text were developed for this study; positive control material was available for both EEHV1 and EMCV to confirm the probes hybridised.
Forward primer (5" to 3" 
sequence) 
Reverse primer (5" to 3" 
sequence) 
Number of 
working 
probes* Predicted target 
TGCACTTCGGGATAAGCCTG TAGCATGTGTGAAGCCCTGG 2 Mycobacteria broad spectrum 
CAACGGCCTCAACCTCGTC CATTGAAAATGGCCCCACCG 2 M. tuberculosis, M. bovis, M. canetti and M. africanum 
AACGCGCTRTCCACCCGGCT GTGATGATCGCCTGRACTTCGGTG 6 M. tuberculosis, M. bovis, M. canetti, M. africanum, M. caprae and M. microtti 
CATGAACGGAGCGCATCAC CGGAGCGGGGATGTAATAGG 4 M. avium and M.avium ssp paratuberculosis 
TTGGCGGCGACAAAGTTAAT TTCGTCTGTCAAGCAACGGA 4 M. avium and M.avium ssp paratuberculosis 
CTCCGTCGTCCGTCGTAATA TCGACAATACGCTGCTTGAA 4 Toxoplasma gondii 
AAAGCCATTTCCGTATGCTG TGTACTCGCATTTGGCTGAC 3 Yersinia spp 
AGAGGCAGGCAGACTTCAAA CCAGCAAACACCCATATTGA N/A Seoul hantavirus 
CGAGAAAGACTGGAATGAGTGA CACGCGTTGAAAGCATGTA N/A Puumala hantavirus 
TGCTGGCTTGAAAAGAATCAA TCCTGAATAAAGCGAGGTCA N/A Hantavirus spp 
ATGACACGATTGCCAATACTTC CTTACTGTAGTGTATGAGACAGC 3 Cowpox virus 
ACGCGGATCCTTCTACTCCT GGCTGATCGAATCTTTCCAA 2 Leptospira interogans 
GCTCTTGCAGCTTCTATGTT CCGCCAACCTGACGGGCAATGG N/A Richettsia typhi 
CCTGGGAAAACCACTGCACA TTGACAAGGTGCAGGAAGATGC 5 Lymphocytic choriomeningitis virus (LCMV) 
TGTGAGCCAGTCGTGATTGT AAGCCTCTTGCAATTCCTCA 5 Encephalomyocarditis virus (EMCV) 
ACAGCCTTCGAAGTGTTGAA TGGGCGACAACTCAACATG 5 EEHV1 
AGTGCATCGTCGGAATATGC TCCCTGAGAGCGGCTTTT 5 EEHV1 
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7.7.6.1 Additional probes 
All probes were designed using Primer3 software and 
manufactured by Eurofins, Germany. Each probe was designed 
to be 60bp long. EEHV probes were designed using the 
Elephantid herpesvirus 1 Raman strain sequence 
(KC462165.1) obtained from the NCBI nucleotide database. 
EEHV1_UPS_1-5 probe sequences were designed for the EE10 
membrane protein gene of EEHV and EEHV1_UPS_11-15, 
were designed for the EE34 membrane protein gene (Table 
29). All EEHV probes were designed to detect EEHV1 only. 
EMCV probes EMCV_UPS_1-5 were designed using the 
Encephalomyocarditis virus strain ATCC VR-129B complete 
genome sequence (KM269482.1) also on the NCBI database, 
the genome is not annotated this means gene information is 
not currently available (Table 30). All EMCV probes were 
designed to detect multiple strains of EMCV. 
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Table 30: Additional EEHV and EMCV probes designed for the microarray 
Forward primer sequence 
(5" to 3" sequence) 
Reverse primer sequence 
(5" to 3" sequence) Probe name Probes (5" to 3" sequence) 
Start 
position 
End 
position 
Target 
pathogen 
ACAGCCTTCGAAGTGTTGAA TGGGCGACAACTCAACATG EEHV1_UPS_1 TTGGCTAGGTGTACGGCTCGTGACGTAGGCAGATAAATAGAGATGATTTGGGGCGGTTCT 106129 106188 EEHV1 
    EEHV1_UPS_2 CTGACTGTGTATCCCACCCAACAAGAATCTGCTATCGTTAGCTTTCACCACCGTACTGAT 106437 106496 EEHV1 
    EEHV1_UPS_3 GCTCGTAATAGTCGTCTGTCTCATCGATTCCCCTCTTTGTAAGACTAACAGGGAAGTTCC 106058 106117 EEHV1 
    EEHV1_UPS_4 ACGCCGGCAATGCAGAAACGACGTTAGTTGTAGTGTTTGTTGCAGTAACTGCGTGTCCGA 105926 105985 EEHV1 
    EEHV1_UPS_5 AAATTATTCTGGCAGACGCACTATTGGCAGCCGTTTCCGAATCATCCATACAACCATCTG 106379 106435 EEHV1 
AGTGCATCGTCGGAATATGC TCCCTGAGAGCGGCTTTT EEHV1_UPS_11 ACCGCAGTTAATCATAGCGCTAGAGTACTGCCTTCTGATTCACAGACTACAGGACCTGCA 148004 148063 EEHV1 
    EEHV1_UPS_12 TACGCTTTCAAGAAATGGCGACACACGTTGAACCTAGGTCTGATCGGAAACGACATATTC 147738 147797 EEHV1 
    EEHV1_UPS_13 CTCTTACTAGCCGCGACTCTCATCTCTCTAAAGTTGACAGAATTTCCAAAAAGCCGCTCT 148125 148184 EEHV1 
    EEHV1_UPS_14 CTGGGAACGGTCATAGCCATGTTTGTCCTCGGCATGATAGTGAAAAGGTTCAGTAACCAG 147801 147860 EEHV1 
    EEHV1_UPS_15 AGATGCTAACATAACGCAAGAGGTAGAGAATCGCTTCTACATGGAATATCTGGACTGTC 147628 147687 EEHV1 
TGTGAGCCAGTCGTGATTGT AAGCCTCTTGCAATTCCTCA EMCV_UPS_1 CGCGGGGCAAGGGAAATCTTTATCAAGTCAGGTTATTGCCCAGGCCGTCTCCAAGACCAT 4788 4847 EMCV 
    EMCV_UPS_2 CCGGGTATAAGGTTTTGGATGTTGAAAGAGCCTTTAGGCCTACCGGTGAGGCTCCTCTTC 5180 5239 EMCV 
    EMCV_UPS_3 AGACGAGGTCAGTTTCCATTCCGTAGTCCAGCAGCTTAAAGCAAGACAGGAAGCGACAAGA 5412 5469 EMCV 
    EMCV_UPS_4 TTTGCAGCAATAATGGATGATCTAGGGCAAAATCCTGATGGCTCTGATTTCACTACGTTC 4915 4974 EMCV 
    EMCV_UPS_5 TGTGGTGGCAACTACCAATCTGCCTGAGTTTAGACCTGTCACAATAGCCCATTACCCTGC 5055 5114 EMCV 
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7.7.6.2 Real Time PCR (RT-PCR) 
RNA was extracted as previously described, reverse 
transcription (RT) was performed to allow amplification of RNA 
viruses by PCR; enabling the formation of cDNA. RT-PCR was 
performed as described by Giles (2015). The following 
components were added to a total volume of 13µl in a PCR 
tube: 1µl random hexamer primer (40uM), 1µl dNTP mix, 10µl 
water and 1µl template (minimum of 50ng). In a thermal 
cycler the samples were heated to 65˚C for 5 minutes, and 
then kept on ice for at least 1 minute. A total of 7µl of 
superscript III mix (Invitrogen, USA) (4µl 5x reverse 
transcriptase reaction buffer, 1µl 0.1M DTT, 1µl RNase 
inhibitor, and 1µl superscript III reverse transcriptase) was 
then added to each reaction. The samples were then incubated 
at 25˚C for 5 minutes followed by one hour at 50˚C, a final 
incubation of 15 minutes at 70˚C was performed to ensure the 
RT enzyme was inactivated. 
7.7.6.3 Multiplex PCR 
7.7.6.3.1     Primers and probes 
Primers and probes developed for use in a microarray assay 
must be highly specific for the target pathogen. There are 
several factors that need to be considered and must be 
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balanced in the probe design process including; sensitivity, 
specificity, noise and bias (Hukkanen et al., 1999). 
For this study, a multiplex PCR was developed to amplify a 
number of pathogens so they could then be detected in using 
the microarray including EEHV1, EMCV, Leptospira 
interrogans, Lymphocytic choriomeningitis, cowpox virus, M. 
bovis, M. tuberculosis, M. avium subspecies paratuberculosis, 
Rickettsia typhi, Puumala hantavirus, Seoul hantavirus, 
Yersinia spp and T.gondii using a series of primers. 
 
A 10x primer mix was made containing 2mM of each primer. 
The cycling conditions for this reaction can be seen in Table 
31. Denaturation, annealing and extension steps were 
repeated for 40 cycles. 
 
Table 31: Cycling conditions for multiplex PCR.  
Step Temperature (oC) Time 
Initial denaturation 94 2 min 
Denaturation 94 30 sec 
Annealing 10 1 min 
Extension 72 1 min 
Final extension 72 10 min 
Final hold 4 indefinitely 
 
7.7.6.4 Biotin labelling and PCR 
PCR products obtained from multiplex PCR (described 
previously) were labelled with biotin prior to hybridisation. The 
protocol followed was performed as described by Giles (2015). 
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The reaction volume was 50µl, consisting of 30 µl nuclease 
free water, 3µl 25mM MgCl2 (Invitrogen, USA), 5µl 10X Mg 
free buffer (Invitrogen, USA), 5µl 10x biotin labelling mix (for 
a 100μl total: 1μl dATP, 1μl dGTP, 1μl dCTP, 0.65μl dTTP, 35μl 
Biotin-dUTP, 61.35μl water, 0.5µl 10x array primer mix), 0.5µl 
taq polymerase (Invitrogen, USA) and 5µl of PCR product. The 
PCR cycling conditions were as follows: 94oC for 10 sec, then 
25 cycles of 94oC for 30 sec, 50oC for 30 sec and 72oC for 2 
min, this was followed by a final extension of 2 min at 72oC. 
 
7.7.6.5 Hybridisation 
Hybridisation was conducted using a protocol for array strips 
as described by Giles et al. (2015); for this study array strips 
were replaced with an array tube (AT) platform. 
 
7.7.7      Confirmatory EMCV testing by PCR 
7.7.7.1 Reverse transcription of RNA 
Each reaction consisted of 1µl random hexamer primer and 
14µl RNA template, this was put into a thermal cycler (Techne 
TC-512 thermal cycler) for 10 min at 70˚C, following this 5ul 
M-MLV buffer (Invitrogen, USA), 1.25µl dNTPS (New England 
Biolabs, USA), 1µl M-MLV enzyme (Invitrogen, USA) and 3µl 
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RNase/DNase free H2O was added to each tube and incubated 
at 37˚C for one hour. 
7.7.7.2 Primers for cDNA and EMCV detection 
Two sets of primers were used: one to detect IFNγ (to confirm 
the presence of Asian elephant cDNA), and one to detect the 
presence of EMCV (Table 32), the primers used were 
synthesised by Eurofins, Germany. IFN sequences were 
obtained from a previous publication (Stanton et al., 2010). 
EMCV primers were developed using Primer3 software.  
 
Table 32: Primers used to amplify IFNγ and EMCV. IFNƴ primers were used to 
confirm the presence of Asian elephant cDNA. 
Primer Sequence (5"-3") 
IFNγ forward GCGTGAAGACCCTTGAGGAA 
IFNγ reverse TCATTTACCGGAGTTTGCATCA 
EMCV forward TGTGGCACAAGCTCCAGTAG 
EMCV reverse TGTTCATCTGTCGCTTCCTG 
 
7.7.7.3 Cycling conditions 
Both PCRs for the detection of cDNA and EMCV utilised the 
same cycling conditions, denaturation, annealing and 
extension steps were repeated for 40 cycles (Table 33). 
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Table 33: Cycling conditions for the detection of cDNA and EMCV. 
Step Temperature (oC) Time 
Initial denaturation 95 2 min 
Denaturation 95 2 min 
Annealing 60 30 sec 
Extension 72 1 min 
Final extension 72 5 min 
Final hold 4 indefinitely 
 
7.7.7.4 Visualisation 
All PCR products were visualised using gel electrophoresis on a 
3% agarose gel using Nancy 520 fluorescent stain. 
7.8      Results 
On the microarray, the majority of heart samples from EEHV-
positive animals tested positive for the presence of EEHV 
(3/4), compared to 3/5 of liver samples, 1/4 of kidney 
samples, and no lung samples were positive. 
 
Iconoclust software used for analysing the array chip after 
hybridisation normalises the signal, this is after an algorithm 
determines the intensity of the spot and the local background 
noise. Signals range from 0 to 1, with 0 being negative and 1 
being the highest possible signal. Normalisation is the local 
background noise subtracted from the average intensity of the 
spot.  
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For both heart and liver samples which tested positive, 
positive hybridisation signal intensity was defined as those at 
0.2 or above, between 0.15 and 0.2 were classed as weak 
positives or further investigation needed. Heart and liver 
tissue from UON_1329 tested positive for EEHV only. Biotin 
markers were located in the top right  
and bottom left corners of the array tube, these spots were 
used as positive controls. All spots that were presented with a 
signal are probes for EEHV1, no co-pathogens were present in 
any samples obtained from UON_1329 (Figure 43). 
 
Figure 43: Hybridisation signals on the AT from heart tissue from 
UON_1329. The image shows a number of hybridisation spots of varying 
strengths. Two biotin markers can be visualised in the top right hand and bottom 
left hand corner and are highlighted with red rings. Positive hybridisation signals for 
EEHV1 are highlighted by blue rings and those that were classed as weak positives 
are highlighted with yellow rings. 
 
In contrast, the liver from this animal presented with 4 
positive hybridisation signals and 3 weaker signals; no signals 
were present for co-pathogens (Table 34). Samples from both 
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the lung and kidney samples from UON_1329 were negative 
for all pathogens. The cut off point for positive signals was 
0.2, and those between 0.15 and 0.2 were classed as weak 
positives or requiring further investigation 
 
 
 
 
 
 
Table 34: Array signal results for UON_1329 showing the presence of 
EEHV1 DNA in both the heart and liver samples.  There were no positive or 
weak positive signals in the lung of kidney. 
UON_1329     
Probe Tissue 
  Heart Liver 
EEHV_UPS_2 0.21 0.22 
EEHV_UPS_3 0.17 0.18 
EEHV_UPS_5 0.19 0.19 
EEHV_UPS_8 0.15 0.21 
EEHV_UPS_9 0.17 0.29 
EEHV_UPS_13 0.24 0.28 
EEHV_UPS_15 0.18 0.19 
 
EEHV was also detected in the heart and liver obtained from 
UON_1189, 11 positive signals and 1 weaker signal for the 
heart and 10 positive signals and 3 weaker for the liver (Table 
35), cut off points were used as described previously. A 
greater number of probes hybridized in comparison to 
UON_1329. DNA/RNA extracted from a kidney sample, 
showed positive results for Hantavirus spp and a weaker 
                                                                                Chapter 7 
277 
 
positive result for cowpox virus; confirmatory PCR was 
performed as further investigation was needed to confirm the 
presence of these pathogens. Probes with no positive 
hybridisation signal are show as N/A in Table 35.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 35:  Array signal results for UON_1189 showing the presence of EEHV1 DNA in 
both the heart and liver samples, and Hantavirus spp and cowpox virus in the 
kidney.  
UON_1189       
Probe Tissue 
  Heart Liver Kidney 
EEHV_UPS_1 N/A 0.17 N/A 
EEHV_UPS_2 0.33 0.32 N/A 
EEHV_UPS_3 0.21 0.20 N/A 
EEHV_UPS_4 0.65 N/A N/A 
EEHV_UPS_5 0.33 0.31 N/A 
EEHV_UPS_6 0.24 0.25 N/A 
EEHV_UPS_7 0.17 0.19 N/A 
EEHV_UPS_8 0.42 0.43 N/A 
EEHV_UPS_9 0.44 0.50 N/A 
EEHV_UPS_10 0.27 0.24 N/A 
EEHV_UPS_11 N/A N/A N/A 
EEHV_UPS_12 N/A 0.17 N/A 
EEHV_UPS_13 0.44 0.44 N/A 
EEHV_UPS_14 0.23 0.20 N/A 
EEHV_UPS_15 0.34 0.37 N/A 
HANTA_L833 
N/A N/A 
0.20 
Cowpox virus 
N/A N/A 
0.17 
 
Heart and liver tissues from UON_1149 were positive for 
EEHV. The liver sample presented with the most hybridised 
probes with three positives. By contrast, for the heart sample 
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there was one positive signal and one weak positive. The 
kidney sample had only one weak positive hybridised probe, 
this was the only EEHV positive kidney sample during the 
study (Table 36), cut off point used as described previously. 
 
 
 
 
 
Table 36: Array signal results for UON_1149 showing the presence of EEHV1 DNA in 
the heart, liver and kidney.  
UON_1149      
Probe Tissue 
  Heart Liver Kidney 
EEHV1_UPS_13 0.25 0.32 0.19 
EEHV1_UPS_14 N/A 0.20 N/A 
EEHV1_UPS_15 0.17 0.24 N/A 
 
 
The array signal results were compared to qPCR data; this can 
be compared with the hybridisation signal from the array to 
determine if the results are semi-quantitative. Based on the 
amount of EEHV present in samples from UON_1189 (as 
determined by qPCR), the highest load was in the heart 
followed by liver, lung and the lowest in the kidney. On the 
array, the signal was the highest for the heart and liver, 
whereas there were no positive signals for the kidney and lung 
samples. EEHV was also detected by qPCR in the samples 
obtained from UON_1329, the highest amount of EEHV was 
present in the liver and the heart, and barely detectable 
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amounts were present in the kidney and lung samples. The 
array method similarly detected the highest EEHV load in the 
liver and heart, while no positive signals were obtained for the 
kidney and lung samples (Figure 44), this would suggest that 
the microarray results are semi-quantitative. 
 
Figure 44: A comparison of EEHV virus DNA load using qPCR and 
microarray. The amount of EEHV using the qPCR method was calculated by 
normalising against IFNγ, this is compared to the signal value obtained from the 
array method. Results from UON_1189 are in dark blue (qPCR) and light blue 
(array), and those from UON_1329 are in dark red (qPCR) and light red (array).  
Statistics was performed on the positive hybridisation signals 
from the heart and liver samples obtained from UON_1189 
using the Pearson product-moment correlation coefficient. This 
suggests that there is a strong positive correlation between 
the amount of EEHV present in samples using PCR and using 
the microarray (r=0.994) (Figure 45). The results also show a 
high significance (p=0.0006). 
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Figure 45: A correlation between qPCR normalised value and 
microarray hybridisation signal for UON_1189. The correlation 
between the two values indicates that a higher microarray signal correlated 
with a higher virus DNA load as measured by qPCR. The results show a 
positive correlation with a Pearson product-moment correlation coefficient 
of 0.994 and is statistically significant with a p value of 0.0006. The 
equation of the line is Y = 0.1565*X - 0.002169. 
 
Statistics performed on the hybridisation signal data (heart 
and liver) from UON_1329 using the Pearson product-moment 
correlation coefficient, suggests that there is a strong positive 
correlation between the values (r=0.9174) (Figure 46).  
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Figure 46: A correlation between qPCR normalised value and 
microarray hybridisation signal for UON_1329. The correlation 
between the two values suggests that a higher microarray signal correlated 
with a higher virus DNA load as measured by qPCR. The results show a 
positive correlation with a Pearson coefficient of 0.917, although it was not 
statistically significant, with a p value of 0.0826. The equation of the line is 
Y = 0.08755*X + 0.02710. 
 
Trunk washes obtained from herds in the UK and in 
Switzerland were also investigated. Trunk washes from four 
animals at a zoological collection in the UK were negative for 
all pathogens, whereas of the samples obtained from animals 
in Switzerland, 2/5 samples were positive for Mycobacterium 
spp, another was determined to be weak positive for 
Mycobacterium spp, and 2/5 were classed as negative for all 
pathogens tested (Table 37), cut off points as described 
previously.  
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Table 37: Array signal results for five animals from a Swiss collection showing the presence of Mycobacterium DNA in three samples.  
 UON_1140 UON_1625 UON_1089 UON_1093 UON_1175 
Probe      
Mycobacterium_02 
 
N/A 0.05 0.11 0.13 0.14 
Mycobacterium_03 
 
N/A 0.09 0.20 0.07 0.25 
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7.8.1      EMCV PCR 
Available tissue samples were further screened for the 
presence of EMCV by PCR using specific primers. Heart, liver, 
lung and kidney samples from UON_1189 and UON_1329, and 
heart, liver and kidney tissue from UON_1149, all tested 
negative for the presence of EMCV (Figure 47). 
 
 
The tissue samples used for EMCV detection by PCR were also 
screened to determine the presence of cDNA. This was 
performed to confirm samples were true negatives, and that 
EMCV was not present due to the lack of cDNA in the samples, 
or presence of PCR inhibitors. Heart, liver and kidney samples 
from UON_1189 contained cDNA; however, the lung sample 
did not. All samples obtained from UON_1329 contained cDNA 
(Figure 48). The positive control material was EMCV (Cell 
culture adapted) ATCC VR-129 (M-variant) isolated from virus 
grown in cell culture. 
Figure 47: Gel electrophoresis using a 3% agarose gel suggesting all samples were 
negative for the presence of EMCV using specific primers.  Lanes A-K are elephants tissue 
samples, A-D UON_1189 heart, liver, lung and kidney, E-H UON_1329 heart, liver lung and kidney, 
and I-K UON_1149 heart, liver and kidney. Lanes L and M are negative and positive control, L is the 
negative control and M is the positive control (EMCV cDNA) (84bp). 
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Figure 48: Gel electrophoresis using a 3% agarose gel showing all but one sample 
contained elephant cDNA.  Lanes A-D: UON_1189 heart, liver, lung and kidney, Lanes E-H: 
UON_1329 heart, liver lung and kidney, and Lanes I-K: UON_1149 heart, liver and kidney. 
Lane L was the negative control and Lane M was the positive control, with the expected bp 
size of 100bp. 
As the number of viral copies was unknown, PCR was 
performed on a serial dilution of the EMCV positive control 
material, the starting concentration of which was not 
available. EMCV cDNA could be detected at the lowest 
concentration tested (1 in 100,000) (Figure 49). 
 
 
Figure 49: Gel electrophoresis using a 3% agarose gel showing pure EMCV cDNA 
and a serial dilution. Lane A = pure EMCV cDNA derived from culture, Lane B = 1/10, Lane 
C = 1/100, Lane D = 1/1000, Lane E = 1/10000 and Lane F = negative control. 
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7.9      Discussion   
This study investigated the potential presence of co-pathogens 
in tissue samples from EEHV1 infected Asian elephants. It is 
currently unknown if co-pathogens play a role in the 
development of haemorrhagic disease, which is currently 
attributed to EEHV infection. There was evidence of co-
pathogens (Hantavirus and cowpox virus) present in the tissue 
sample from UON_1189, however, further testing showed this 
to be non-specific binding/cross hybridization. However, a 
number of trunk wash DNA samples tested positively for the 
presence of Mycobacteria spp, this was subsequently 
confirmed via PCR. 
 
The cut off values used for determining positive and negative 
samples on microarrays have not been standardised and can 
be variable. The microarray assay cut off values were set at a 
low level of >0.2 for positives, 0.15-0.19 were classed as 
‘further investigation by PCR needed’, and below 0.15 were 
classed as negative. A threshold value of 0.2 was selected as 
there was very little background noise, and signals were weak 
for positive control samples. A low signal in this case could be 
due to probes not performing effectively. By contrast, the use 
of a related version of this microarray for a study of rodent 
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pathogens, described by Giles et al. (2015), used a cut off 
threshold of >0.4. 
Results confirmed that EEHV was present in 7/18 of the 
clinical case samples from the five elephants studied.   
Four of these five animals were positive for EEHV; this had 
previously been determined by qPCR. Heart and liver samples 
appeared to give the strongest positive results, while one 
kidney sample gave a weak positive result for EEHV. The 
strength of the hybridisation signal reflected the quantitative 
results from the prior qPCR testing for both UON_1329 and 
UON_1189. However, while results from UON_1189 were 
clearly significant, those from UON_1329 were not, this may 
be due to the low number of data points obtained and 
analysed. Array results from heart and liver samples would 
suggest that the microarray method is potentially semi 
quantitative. However, EEHV was not detected by microarray 
in either the kidney or the lung samples, although it had been 
detected by qPCR in both samples at low levels. This suggests 
that the microarray is not sensitive enough to detect low 
levels of EEHV. This is the likely explain explanation as to why 
EEHV was not detected in trunk washes using the microarray, 
but has previously been detected using qPCR. Trunk washes 
are usually obtained from animals that are asymptomatic and 
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are sporadically shedding EEHV and are not showing clinical 
signs, lower levels of the virus are therefore expected.  
Cross hybridisation/non-specific binding was experienced 
during this study (as described above), it is a common 
problem when using microarrays, and is thought to be the 
main reason for diminished microarray result quality, once 
improved by either probe amendment or reviewing the 
hybridisation process, the validity of the results may increase 
(Koltai and Weingarten-Baror, 2008). However, there are a 
number of studies where cross hybridisation is the aim, Adjaye 
et al. (2004) successfully developed an array to detect both 
human and bovine orthologous genes. 
 
To confirm array findings that samples tested using the array 
were negative for EMCV, a PCR was performed to check for 
EMCV; results confirmed the negative finding. By contrast, a 
previous study investigating the presence of co-pathogens in 
tissue samples from EEHV positive elephants identified one 
animal which presented with a concurrent infection of both 
EEHV and EMCV (Richman et al., 1999). 
 
All trunk washes tested negative for EEHV on the microarrays; 
this was unexpected, as previous trunk wash samples for 8/9 
of these animals had tested positive for EEHV using qPCR. 
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However, Mycobacterium spp was detected in the trunk 
washes of 3 animals from Switzerland, further testing by PCR 
was not able to confirm the species present, however, it was 
confirmed not to be M.bovis, M.bovis BCG, M. paratuberculosis 
or M. microti. This would suggest a non-pathogenic species of 
Mycobacteria was present in the sample; this would likely be 
an environmental Mycobacteria species. Looking for 
Mycobacteria spp in elephant oro-nasal secretions can present 
additional challenges, depending on the findings, as the 
presence of M.bovis or M.tuberculosis would require 
immediate destruction of the samples, and notification of the 
relevant authorities. 
 
The array was not as sensitive as PCR or qPCR in the detection 
of low levels of EEHV, this was determined due to EEHV not 
being detected in trunk washes samples that had previously 
tested positive by qPCR. Previous studies have also reported 
poor microarray sensitivity, this may be due to poor 
hybridisation process or issues with reagents, such as Relógio 
et al. (2002) found higher concentrations (70-80%) of 
formamide resulted in very poor sensitivity. Probe design is 
also a key factor in regards to microarray sensitivity. Binder et 
al. (2004) reported that probes with an increased number of C 
nucleotides per oligomer showed an increased sensitivity, in 
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comparison to low sensitivity probes containing high numbers 
of G and T nucleotides, the study found probes with a high 
number of A nucleotides appear to be the least sensitive. 
 
Further redesigns could include using longer probe sequences, 
which would allow the detection of related species. It has been 
suggested than longer probes up to 65-70bp are more 
effective, this could be due to more base pairs are available 
for hybridisation, however, if the probes are not correctly 
designed longer probes may result in more cross-
hybridisation. Using longer probes would potentially produce a 
stronger signal (Shaw et al., 1987, Hukkanen et al., 1999). 
However, for this study shorter probe sequences (15-30bp) 
may be more useful, as this would allow for greater specificity 
and would allow strain identification (Wang et al., 2003). 
Despite this, the number of strains identified may be limited, 
this may not be beneficial for viruses like EMCV where there 
are a large number of strains, designing probes within short 
sequences and covering a large number of strains may be 
difficult.  Further adjustments to improve the microarray could 
also be made. This study uses sodium chloride and sodium 
citrate (SSC) and formamide and dithiothreitol (DTT) in the 
hybridisation buffer whereas the addition of other components 
may increase the efficiency of the microarray. The addition of 
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dextran sulfate to the hybridisation solution may increase the 
rate of hybridisation resulting in a stronger signal (Ku et al., 
2004). This study added Denhardt’s solution into the 
hybridisation buffer to reduce the chance of nonspecific 
binding. However, other components such as sonicated 
salmon sperm DNA and poly A can also be used (Russell et al., 
2008). Changes could also be made to the hybridisation 
temperature, using the correct temperature is important 
during this step, as a temperature that is too low will cause a 
decrease in specificity due to an increase in non-specific 
binding. In contrast if the temperature is too high sensitivity 
will decrease due to a reduction in the hybridisation of the 
specific target (Russell et al., 2008). 
 
This study also only used tissues from 5 dead animals and 9 
asymptomatic animals; to make this study more statistically 
robust, more samples from a larger number of animals would 
be required. The availability of tissues for this type of assay is 
also challenging; tissue from clinical cases is difficult to obtain 
as the necropsy of zoo elephants may not occur until several 
days after death. This makes collecting tissue samples for RNA 
extraction difficult, as tissue must be placed in RNA later as 
soon as possible after death as to prevent degradation. This 
likely delay in sample collection, and the resulting probable 
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degradation of RNA, may have contributed to lack of detection 
of any RNA pathogens by the microarrays. 
 
We found no evidence for a role for EMCV or other possible co-
pathogens in some clinical cases of EEHV. Our findings 
suggest it would be beneficial to investigate clinical cases of 
EEHV for multiple pathogens using a more sensitive assay, 
such as PCR or qPCR. Further studies are needed to confirm 
the quantitative relationship between microarray signals and 
qPCR values. Investigating pathogens present in rodent 
populations in captive elephant environments may also help to 
detect an outbreak of diseases such as anthrax, cowpox virus, 
leptospirosis, plague, toxoplasmosis, and EMCV (discussed in 
1.4.2) which have all been reported in elephants, and are 
thought to be transmitted by infected rodents to elephants. If 
an infectious pathogen is detected in the local rodent 
population and an outbreak is suspected steps can be taken to 
reduce the potential of transmission, this may include pest 
control. 
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8      General discussion 
The main objectives of this thesis included investigating a 
number of aspects of EEHV; 1. Is there a link between EEHV 
shedding and the physiological stress of pregnancy? 2. The 
role of host genetics and potential co-pathogens. 3. The 
culture of elephant umbilical endothelial cells as a potential 
tool for virus isolation 4. A comparison of the virus DNA loads 
in the tissues of two dead animals that died with clinical signs 
consistent with EEHV. This thesis has added further 
information to that currently available for EEHV 
 
In the study of EEHV there are lots of unknowns, including 
what stressors or triggers cause a reactivation of EEHV or 
increase EEHV shedding. Previous studies had suggested that 
the physiological stress of pregnancy may increase the 
amount or frequency the animal sheds EEHV in comparison to 
their non-pregnant counterparts (Stanton et al., 2010). This 
thesis has shown no evidence for increase in shedding 
associated with pregnancy; however, the main limitation of 
the current study is the limited number of animals available 
for inclusion. Further studies are warranted to confirm the 
findings, however, due to the small size of captive herds, the 
number of animals in each cohort is likely to be small, 
especially the number of pregnant animals. In order to gain 
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maximum value from each study and to identify potential 
stressors, thorough notes should be kept by keepers although 
this may not always be possible. 
 
It is currently not known if anti-viral drugs are effective in 
treating clinical EEHV. One way to determine this would be to 
grow EEHV in culture and treat the culture with different drugs 
to determine their efficacy. This is currently not possible as a 
cell culture system for the growth of EEHV has not been 
developed. As discussed in chapter 4, cell culture work 
successfully isolated cells. However, a subsequent revival of 
cells from storage was not successful. In the future further 
cells could be isolated using this method; however, it may not 
be easy to achieve due to the difficulties in obtaining fresh 
Asian elephant umbilical cords, contamination issues, and the 
limited number of animals in the UK. Also in protected contact 
environments the umbilical cord first must be retrieved by 
members of staff, this may not always be possible. Once a cell 
culture line has been established, the cells can be made 
immortal which allows for experimentation without starting 
from a primary cell line. Immortality can be established in a 
number of ways, including introducing telomerase and 
telomerase reverse transcriptase (TERT) into the cells, which 
increases stability making them immortal, over expressing 
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hTERT has also show to immortalise endothelial cell (Chang et 
al., 2005, Tsai et al., 2010). Cells can also be immortalised by 
the introduction of a viral vector such as SV40 or human 
papillomavirus (Jha et al., 1998, Hubbard and Ozer, 1999). 
The main advantage of cell immortality is that there is 
indefinite proliferation which allows for prolonged periods of 
study. However, the main disadvantage is that once cells 
become immortalised they may behave differently in 
comparison to their origin (Burdall et al., 2003).  
 
This thesis presents a genogram showing how Asian elephants 
in Europe and the USA are related, and highlights those whose 
deaths are thought to be associated with EEHV. The genogram 
highlights that there may be a potential genetic or familial 
component linking EEHV associated deaths. Whilst a genetic 
link is mechanistically possible as it has been reported that 
HHV6 integrates into the telomeres of chromosomes and can 
be inherited (Daibata et al., 1999), it would need further study 
to investigate this further in the case of EEHV. A Fluorescent 
In Situ Hybridization (FISH) metaphase chromosome spread 
could be used, this method was used by Tanaka‐Taya et al. 
(2004) to determine if HHV6 had been inherited in an 
integrated form. If future work confirms a link between 
genetics and EEHV this may create potential issues as it may 
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force certain animals to be removed from breeding 
programmes or to be re-located causing issues for many 
establishments. It would also be difficult to increase genetic 
diversity in captive environments as it would not be ethical to 
take new animals from the wild to increase the genetic pool. 
However, wild animals contributing to the captive genetic pool 
by the use of cryopreservation has been a long standing idea 
(Ballou, 1992). This type of genetic enrichment using frozen 
and thawed semen as a form of genetic enrichment has been 
performed successfully in the insemination of a captive African 
elephant in Austria (Hildebrandt et al., 2012). As artificial 
insemination has been successful in the production of Asian 
elephant calves, this method may also be successful in 
expanding the captive Asian elephant gene pool, however, 
further research is needed (Hildebrandt et al., 2012, Hermes 
et al., 2013). 
 
Further investigation is needed into the potential involvement 
of co-pathogens in EEHV associated deaths, this thesis found 
none of the pathogens selected were detected in EEHV 
positive tissue samples. This research has provided evidence 
to suggest microarrays may not be the most appropriate way 
of screening for multiple pathogens in the case of EEHV 
associated deaths.  Future work on co-pathogens is possible; 
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however, the relationship between co-pathogens and EEHV is 
still unclear. To establish whether a co-pathogen is involved in 
EEHV associated deaths would be difficult, as it would require 
a large number of samples from a large number of deaths 
associated with EEHV. This is a major limiting factor when 
studying EEHV as there is limited number and availability of 
samples; it is therefore difficult for studies to be statistically 
significant. When investigating multiple pathogens, it can 
difficult, due to a number of factors including the nature of 
some pathogens, such as if TB was found to be present this 
may cause implications for laboratory containment and for the 
establishment keeping the positive animal.  
 
However, there are other methods that could be used to look 
at multiple pathogens in EEHV related deaths such as next 
generation sequencing and multiplex PCR. Next generation 
sequencing has been used to screen samples to determine the 
multiple pathogens present, the identification of viral strains 
and the identification of unknown viruses (Hummelen et al., 
2010, Beerenwinkel and Zagordi, 2011, Yozwiak et al., 2012). 
This technique may be useful in the study of EEHV in the 
identification of potential co-pathogens; however, it would 
need further investigation to determine the relationship 
between co-pathogens.  
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EEHV appears to be a problem in both captive and wild 
populations, however, it is currently unknown if studying EEHV 
in captive elephants can be translated into wild populations. 
Deaths from EEHV may be seen more frequently in captive 
populations due to the elimination of other threats such as 
poaching and habitat loss. There are many arguments against 
keeping elephants in captive environments such as 
implications on their welfare, differences in social groupings, 
lack of space, early removal from mother and isolation (Clubb 
and Mason, 2002, Rees, 2009). Keeping elephants in zoos can 
be difficult, especially keeping bulls due to their aggression; as 
such this has resulted in a number of female only herds 
(Cooper et al., 1990, Frei, 2016). A zoo in the UK recently 
announced the relocation of their all-female Asian elephant 
herd due to the reproductive potential of two females; they 
report that breeding is better when a male is present in 
comparison to artificial insemination, and that the move will 
help with the long term survival of the species (Twycross Zoo, 
2017).  
 
The literature suggests that many zoos are involved in 
elephant conservation programmes in range countries; this 
would suggest that zoos are having a positive impact by 
providing funds for conservation. However, if the end result in 
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studying EEHV is to conserve wild elephants, funding may be 
better spent on issues having a greater impact on wild 
elephants such as human elephant conflict, poaching and 
habitat loss. 
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9      Future work 
Future work arising from this study may include a further 
longitudinal study, investigating other potential stressors and 
establishing their impact on the elephants’ susceptibility to 
EEHV. This would need the inclusion of appropriate 
glucocorticoid measurements to determine stress levels.  
However, careful interpretation would be needed as 
glucocorticoid measurements are often used an indicator of 
stress, but they can increase under a number of circumstances 
such as increased activity levels, arousal or excitement. Other 
potential stressors/stress relievers that could be investigated 
to determine their impact on the elephants’ susceptibility 
could include the transfer of animals to another collection, 
death of a herd mate, changes made to nutrition, enrichment 
provision, and the introduction of new animals, sickness due 
to other illnesses, public interaction and changes to 
enclosures.  
 
As we have successfully developed a method for culturing 
endothelial cells, this could lead to further attempts in 
establishing stocks of endothelial cells for use in attempts to 
create stocks of EEHV for infection, which could be used in 
drug efficacy and vaccine development studies. An EEHV 
infection could then be attempted, to determine if cell to cell 
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transmission occurs. A sample of infected tissue could be 
placed on to cultured cells, the supernatant could then be 
tested using PCR to determine if an infection was successful 
by measuring the amount of EEHV present. Establishing a cell 
culture system and the ability to grow EEHV in a laboratory 
environment would facilitate vaccine development and drug 
efficacy testing. Being able to establish stocks of the virus 
would allow for research without having samples from infected 
elephants. However, vaccine development is expensive, and it 
would be difficult to test in Asian elephants, due to the 
number of elephants that would be needed and also for ethical 
reasons. It may also be possible to establish an immortal cell 
line using hTERT vectors, this would allow cells to proliferate 
indefinitely and would avoid the issues encountered when 
using primary cell lines.   
 
To determine the type of tissue to be used in an infection, it is 
important to establish which tissues have the highest virus 
DNA loads. There are currently a limited number of 
publications investigating the tissue tropism of EEHV1 by 
determining virus DNA load. The study determined EEHV1 to 
have a broad tissue tropism, with higher virus DNA loads 
particularly in the heart and the liver. Only two animals were 
included in this study; determining the tissue tropism of 
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EEHV1 in other deaths may provide further information on 
which tissues present with the highest virus DNA loads. 
Understanding tissue tropism is important for a number of 
reasons, such as it can impact on treatment, it can be useful 
in determining a proxy animal model and useful in comparing 
different strains (Cullen, no date). As the preliminary study 
within this thesis suggests the possibility of a genetic or 
familial link in susceptibility to the virus, future work could 
build on this. This could include investigating whether EEHV 
integrates into the chromosomes of Asian elephants; a 
fluorescence in situ hybridisation (FISH) test could be used to 
detect EEHV DNA on chromosomes. If EEHV DNA was present 
on chromosomes it could indicate the possibility of EEHV 
transmission having a heritability factor. 
 
The genogram created within this study could be expanded or 
another genogram could be created which assesses all captive 
elated Asian elephants in western zoos. However, there may 
be limitations to this as the relatedness for each animal may 
be unknown or that only the mother is known.  
 
We determined there were no pathogens from the selected 
panel present in EEHV positive tissues from four deaths. This 
study could also be built upon. The microarray was able to 
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detect EEHV and was comparable to qPCR data, suggesting it 
was semi-quantitative. A microarray would need to be 
validated for use in EEHV diagnostics; it may be a useful tool if 
all strains of EEHV could be detected in a sample. It may also 
be useful in determining if other pathogens are also present. 
For a microarray to be successful in determining pathogens 
within elephant samples the method would also need to be 
validated. Future work could also include screening further 
samples, and including other pathogens on the chip. The 
microarray performed poorly in the study outlined in this 
thesis, it would need a significant amount of development to 
enable it to be useful in diagnostics and screening. A PCR 
based assay for multiple gene targets could be used as 
alternative, a number of publications have shown that 
multiplex PCR is successful in determining a number of 
different pathogens or strains (Stockton et al., 1998, Oliveira 
and de Lencastre, 2002, Waggoner et al., 2016, Pham et al., 
2017). 
 
There are a number of challenges when working with 
endangered species. For example, importing and exporting 
samples can be difficult to obtain if the animal is listed under 
CITES, due to the need for import and export permits which 
limits the samples that can be obtained especially if there is a 
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time factor. There are also difficulties in obtaining samples 
from animals particularly if they are considered dangerous, as 
it may be required for the keeper to physically enter the 
animals’ enclosure such as in the acquisition of a placenta. 
Working with endangered species may also mean certain 
experiments are limited to working with animal models such 
as drug trials and vaccine development, this is due to ethical 
issues and the number of animals available.  
 
When looking at the challenges involved in working with 
endangered species it highlights an important question of 
whether Asian elephants should be kept in captivity. There is 
little information to suggest that keeping and breeding Asian 
elephants in zoos is justified, a number of breeding 
programmes have been developed to try to enable captive 
populations to become self-sustainable.  However, there has 
been limited breeding success in zoo elephants leading to 
breeding programme failure (Taylor and Poole, 1998). It has 
been suggested that the breeding performance of captive 
Asian elephants located in logging camps is more comparable 
to wild elephants and better than those kept in zoos 
(Krishnamurthy and Wemmer, 1995, Taylor and Poole, 1998). 
There are also a number of welfare issues in relation to 
keeping elephants in captivity, such as poor healthy (obesity 
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and foot problems) and poor longevity. Keeping elephants in 
zoos may not currently contribute to wild Asian elephant 
conservation; to enable animals to be released into the wild 
zoos would need to be able to not only sustain the number of 
captive elephants but exceed them, a surplus would need to 
be achieved. To highlight the downward trend of elephant 
populations in captivity, using a population model to predict 
the population size of Asian elephants in North American zoos, 
Wiese (2000) suggested that the population will drop to 
around 10 individuals by 2050. Limited information is available 
for Asian elephant captive populations. In addition, there may 
be evidence to suggest that viruses such as EEHV and TB may 
have increased in captive populations due to the movement of 
animals between zoos, which would be counterproductive in 
the conservation effort (Richman et al., 1999, Mikota et al., 
2000). Although there has been a significant monetary input 
into EEHV research from both public and academic funds, this 
may not be justified from a conservation standpoint, as 
currently there is limited information about how EEHV impacts 
wild populations, and it is unknown if studying EEHV in captive 
populations is going to be of benefit to wild populations. There 
is currently no evidence to suggest that addressing EEHV in 
captive populations will contribute to creating a sustainable 
captive population or conserving wild Asian elephants. Given 
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the challenges in studying EEHV and the development of 
potential vaccines or drug treatments, a greater impact on the 
survival of Asian elephants funding might be better directed 
into reducing habitat loss. 
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11      Appendix 
 
11.1      Genogram 
A genogram was constructed for 621 Asian elephants located 
in North America and Europe. Please see the supplemental CD 
disc for the complete genogram. 
